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A B S T R A C T
Background
The global burden of poor maternal, neonatal, and child health (MNCH) accounts for more than a quarter of healthy years of life lost
worldwide. Targeted client communication (TCC) via mobile devices (MD) (TCCMD) may be a useful strategy to improve MNCH.
Objectives
To assess the eQects of TCC via MD on health behaviour, service use, health, and well-being for MNCH.
Search methods
In July/August 2017, we searched five databases including The Cochrane Central Register of Controlled Trials, MEDLINE and Embase. We
also searched two trial registries. A search update was carried out in July 2019 and potentially relevant studies are awaiting classification.
Selection criteria
We included randomised controlled trials that assessed TCC via MD to improve MNCH behaviour, service use, health, and well-being.
Eligible comparators were usual care/no intervention, non-digital TCC, and digital non-targeted client communication.
Data collection and analysis
We used standard methodological procedures recommended by Cochrane, although data extraction and risk of bias assessments were
carried out by one person only and cross-checked by a second.
Main results
We included 27 trials (17,463 participants). Trial populations were: pregnant and postpartum women (11 trials conducted in low-, middle-
or high-income countries (LMHIC); pregnant and postpartum women living with HIV (three trials carried out in one lower middle-income
country); and parents of children under the age of five years (13 trials conducted in LMHIC). Most interventions (18) were delivered via text
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messages alone, one was delivered through voice calls only, and the rest were delivered through combinations of diQerent communication
channels, such as multimedia messages and voice calls.
Pregnant and postpartum women
TCCMD versus standard care
For behaviours, TCCMD may increase exclusive breastfeeding in settings where rates of exclusive breastfeeding are less common (risk ratio
(RR) 1.30, 95% confidence intervals (CI) 1.06 to 1.59; low-certainty evidence), but have little or no eQect in settings where almost all women
breastfeed (low-certainty evidence). For use of health services, TCCMD may increase antenatal appointment attendance (odds ratio (OR)
1.54, 95% CI 0.80 to 2.96; low-certainty evidence); however, the CI encompasses both benefit and harm. The intervention may increase
skilled attendants at birth in settings where a lack of skilled attendants at birth is common (though this diQered by urban/rural residence),
but may make no diQerence in settings where almost all women already have a skilled attendant at birth (OR 1.00, 95% CI 0.34 to 2.94; low-
certainty evidence). There were uncertain eQects on maternal and neonatal mortality and morbidity because the certainty of the evidence
was assessed as very low.
TCCMD versus non-digital TCC (e.g. pamphlets)
TCCMD may have little or no eQect on exclusive breastfeeding (RR 0.92, 95% CI 0.79 to 1.07; low-certainty evidence). TCCMD may reduce
'any maternal health problem' (RR 0.19, 95% CI 0.04 to 0.79) and 'any newborn health problem' (RR 0.52, 95% CI 0.25 to 1.06) reported up
to 10 days postpartum (low-certainty evidence), though the CI for the latter includes benefit and harm. The eQect on health service use
is unknown due to a lack of studies.
TCCMD versus digital non-targeted communication
No studies reported behavioural, health, or well-being outcomes for this comparison. For use of health services, there are uncertain eQects
for the presence of a skilled attendant at birth due to very low-certainty evidence, and the intervention may make little or no diQerence
to attendance for antenatal influenza vaccination (RR 1.05, 95% CI 0.71 to 1.58), though the CI encompasses both benefit and harm (low-
certainty evidence).
Pregnant and postpartum women living with HIV
TCCMD versus standard care
For behaviours, TCCMD may make little or no diQerence to maternal and infant adherence to antiretroviral (ARV) therapy (low-certainty
evidence). For health service use, TCC mobile telephone reminders may increase use of antenatal care slightly (mean diQerence (MD) 1.5,
95% CI –0.36 to 3.36; low-certainty evidence). The eQect on the proportion of births occurring in a health facility is uncertain due to very
low-certainty evidence. For health and well-being outcomes, there was an uncertain intervention eQect on neonatal death or stillbirth, and
infant HIV due to very low-certainty evidence. No studies reported on maternal mortality or morbidity.
TCCMD versus non-digital TCC
The eQect is unknown due to lack of studies reporting this comparison.
TCCMD versus digital non-targeted communication
TCCMD may increase infant ARV/prevention of mother-to-child transmission treatment adherence (RR 1.26, 95% CI 1.07 to 1.48; low-
certainty evidence). The eQect on other outcomes is unknown due to lack of studies.
Parents of children aged less than five years
No studies reported on correct treatment, nutritional, or health outcomes.
TCCMD versus standard care
Based on 10 trials, TCCMD may modestly increase health service use (vaccinations and HIV care) (RR 1.21, 95% CI 1.08 to 1.34; low-certainty
evidence); however, the eQect estimates varied widely between studies.
TCCMD versus non-digital TCC
TCCMD may increase attendance for vaccinations (RR 1.13, 95% CI 1.00 to 1.28; low-certainty evidence), and may make little or no diQerence
to oral hygiene practices (low-certainty evidence).
TCCMD versus digital non-targeted communication
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TCCMD may reduce attendance for vaccinations, but the CI encompasses both benefit and harm (RR 0.63, 95% CI 0.33 to 1.20; low-certainty
evidence).
No trials in any population reported data on unintended consequences.
Authors' conclusions
The eQect of TCCMD for most outcomes is uncertain. There may be improvements for some outcomes using targeted communication
but these findings were of low certainty. High-quality, adequately powered trials and cost-eQectiveness analyses are required to reliably
ascertain the eQects and relative benefits of TCCMD. Future studies should measure potential unintended consequences, such as partner
violence or breaches of confidentiality.
P L A I N   L A N G U A G E   S U M M A R Y
Communicating to pregnant woman and parents through their mobile devices to improve maternal, neonatal, and child health
Aim of this review
We assessed the eQect of sending targeted messages by mobile devices to pregnant women and parents of young children about health
and healthcare services.
Key messages
There are gaps in the evidence regarding the eQects of targeted messages by mobile devices to pregnant women and parents of young
children about health and healthcare services. Some of these messages may improve some people's health and their use of health services,
but others may make little or no diQerence. The existing evidence is mostly of low or very low certainty.
What was studied in the review?
Targeted client communication (TCC) is an intervention in which the health system sends information to particular people, based on their
health status or other factors specific to that population group. Common types of TCC are text messages reminding people to attend
appointments or that oQer healthcare information and support. Our review assessed whether TCC can change pregnant women's and
parents' behaviour, health service use, health, and well-being.
What happens when pregnant women receive targeted messages by mobile device?
Compared to women who get no messages
Women may breastfeed more in settings where exclusive breastfeeding is not common. They may also go to more antenatal care
appointments. They may use skilled birth attendants more where this is less common. We do not know if the messages aQect women's or
babies' health because the certainty of the evidence is very low.
Compared to women who get messages sent in other ways
Women and newborns may have fewer health problems during the first 10 days aIer birth. The messages may make little or no diQerence
to the number of women who breastfeed. We do not know if they make women use more health services.
Compared to women who get untargeted messages
The messages may make little or no diQerence to whether women get influenza vaccines during pregnancy. We do not know if the messages
aQect women's or babies' health or lead women to use skilled birth attendants more because the evidence is lacking or of very low certainty.
What happens when pregnant women living with HIV receive targeted messages by mobile device?
Compared to women who get no messages
Women may go to slightly more antenatal care appointments. We do not know whether the messages lead more women to give birth in
a health facility or improve babies' health because the evidence is of very low certainty. The messages may make little or no diQerence
to whether pregnant women and babies follow antiretroviral (ARV) treatment (used to treat HIV) according to plan. We do not know if the
messages aQect women's health because the evidence is missing.
Compared to women who get messages sent in other ways
We do not know what the eQect of these messages is because we lack evidence.
Compared to women who get untargeted messages
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More parents may follow their babies' ARV treatment according to plan. We do not know if the messages improve women's or babies' health
or their use of services because the evidence is missing.
What happens when parents of young children receive targeted messages by mobile device?
Compared to parents who get no messages
More parents may take their children to healthcare services such as vaccination appointments. But we do not know if the messages improve
children's health or their health behaviour because the evidence is missing.
Compared to parents who get messages sent in other ways
Slightly more parents may take their children to vaccination appointments. The messages may make little or no diQerence to children's
toothbrushing habits. We do not know if the messages aQect children's health because the evidence is missing.
Compared to parents who get untargeted messages
Fewer parents may take their children to vaccination appointments, but this evidence is mixed. We do not know if the messages aQect
children's health due to lack of evidence.
How up-to-date is this review?
We searched for studies published up to August 2017. We carried out a search update in July 2019 and relevant studies are reported in the
'Characteristics of studies awaiting classification' section.
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)



































































































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Digital targeted client communication via mobile devices compared to standard care or no intervention (pregnant and
postpartum women) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to standard care or no intervention (pregnant and postpartum women) for improving mater-
nal, neonatal, and child health
Patient or population: pregnant and postpartum women
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices
Comparison: standard care or no intervention
Anticipated absolute effects* (95% CI)Outcomes
Risk with standard
care























4 RCTs reported on 5 morbidity outcomes and the CIs for most outcomes
encompassed both benefit and harm: severe obstetric complications
up to 6 weeks postpartum (RR 0.86, 95% CI 0.70 to 1.07); 'any maternal
health problem' up to 10 days postpartum (RR 0.50, 95% CI 0.90 to 2.76);
breast pain up to 3 months postpartum (RR 0.28, 95% CI 0.09 to 0.80);
breast engorgement up to 3 months postpartum (RR 0.58, 95% CI 0.31 to
1.10); number of acute maternal episodes requiring a clinic visit up to 3
months postpartum (MD 0.06, 95% CI –0.19 to 0.31). 1 study also reported







We are uncertain of the effect of the intervention
on maternal mortality and morbidity because the








The results of pooled analysis of 3 RCTs for neonatal morbidity and mor-
tality combined was consistent with no effect but CIs encompassed ben-
efit and harm (OR 1.00, 95% CI 0.61 to 1.64). 1 RCT reported that the inter-
vention reduced number of acute neonatal episodes requiring a clinic vis-






We are uncertain of the effect of the intervention
on neonatal mortality and morbidity because the






1000 per 1000 920 per 1000 (790 to
1000)




In settings where 100% of women report exclu-
sive breasting, the intervention may make lit-
tle or no difference to exclusive breastfeeding
(though an increase would not be possible). The































































































































































































667 per 1000 867 per 1000 (707 to
1000)
RR 1.30 (1.06 to 1.59) 135 (1
RCT)
The intervention may increase short-term exclu-
sive breastfeeding in settings where rates of ex-
clusive breastfeeding are lower.
Service utili-
sation – atten-













The intervention may increase attendance for an-
tenatal care appointments, but the CI includes
both an increase and a decrease.
Low-risk setting












Results were presented separately for urban and rural populations. The
study reported intervention benefit in urban populations (cluster-adjust-
ed OR 4.45, 95% CI 1.36 to 14.51), but not in rural populations (cluster ad-





The intervention may make little or no difference
to the proportion of births occurring with skilled
attendance in settings where skilled attendance
at is common.
In settings where skilled attendance at birth is
less common, the intervention may increase the
proportion of births occurring with skilled at-
tendance in urban areas. The intervention may
slightly reduce skilled attendance in rural set-




No studies reported this outcome. — (0 stud-
ies)
— The effect of the intervention on unintended con-
sequences is unknown as there was no direct evi-
dence identified.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; MD: mean difference; OR: odds ratio; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded one level for risk of bias: all studies had unclear sequence generation or allocation concealment, or both.




























































































































































































cDowngraded one level due to inconsistency: eQect estimates vary in terms of direction and magnitude of eQect.
dDowngraded one level for imprecision: few events.
 
 
Summary of findings 2.   Digital targeted client communication via mobile devices compared to non-digital targeted client communication (pregnant
and postpartum women) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to non-digital targeted client communication (pregnant and postpartum women) for improv-
ing maternal, neonatal, and child health
Patient or population: pregnant and postpartum women
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices
































Health status and well-being –
maternal mortality and morbid-
ity ('any maternal health prob-













The intervention may reduce the proportion of women reporting a
maternal health problem up to 10 days after birth.
Health status and well-being –
neonatal mortality and morbid-
ity ('any newborn health prob-













The intervention may reduce the proportion of women reporting a
newborn health problem up to 10 days after birth. But the CI includes
both an increase and a decrease in reporting.















The intervention may make little or no difference to the proportion
who breastfeed exclusively (though an increase would not be possible
due to 100% breastfeeding in the control arm). The CI encompasses
no beneficial effect and harm. It is possible the effect of the interven-



































































































































































































— The effect of the intervention on attendance for antenatal care is un-
known as there was no direct evidence identified.
Service utilisation: intrapartum





— The effect of the intervention on intrapartum care is unknown as there
was no direct evidence identified.




— The effect of the intervention on unintended consequences is un-
known as there was no direct evidence identified.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded one level for risk of bias: unclear risk of bias for allocation concealment and incomplete outcome data.
bDowngraded one level for imprecision: few events.
 
 
Summary of findings 3.   Digital targeted client communication via mobile devices compared to digital non-targeted client communication (pregnant
and postpartum women) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to digital non-targeted client communication (pregnant and postpartum women) for improv-
ing maternal, neonatal, and child health
Patient or population: pregnant and postpartum women
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices























































































































































































































Health status and well-being –
maternal mortality and morbidi-
ty




— The effect of the intervention on maternal morbidity and mortal-
ity is unknown as there was no direct evidence.
Health status and well-being –
neonatal mortality and morbidi-
ty




— The effect of the intervention on neonatal morbidity and mortali-
ty is unknown as there was no direct evidence.
Health behaviour change: breast-
feeding




— The effect of the intervention on breastfeeding is unknown as
there was no direct evidence.
Service utilisation – attendance
antenatal care appointments (at-













The intervention may make little or no difference to attendance
for antenatal influenza vaccination, but the CI includes both an
increase and a decrease in attendance.
Service utilisation: intrapartum














We are uncertain of the effect of the intervention on the propor-
tion of women having a skilled attendant at birth because the
certainty of the evidence was very low.




— The effect of the intervention on unintended consequences is un-
known as there was no direct evidence.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded one level for imprecision: 95% confidence intervals that encompass a potential harmful eQect and a potential beneficial eQect of the intervention.
bDowngraded one level for risk of bias: trial at unclear risk of bias for several domains.































































































































































































Summary of findings 4.   Digital targeted client communication via mobile devices compared to standard care or no intervention (pregnant and
postpartum women with HIV) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to standard care or no intervention (pregnant and postpartum women with HIV) for improving
maternal, neonatal, and child health
Patient or population: pregnant and postpartum women with HIV
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices
Comparison: standard care or no intervention























Health status and well-being:
maternal morbidity and mortali-
ty combined
No studies reported this outcome. — (0 stud-
ies)
— The effect of the intervention on maternal morbidity
and mortality is unknown as there was no direct evi-
dence.
Health status and well-being –
neonatal morbidity and mortali-
ty combined
Follow-up: up to 4 weeks









The intervention may make little or no difference to
neonatal mortality and morbidity. However, the CI in-
cludes both an increase and a decrease in neonatal
mortality and morbidity.
Service utilisation – antenatal
care: communications with HCWs












tions with HCW for
antenatal care was








The intervention may slightly increase attendance for
antenatal care appointments.
Service utilisation – intrapartum
care: birth in health facility
Follow-up: at delivery










We are uncertain of the effect of the intervention on the
proportion of women giving birth in a health facility be-
cause certainty of the evidence was very low.
Health status and well-being –
neonatal health: infant HIV test
positive










We are uncertain of the effect of the intervention on the
proportion of infants testing positive for HIV because





























































































































































































Follow-up: 8 weeks postpartum
Health behaviour change: adher-
ence to ARV therapy
Follow-up: up to 6–8 weeks post-
partum
1 study reported maternal antenatal ARV usage
(RR 1.04, 95% CI 0.91 to 1.19), maternal postna-
tal ARV usage (RR 0.87, 95% CI 0.61 to 1.24), and
infant ARV/PMTCT treatment adherence at 6–8





The intervention may make little or no difference to ma-
ternal and infant ARV treatment adherence. However,
the CI includes benefit and harm.
Unintended consequences No studies reported this outcome. — (0 stud-
ies)
— The effect of the intervention on unintended conse-
quences is unknown as there was no direct evidence.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
ARV: antiretroviral; CI: confidence interval; HCW: healthcare worker; MD: mean difference; PMTCT: prevention of mother-to-child transmission; RCT: randomised con-
trolled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded two levels for imprecision: few events and a 95% confidence intervals that encompass a potential large harmful eQect and a potential large beneficial eQect of
the intervention.
bDowngraded two levels for risk of bias: more women were newly diagnosed with HIV in the control arm (55% with intervention versus 66% with control; P = 0.015), randomisation
procedures and allocation concealment were not described, lack of blinding of participants, and only per-protocol analysis reported with unexplained dropouts (Kassaye 2016).
cDowngraded one level for imprecision: 95% confidence intervals that encompass a harmful eQect and a potential beneficial eQect of the intervention.
dDowngraded one level for risk of bias: for one trial randomisation procedures and allocation concealment were not described, lack of blinding of participants, and only per-
protocol analysis reported with unexplained dropouts.




Summary of findings 5.   Digital targeted client communication via mobile devices compared to non-digital targeted client communication (pregnant
and postpartum women with HIV) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to non-digital targeted client communication (pregnant and postpartum women with HIV) for
improving maternal, neonatal, and child health
Patient or population: pregnant and postpartum women with HIV
Setting: community and healthcare settings
























































































































































































































Health status and well-being:
maternal morbidity and mor-
tality combined




— The effect of the intervention on maternal morbidity and mor-
tality is unknown as there was no direct evidence.
Health status and well-being –
neonatal morbidity and mortal-
ity combined




— The effect of the intervention on neonatal morbidity mortality
is unknown as there was no direct evidence.
Service utilisation – antenatal
care




— The effect of the intervention on attendance for antenatal care
is unknown as there was no direct evidence.
Service utilisation – intra-
partum care




— The effect of the intervention on intrapartum care is unknown
as there was no direct evidence.
Health status and well-being –
neonatal health: infant HIV sta-
tus




— The effect of the intervention on the proportion of infants test-
ing positive for HIV is unknown as there was no direct evidence.
Health behaviour change: ad-
herence to ARV therapy




— The effect of the intervention on adherence to ARV therapy is
unknown as there was no direct evidence.




— The effect of the intervention on unintended consequences is
unknown as there was no direct evidence.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
ARV: antiretroviral;CI: confidence interval; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.





























































































































































































Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
 
 
Summary of findings 6.   Digital targeted client communication via mobile devices compared to digital non-targeted client communication (pregnant
and postpartum women with HIV) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to digital non-targeted client communication (pregnant women and postpartum with HIV) for
improving maternal, neonatal, and child health
Patient or population: pregnant and postpartum women with HIV
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices



























Health status and well-being
–maternal morbidity and mortal-
ity combined




— The effect of the intervention on maternal morbidity and
mortality is unknown as there was no direct evidence.
Health status and well-being –
neonatal morbidity and mortali-
ty combined




— The effect of the intervention on neonatal morbidity mortali-
ty is unknown as there was no direct evidence.
Service utilisation – antenatal
care




— The effect of the intervention on attendance for antenatal
care is unknown as there was no direct evidence.
Service utilisation – intrapartum
care




— The effect of the intervention on intrapartum care is un-
known as there was no direct evidence.
Health status and well-being –
neonatal health: infant HIV sta-
tus




— The effect of the intervention on the proportion of infants






























































































































































































Health behaviour change: adher-
ence to ARV therapy
Follow-up: 6 weeks postpartum









The intervention may increase infant ARV adherence.




— The effect of the intervention on unintended consequences is
unknown as there was no direct evidence.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
ARV: antiretroviral; CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded twice for risk of bias: trial at high or unclear risk of bias across all applicable domains.
 
 
Summary of findings 7.   Digital targeted client communication via mobile devices compared to standard care or no intervention (parents of children
aged under five years) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to standard care or no intervention (parents of children aged < 5 years) for improving mater-
nal, neonatal, and child health
Patient or population: parents of children aged < 5 years
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices
























































































































































































































Health status and well-being –
child morbidity and mortality com-
bined




— The effect of the intervention on child morbidity and mortality is
unknown as there was no direct evidence.
Health status and well-being –
child nutritional status




— The effect of the intervention on child nutritional status is un-
known as there was no direct evidence.
Health behaviour change – breast-
feeding




— The effect of the intervention on breastfeeding is unknown as
there was no direct evidence.
Service utilisation – attendance
for necessary healthcare (atten-
dance for vaccinations at 6–12
months, attendance at HIV medical
appointments)












The intervention may increase attendance for necessary health-
care. However, the result varied considerably according to
whether the healthcare attendance was for vaccinations at 6
months, vaccinations at 12 months, or an HIV medical appoint-
ment, and between studies within each of these outcome cate-
gories.
Health behaviour change – hygiene
practices




— The effect of the intervention on hygiene practices is unknown as
there was no direct evidence.
Health behaviour change – correct
treatment taken




— The effect of the intervention on taking correct treatment is un-
known as there was no direct evidence.




— The effect of the intervention on unintended consequences is un-
known as there was no direct evidence.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded one level for risk of bias: most studies at unclear risk of bias for allocation concealment.































































































































































































Summary of findings 8.   Digital targeted client communication via mobile devices compared to non-digital targeted client communication (parents of
children aged under five years) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to non-digital targeted client communication (parents of children aged < 5 years) for improv-
ing maternal, neonatal, and child health
Patient or population: parents of children aged < 5 years
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices



























Health status and well-being – child
morbidity and mortality combined




— The effect of the intervention on child morbidity and mor-
tality is unknown as there was no direct evidence.
Health status and well-being – child
nutritional status




— The effect of the intervention on child nutritional status is
unknown as there was no direct evidence.
Health behaviour change – breast-
feeding




— The effect of the intervention on breastfeeding is unknown
as there was no direct evidence.
Service utilisation – attendance for
necessary healthcare (attendance
for vaccinations at 14 weeks)









The intervention may slightly increase attendance for vac-
cinations. However, the CI includes both no increase and a
large increase in attendance.
Health behaviour change – hygiene
practices (oral health in children
at 4 weeks, Visible Plaque Index,














The intervention may make little or no difference to oral hy-
giene practices. However, the CI includes both benefit and
harm.
Health behaviour change – correct
treatment taken




— The effect of the intervention on taking correct treatment is
unknown as there was no direct evidence.




— The effect of the intervention on unintended consequences





























































































































































































*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded two levels for risk of bias: study at unclear or high risk of bias across all but one domain.
bDowngraded one level for imprecision: confidence interval encompasses both benefit and harm.
cDowngraded one level for risk of bias: study at unclear risk of bias for sequence generation and allocation concealment.
 
 
Summary of findings 9.   Digital targeted client communication via mobile devices compared to digital non-targeted client communication (parents of
children aged under five years) for improving maternal, neonatal, and child health
Digital targeted client communication via mobile devices compared to digital non-targeted client communication (parents of children aged < 5 years) for improv-
ing maternal, neonatal, and child health
Patient or population: parents of children aged < 5 years
Setting: community and healthcare settings
Intervention: digital targeted client communication via mobile devices



























Health status and well-being –
child morbidity and mortality
combined




— The effect of the intervention on child morbidity and mortali-
ty is unknown as there was no direct evidence.
Health status and well-being –
child nutritional status




— The effect of the intervention on child nutritional status is un-

































































































































































































— The effect of the intervention on breastfeeding is unknown as
there was no direct evidence.
Service utilisation – attendance
for necessary healthcare – at-
tendance for vaccinations at 6
months
Follow-up: 6 months









The intervention may reduce attendance for vaccinations,
but the CI includes both an increase and a decrease in atten-
dance.
Health behaviour change – hy-
giene practices




— The effect of the intervention on hygiene practices is un-
known as there was no direct evidence.
Health behaviour change – cor-
rect treatment taken




— The effect of the intervention on taking correct treatment is
unknown as there was no direct evidence.




— The effect of the intervention on unintended consequences is
unknown as there was no direct evidence.
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
aDowngraded one level for risk of bias: unclear risk of bias for allocation concealment, high risk of bias for incomplete outcome reporting and other bias.
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B A C K G R O U N D
Description of the condition
The enormous burden of disease due to poor sexual, reproductive,
maternal, newborn, child, and adolescent health (SRMNCAH)
renders them urgent global health priorities. In 2016, poor
maternal and neonatal health, and communicable and nutritional
diseases, which particularly adversely aQect children, accounted
for more than a quarter of healthy years of life lost worldwide
(Hay 2016). Neonatal preterm birth complications, HIV/AIDS,
neonatal encephalopathy due to birth asphyxia and trauma, lower
respiratory infections, and diarrhoeal diseases were among the
10 leading causes of total years of life lost, with the burden
heavily concentrated in children under five years of age (Naghavi
2017). Those living in low- and middle-income countries are
disproportionately aQected by poor SRMNCAH (Black 2016).
In 2015, an estimated 303,000 women died during and following
pregnancy and childbirth, and maternal mortality remains a
leading cause of death for adolescent women. The vast majority
of these deaths occurred in low-resource settings, and most
could have been prevented (Alkema 2016). Almost three-quarters
of maternal deaths are due to direct obstetric causes, such as
haemorrhage, hypertensive disorders, sepsis, abortion, embolism,
and complications of labour (Say 2014). The majority of indirect
causes of maternal deaths are due to the exacerbation of pre-
existing conditions; with HIV accounting for an estimated 5.5% of
global maternal deaths (Say 2014). Intrinsically linked to maternal
health, 1.7 million stillbirths occurred in 2016 worldwide, with key
causes including pregnancy and childbirth complications, lifestyle
factors, diabetes and hypertension, maternal infections, preterm
birth, and birth defects (Naghavi 2017; WHO 2017). Furthermore,
five million children under the age of five years died in 2016,
with almost half of these deaths occurring among newborns. The
three leading global causes of death in children aged under five
years were lower respiratory infections, neonatal preterm birth
complications, and neonatal encephalopathy due to birth asphyxia
and trauma (Naghavi 2017). Of those who survive, one-third of
children fail to reach their full physical, cognitive, psychological,
or socioemotional potential (or a combination of these) as a
result of poverty, poor health and nutrition, insuQicient care and
stimulation, and other risk factors of importance to early childhood
development (Every Women Every Child 2015).
Indicative of the continued global commitment to the survival and
well-being of women and children, the UN Secretary General's
Global Strategy for Women's and Children's Health was launched
in 2010. In 2015, this was recast as the Global Strategy for
Women's, Children's and Adolescents' Health aligning its priorities
with the ambitious targets relating to the improvement of sexual,
reproductive, maternal, newborn, and child health which feature
in the Sustainable Development Goals (UN 2015). In 2011, the
World Health Organization (WHO) published its global review
of RMNCAH interventions, Essential Interventions, Commodities
and Guidelines for Reproductive, Maternal, New-born and Child
Health, with the aim of developing consensus on the content of
packages of interventions to address the main causes of maternal,
newborn, and child deaths (PMNCH 2011). The health issues
targeted by the recommended interventions span adolescence and
prepregnancy health (e.g. prevention and management of sexually
transmitted infections (STIs) including HIV, family planning, and
preconception care); pregnancy (e.g. provision of safe abortion
and postabortion care; appropriate antenatal care (ANC) including
screening for maternal illness, preventive dietary supplements,
and immunisations; prevention of pre-eclampsia); childbirth (e.g.
medical interventions such caesarean section where indicated);
maternal postnatal care (e.g. detection and management of sepsis;
family planning); newborn postnatal care (e.g. early initiation of
exclusive breastfeeding; kangaroo care (prolonged skin-to-skin
contact between baby and carer); detection and management of
infections); and infancy and childhood (e.g. adequate nutrition;
prevention and management of illness). However, despite some
progress, the burden of poor sexual, reproductive, maternal,
newborn, and child health remains substantial. New interventions
are urgently needed to support further improvement in SRMNCAH,
especially in low- and middle-income countries.
Description of the intervention
Targeted client communication (TCC), also referred to as health
promotion messaging or behaviour change communication, is the
transmission of targeted health content to a specified population
or people within a predefined health or demographic group (WHO
2018). TCC can fall along a continuum of tailored communication,
such as individualised or personalised notifications, as well
as untailored content which draws on predetermined content
developed for the identified population group (Hawkins 2008).
In order to define the populations for the TCC, eligible people
need to be identified and subscribed into a system that allows
the transmission of the health content information. Additionally,
the health system initiates the first transmission of information,
rather than a client seeking information, as in telemedicine and on-
demand information services. Following this initial communication
from the health system to the client, clients may subsequently
respond or continue engagement with the health system, also
referred to as bidirectional communication. In contrast, non-
targeted client communication (non-TCC) is the transmission of
health promotion content delivered to the general population or an
undefined population.
TCC has the potential to improve RMNCAH through targeting
knowledge, motivation, and behaviour change in order to increase
client demand and utilisation of the essential interventions
detailed in the WHO Guidelines for Reproductive, Maternal, New-
born and Child Health described above (PMNCH 2011). For
example, for the successful promotion of breastfeeding, TCC may
enhance the provision of health system services through the
provision of education relating to breastfeeding, providing links to
local services, and providing social support.
Mobile devices may be a particularly eQective way of delivering
TCC. Mobile phone ownership is almost universal in high-income
countries and estimated to have reached over 90% in low- and
middle-income countries (ICT 2016). Phones are generally carried
wherever people go and can be accessed 24 hours a day. Given
their broad reach, mobile devices may provide a cost-eQective
mechanism for engaging with target populations and delivering
health information relating to SRMNCAH.
How the intervention might work
TCC via mobile devices can be used to target the individual-
level knowledge, attitudes, and behaviours of importance for the
prevention and management of health issues, including those
relating to the WHO essential interventions for reproductive,
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maternal, new-born, and child health (PMNCH 2011). For example,
mobile device-based interventions can (Kaufman 2017):
• provide information and education relevant to the health
issue being targeted (e.g. information relating to breastfeeding,
adequate child nutrition, vaccinations, and the recognition of
symptoms of severe childhood infections);
• facilitate timely access to health advice and services when
required (e.g. by providing details of local healthcare services);
• provide reminders (e.g. for HIV medication adherence; for
antenatal appointment attendance; for childhood vaccination
appointment attendance);
• provide social and psychological support for the behaviour
change targeted (e.g. through the provision of encouragement
and positive reinforcement; and specifically targeting of
psychological factors such as lack of motivation and low self-
eQicacy).
Why it is important to do this review
Mobile device-based interventions are of particular interest given
their low-cost and potential for widespread delivery, however, the
current evidence base supporting their implementation for the
improvement of maternal, newborn, and child health is limited.
The most recent reviews concerned with the eQectiveness of mobile
device-based interventions for maternal, newborn, or child health
have been limited to studies conducted in low/middle-income
countries and have included non-randomised controlled trials,
which are prone to bias (Lee 2016). Broader reviews of randomised
controlled trials (RCTs) of digital health interventions for healthcare
consumers (e.g. Free 2013a) are in need of updating to consider
the more recent emerging evidence in this field. Other reviews
of relevance, concerned with preventive healthcare, reminders
for appointment attendance, and self-management of long-term
illnesses have focused specifically on SMS (short message service)
and MMS (multimedia message service) mobile phone messaging
(de Jongh 2012; Gurol-Urganci 2013; Vodopivec-Jamsek 2012),
thereby excluding other phone-based delivery mechanisms, such
as voice calls, Interactive Voice Response (IVR), and mobile
application delivered instant messages.
This review is one of two linked systematic reviews which
were carried out to directly inform WHO guidelines on digital
interventions for health system strengthening (WHO 2019). This
review focuses on the eQectiveness of TCC via mobile devices
for maternal, newborn, and child health, and the other review
examines the eQectiveness of TCC via mobile devices for sexual
and reproductive health (Palmer in preparation). Although the
potential for mobile and digital technologies is acknowledged,
there remains considerable demand from ministries of health,
donors, and decision-makers for evidence-based guidance on the
value of digital tools for improving health. In response to this global
need for government decision-makers, the WHO has developed a
guideline on digital interventions for health system strengthening
to inform government-led investments. In combination, the current
review, and the linked review focusing on sexual and reproductive
health (Palmer in preparation) complement a qualitative evidence
synthesis on the use of TCC for RMNCAH (Ames 2019); combined,
these reviews aim to provide a comprehensive overview of
the impact, acceptability, and implementation considerations for
formulating guideline recommendations.
O B J E C T I V E S
The overall aim of this review was to assess the eQects of TCC
via mobile devices on health behaviour, service use, and health
and well-being for maternal, new-born and child health. This
review focuses on RMNCH priorities in LMIC relating to the WHO
essential interventions for reproductive, maternal, new-born and
child health (PMNCH 2011).
Our specific objectives relate to three distinct populations and
outcomes relevant to these populations. For each population group
outlined below, we sought to determine whether targeted client
communication via mobile devices can address challenges related
to health and well-being, health behaviour, and service utilization.
Interventions and comparisons are the same throughout.
• To assess the eQects of TCC via mobile devices on behavioural,
health/well-being, and service utilisation outcomes relevant
to maternal and new-born health among pregnant and
postpartum women (up to 6 weeks) and their partners or others
who support them.
• To assess the eQects of TCC via mobile devices on behavioural,
health/well-being, and service utilisation outcomes relevant
to maternal and new-born health among pregnant and
postpartum women (up to 6 weeks) living with HIV and their
partners or others who support them.
• To assess the eQects of TCC via mobile devices, delivered
to parent and caregivers (i.e. legal guardians, not healthcare
professionals) of children under the age of 5 years,
on behavioural, health/well-being, and service utilisation
outcomes relevant to child health
Secondary objectives
Had there been suQicient studies we planned to assess whether
the eQects of targeted client communication accessible via mobile
devices diQer according to:
• Purpose of the intervention (e.g. to remind/recall versus to
inform/educate or to support);
• Income region (by World Bank income group) (World Bank 2017);
• Delivery mechanism (e.g. voice, SMS, interactive voice
response).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs). We included
full-text studies, conference abstracts, and unpublished data
irrespective of their publication status and language of publication.
We excluded small-scale studies which had randomised fewer than
20 participants.
Types of participants
We included trials with the following participants:
• pregnant and postpartum women up to six weeks aIer birth,
and their partners or others who supported them (where
pregnancy status had not been disaggregated, studies in which
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at least 70% of women were pregnant or up to six weeks
postpartum);
• pregnant and postpartum women up to six weeks aIer birth
living with HIV, and their partners or others who supported them
(where HIV status had not been disaggregated, studies in which
at least 70% of pregnant and postpartum women were living
with HIV);
• parents and carers of children aged under five years (where age
had not been disaggregated, studies in which at least 70% of
children were under five years of age).
Types of interventions
We included trials that assessed TCC delivered via mobile devices,
where the content of the communication was intended to improve
maternal, new-born, or child health, or a combination of these.
Targeted client communication
By TCC, we mean the transmission of targeted health content to
a specified population or people within a predefined health or
demographic group. Unless otherwise stated, we use the terms
'clients', 'patients', and 'consumers' to refer to the individuals
whose behaviour, health service use, or health and well-being were
being targeted.
We included all of the following:
• studies in which the healthcare consumers were the recipients
of the transmitted information;
• studies in which health content was transmitted from the
health system to the client, also referred to as unidirectional
communication;
• studies in which health content was transmitted from the client
to the health system or a health worker, provided that the first
communication was initiated by the health system to the client's
mobile device. This can occur as bidirectional communication in
which clients may respond or exchange with the health system
following an initial communication from the health system to
the client.
We excluded:
• studies in which the communication between the client and
health system was first initiated by the client. Studies in which
clients initiated contact with providers were included in a
separate review on client-to-provider telemedicine (Gonçalves-
Bradley 2018);
• studies in which health content was transmitted to the general
population or an undefined population group;
• studies in which the client used fully automated services,
including websites, to self-care or access clinical information;
• studies in which TCC was combined with a health worker tool for
tracking client's health status, as this combination was included
in a separate review (Agarwal 2018).
Mobile device/multimedia delivery of targeted health
communication
By mobile devices, we mean mobile phones of any type (but not
analogue landline telephones), as well as tablets and personal
digital assistants, which facilitate communication via diQerent
multimedia channels including SMS, voice calls, IVR, MMS, and
smartphone applications (apps) when used for instant messaging
purposes.
We included studies that used the following communication
channels:
• mobile text messaging (including SMS, and unstructured
supplementary service data (USSD));
• MMS, including video and audiovisual messages;
• IVR;
• voice calls and call-backs;
• WhatsApp and other instant messaging services (such as
Facebook messenger);
• apps, only when they provided an instant messaging function to
provide TCC.
We excluded studies that use the following communication
channels:
• web portals, applications, and websites that did not have a
targeted communication component to notify clients (i.e. which
did not provide an instant messaging function, and thereby
provided passive information which relied on clients to actively
access);
• emails alone;
• social media websites such as Facebook, Baidu, Twitter (unless
there was explicit mention of the provision of instant messaging
services to individuals to provide target client communication).
Mixed modes of delivery
We included studies in which the intervention delivered to mobile
devices was the primary intervention component under evaluation.
When considering interventions delivered by multiple modes, we
included interventions involving additional components which
could have conceivably been delivered by a mobile device (e.g. an
intervention delivered by SMS in combination with email, websites,
social media) as all of these delivery mechanisms would allow the
entire intervention to be received via a mobile device. Interventions
including additional components that could not conceivably be
delivered by a mobile device were excluded (e.g. an intervention
delivered by SMS in combination with face-to-face counselling).
Content and purpose of the targeted client communication
We included TCC dealing with the health issues listed below. We
derived the list of health issues from two key resources by the WHO
on Essential Interventions for RMNCH:
• Partnership for Maternal, Newborn & Child Health. 2011. A
Global Review of the Key Interventions Related to Reproductive,
Maternal, Newborn and Child Health (RMNCH) (PMNCH 2011);
and
• WHO, Packages of Interventions for Family Planning, Safe
Abortion care, Maternal, Newborn and Child Health (WHO 2010).




• skilled attendant at birth;
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
• emergency obstetric care;
• postpartum care;
• kangaroo mother care;
• tetanus immunisation;
• anaemia prevention and control;
• STI testing and treatment in pregnancy;
• sexual violence;
• malaria prevention and treatment;
• smoking cessation during pregnancy;
• antiretroviral (ARV) adherence (for pregnant and postpartum
women living with HIV);
• early infant diagnosis (for pregnant and postpartum women
living with HIV);
• retention of mother and infant pairs in elimination of mother-to-
child transmission (eMTCT) care (for pregnant and postpartum
women living with HIV).





• integrated management of newborn and childhood illnesses
(IMNCI);
• water, sanitation, and hygiene (WASH);
• Management of diarrhoeal illnesses, oral rehydration salts
(ORS), zinc;
• growth monitoring and nutrition;
• early infant diagnosis in HIV-exposed children; ARV therapy for
HIV-exposed and HIV-infected children;
• early childhood development.
Interventions could serve at least one of the following purposes
(Kaufman 2017):
• to inform and educate identified clients;
• to remind and recall identified clients;
• to teach skills to identified clients;
• to provide support (i.e. for the behaviour change targeted,
disease prevention, or health improvement);
• facilitate decision-making;
• enable communication.
We have only included health issues that could potentially be
addressed through targeted communication to the client, as
opposed to those that relate to the provision of clinical care
which would be targeted through communication to the healthcare
provider. Further details of outcomes that were included can be
found below.
Types of comparisons
We included trials with the following comparisons:
• targeted communication delivered to the client via mobile
device compared with standard care or no intervention;
• targeted communication accessible to the client via mobile
device compared with targeted, non-digital communication
(e.g. letters, face-to-face communication with clients);
• targeted communication accessible to the client via mobile
devices compared with non-targeted, digital communication via
mobile devices (e.g. digital communications which did not target
issues relating to maternal, newborn or child health)
We excluded comparisons of:
• one type of targeted communication accessible to the client
via mobile devices compared with another type of targeted
communication accessible via mobile devices held by the client
(e.g. mobile messaging compared with mobile voice);
• studies that compare diQerent technical specifications of
telecommunication technologies (e.g. diQerent communication
channels, soIware, etc.);
• studies comparing TCC via mobile device in addition to another
intervention that could not conceivably be delivered by mobile
device (e.g. face-to-face counselling), compared with TCC via
mobile device alone;
• studies comparing TCC via mobile device in addition to another
intervention that could not conceivably be delivered by mobile
device (e.g. face-to-face counselling), compared with standard
care/no intervention.
Types of outcome measures
The outcome measures extracted were according to the population
targeted. Below we present the outcomes relevant for pregnant
and postpartum women (up to six weeks) living without HIV and
living with HIV and the outcomes extracted for children under the
age of five years. We extracted both objectively measured and self-
reported outcomes for all lengths of follow-up reported.
Where a study reported the same outcome measure for multiple
time points, we extracted data for the outcome at the longest
follow-up time point. Where we identified studies that reported
multiple outcome measures falling under the same outcome
category, we extracted all outcome measures. For example, under
the outcome category of 'partner violence', we would have
extracted measures of sexual, physical, and emotional violence, to
ensure that we were able to reflect diQerent aspects within a single
outcome category.
Where we identified studies that reported multiple outcome
measures of the same outcome, we applied a set of rules
to decide which outcome measure(s) to report in our review
in order to avoid over-representing single trials that reported
on multiple measures relating to a single outcome. Where a
study reported both dichotomous and continuous measures
relating to a single outcome, we applied the following rules to
identify one dichotomous outcome measure and one continuous
outcome measure to present. The rationale for presenting both a
dichotomous and a continuous outcome measure, where available,
was because trials may have been underpowered to detect a
diQerence in a clinically important dichotomous outcome (e.g.
proportion adherent to medication), but may have power to detect
a mean diQerence (MD) in the equivalent continuous outcome (e.g.
MD in number of days covered by medication).
Where objective measurement was possible, we prioritised
reporting an objectively measured outcome over a self-reported
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outcome measure. For example, had a study included the outcome
of STI status, and recorded both biochemically confirmed STI
status and self-reported STI status, we would have reported the
biochemically confirmed STI status outcome. For outcomes that
had not been directly objectively measured, likely for some health
behaviour outcomes, we listed the outcomes of the trial (without
considering either eQect size or its statistical significance) and two
review authors made a decision about which was most 'clinically'
important or which was the most appropriate measure of the
outcome under focus (or both). For example, in terms in clinical
importance, if a study reported the outcome measure of attendance
to at least one antenatal appointment and the outcome measure
of attendance to all antenatal appointments, we presented the
outcome relating to attendance to all antenatal appointments as
this likely to have greater clinical impact.
Primary outcomes
Pregnant and postpartum women (living without HIV and living with
HIV)
The following outcomes were identified based on the list of
health issues that could be targeted by included interventions. As
described above, these are based on two key resources by the WHO
on Essential Interventions for RMNCH:
• the Partnership for Maternal, Newborn & Child Health. 2011. A
Global Review of the Key Interventions Related to Reproductive,
Maternal, Newborn and Child Health (RMNCH) (PMNCH 2011);
and
• WHO, Packages of Interventions for Family Planning, Safe
Abortion care, Maternal, Newborn and Child Health (WHO 2010).
Health behaviour change
• Smoking cessation; b. alcohol consumption; c. adherence to
preventive regimens for pre-eclampsia (calcium, magnesium,
low-dose aspirin); d. adherence to antenatal regimens (e.g.
folic acid); e. adherence to preventive/treatment regimens for
anaemia (ante- and postnatal iron supplements); f. adherence
to malaria prevention strategies (insecticide-treated nets (ITNs),
intermittent-preventive treatment (IPTp) with sulphadoxine-
pyrimethamine (SP)); g. adherence to treatment for treatable
infections (e.g. chlamydia, syphilis, mastitis); h. adherence
to management strategies for pre-existing conditions, e.g.
diabetes; i. adherence treatment for mental health conditions;
j. initiation of kangaroo care; k. initiation of breastfeeding; l.
postpartum contraceptive uptake; m. adherence to deworming
regimen; n. other lifestyle changes, e.g. exercise, health diet; o.
adherence to ARVs (tablet count, prescription data).
Service utilisation
• ANC: a. attendance for ANC appointment (e.g. more
than one appointment with skilled personnel, more than
four appointments with skilled personnel, attendance for
vaccinations, attendance for screening, e.g. HIV, syphilis,
anaemia, hypertensive disorders, attendance for malaria
prevention services e.g. ITNs, IPTp with SP); b. attendance for
high-risk pregnancies (preterm, multiple pregnancies, previous
maternal haemorrhage); c. attendance to eMTCT care.
• Intrapartum care: a. place of birth (home, hospital); b. skilled
attendant at birth.
• Postnatal care: a. attendance for postpartum care
appointment; b. attendance for information and counselling
on nutrition, safe sex, family planning and provision of
contraceptive methods; c. attendance to eMTCT care.
• Postnatal care (newborn): a. attendance for postpartum care
appointment.
Health status and well-being
• Maternal morbidity/mortality (physical): a. STI (any) status;
b. HIV status/HIV management (CD4 count, viral load); c.
tetanus; d. syphilis; e. anaemia (e.g. haemoglobin, haematocrit,
ferritin); d. malaria; e. pre-eclampsia (blood pressure); f.
birth-related complications (e.g. severe bleeding, receipt of
blood transfusion, postdelivery haemoglobin, infection); g.
postabortion complications (e.g. incomplete abortion, severe
bleeding, infection); h. mastitis; i. maternal mortality (objective
and self-reported measures).
• Maternal morbidity (mental): a. depression (validated
measure); b. anxiety (validated measure); c. puerperal
psychosis.
• Neonatal Health: a. gestational age at birth; b. birth weight; c.
Apgar score; d. perinatal death; e. neonatal death; d. HIV status.
• Partner violence: a. sexual violence; b. physical violence; c.
emotional violence (objective, e.g. hospital admissions and self-
report measures).
• Well-being: a. validated measures of health-related quality of
life.
Parents and other carers of children under five years of age
Health behaviour change of parent/carer
• Breastfeeding: a. duration of breastfeeding; b. exclusive
breastfeeding (among babies under six months of age).
• Nutrition: a. introduction of complementary foods (among
babies aged six to eight months); b. dietary diversity/adequacy
(children aged six to 23 months who received foods from four or
more food groups); c. minimum meal frequency; d. consumption
of iron-rich or iron-fortified foods; e. adherence to vitamin A
supplements.
• Hygiene practices: a. handwashing; b. general hygiene (e.g.
washing kitchen utensils, sterilisation of household goods); c.
cord care; d. safe disposal of faeces.
• Treatment adherence: a. adherence to ARV in HIV-exposed and
HIV-positive children; b. adherence to prescribed regimen for
other illnesses (e.g. local infections); c. adherence to treatment
for malnutrition; d. correct treatment for diarrhoeal disease (e.g.
use of ORS, rice water); e. adherence to prescribed regimen for
prevention of malaria (ITNs, IPTp with SP).
Service utilisation
• a. attendance for vaccinations (including measles/diphtheria/
pertussis/tetanus vaccine); b. attendance to healthcare services
when child showed symptoms of severe illness (e.g. sepsis); c.
antibiotic treatment for pneumonia; d. time to diagnosis of HIV
in HIV-exposed infants.
Health status and well-being of child
• Normal growth: a. weight; b. height; c. body mass index; d.
growth trajectories (e.g. stunting).
• Nutritional status: a. anaemia; b. vitamin deficiencies.
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• Disease: a. malaria; b. measles; c. HIV; d. pneumonia; e.
diarrhoeal disease; f. tetanus; g. pertussis; h. diphtheria; i. other
infections; j. CD4 count, viral load (among children with HIV); k.
child mortality.
• Cognitive development: a. achievement of developmental
milestones.
Secondary outcomes
We extracted the following secondary outcomes for all populations.
• Patient/client acceptability and satisfaction with the
intervention (among those who received the intervention).
• Resource use, including cost to the system (e.g. human
resources/time, supplies, and equipment). This measure had to
be prespecified and available directly from the main trial report
(i.e. we did not search for separate reports on cost-eQectiveness
analyses).
• Unintended consequences (these could have included:
misreading or misinterpretation of data; transmission of
inaccurate data; loss of verbal and non-verbal communication
cues, including between provider and client; issues of privacy
and disclosure; aQecting interpersonal relationships; negative
impact on equity; issues with implementation fidelity resulting
in an undesirable eQect on health outcomes, such as failure
or delay in the message delivery that results in missed
appointments).
Reporting one or more of the outcome measures listed here in the
trial was not an inclusion criterion for the review.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases:
• Cochrane Central Register of Controlled Trials (CENTRAL, the
Cochrane Library) (August 2017);
• MEDLINE (OvidSP) (July 2017);
• Embase Classic + Embase (OvidSP) (August 2017);
• POPLINE (August 2017);
• WHO Global Health Library (August 2017).
Search strategies were tailored according to database
requirements. The search strategies for each database are reported
in Appendix 1; Appendix 2; Appendix 3; Appendix 4; and Appendix
5. The search strategies were designed to retrieve studies relevant
to the two linked reviews: 1. Targeted client communication via
mobile devices for improving maternal, neonatal, and child health,
and 2. Targeted client communication via mobile devices for
improving reproductive and sexual health (Palmer in preparation).
We searched for studies published since 2010. A review entitled
"The eQectiveness of mobile-health technology-based health
behaviour change or disease management interventions for health
care consumers: a systematic review" by Free 2013a carried out
searches for studies published up to 2010. With the exception of our
focus on a narrower range of health issues (sexual, reproductive,
maternal, newborn, child health), our inclusion and exclusion
criteria were consistent with Free 2013a. Therefore, we included all
relevant studies from Free 2013a covering the period up to 2010.
Searches were initially carried out in July/August 2017 and all
relevant studies identified up to this date have been reported in this
review. Prior to publication, a search update was carried out in July
2019. Relevant studies from the update search were not included
in the review but reported in the Characteristics of studies awaiting
classification section. The PRISMA diagram in Figure 1 represents
the flow of studies up to July 2019.
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Figure 1.   Study flow diagram. MNCH: maternal, neonatal, and child health; SRH: sexual and reproductive health.
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Figure 1.   (Continued)
 
Searching other resources
We searched for ongoing trials in the following trial registries:
• WHO ICTRP (International Clinical Trials Registry Platform;
www.who.int/ictrp) (July 2019; Appendix 6);
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (www.clinicaltrials.gov) (July 2019; Appendix
7).
We also searched Epistemonikos (www.epistemonikos.org/) (July
2019) to identify all relevant systematic reviews and screened them
for relevant primary studies. Additionally, WHO issued a call for
papers through popular digital health communities of practice
such as the Global Digital Health Network and Implementing Best
Practices, to identify additional primary studies as well as grey
(unpublished) literature.
On completion of screening, we ran a search for all related citations
of the included studies, and these citations were screened.
Data collection and analysis
The review was carried out as described in the protocol (Palmer
2018a), with exceptions noted in the DiQerences between protocol
and review section.
Selection of studies
Two review authors independently screened all titles and abstracts
identified from searches to determine those which met the
inclusion criteria. We retrieved in full text any papers identified as
potentially relevant. Two review authors independently screened
full-text articles for inclusion or exclusion, with discrepancies
resolved by discussion and by consulting a third review author
where necessary. Selected potentially relevant papers excluded
from the review at the full-text stage are listed as excluded studies,
with reasons provided in the Characteristics of excluded studies
table. We recorded citation details and any available information
about ongoing studies (see Characteristics of ongoing studies
table). We collated and reported details of duplicate publications,
so that each study (rather than each report) was the unit of interest
in the review. The screening and selection process is presented in
an adapted PRISMA flow chart (Figure 1) (Liberati 2009).
Data extraction and management
One review author extracted data from included studies, and this
was cross-checked by a second review author. Any discrepancies
were resolved by discussion until consensus was reached, or
through consultation with a third review author where necessary.
We developed and piloted a data extraction form using the
Cochrane Consumers and Communication Review Group Data
Extraction Template (available at: cccrg.cochrane.org/author-
resources).
Data extracted included the following items:
• methods: study design; total duration of study; study setting;
and date of study;
• participants: number randomised; number lost to follow-up/
withdrawn; number analysed; mean age; age range; gender; and
inclusion criteria and exclusion criteria;
• interventions: details of intervention and comparison group
conditions (including detail of what 'standard care' included).
This included intervention delivery mechanism (e.g. text
messages/MMS/apps/combined); how the intervention was
developed; if the intervention was personalised; and frequency
and duration of intervention receipt;
• outcomes: primary and secondary outcomes specified and
collected; unintended consequences; and time points reported;
• notes: funding for trial and notable conflicts of interest of trial
authors.
All extracted data was entered into Review Manager 5 (Review
Manager 2014) by one review author, and checked for accuracy
against the data extraction sheets by a second review author
working independently.
Assessment of risk of bias in included studies
We assessed and reported the methodological risk of bias of
included studies in accordance with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011), and the
guidelines of the Cochrane Consumers and Communication
Review Group (Ryan 2013), which recommends the explicit
reporting of the following individual elements for RCTs:
random sequence generation; allocation sequence concealment;
blinding (participants, personnel); blinding (outcome assessment);
completeness of outcome data; selective outcome reporting;
and other bias. We considered blinding separately for diQerent
outcomes where appropriate (e.g. blinding may have the potential
to diQerently aQect subjective versus objective outcome measures).
Under 'Other bias', we considered other potential sources of bias
such as the presence of baseline imbalances related to the outcome
under study, and evidence of contamination. For cluster-RCTs we
also assessed and reported the risk of bias associated with an
additional domain: selective recruitment of cluster participants. We
judged each item as being at high, low, or unclear risk of bias as set
out in the criteria provided by Higgins 2011, and provided a quote
from the study report and a justification for our judgement for each
item in the 'Risk of bias' table. One review author independently
assessed the risk of bias of included studies and a second review
author cross-checked all assessments. Any disagreements were
resolved by discussion to reach consensus.
Measures of treatment e>ect
For individually randomised controlled trials reporting
dichotomous outcomes, we analysed data based on the number
of events and the number of people assessed in the intervention
and comparison groups. We used these to calculate the risk
ratio (RR) or odds ratio (OR) and 95% confidence interval (CI).
For continuous measures, we analysed data based on the mean,
standard deviation (SD) and number of people assessed for
both the intervention and comparison groups to calculate mean
diQerence (MD) and 95% CI. If the MD was reported without
individual group data, we used this to report the study results. If
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more than one study measured the same outcome using diQerent
tools, we calculated the standardised mean diQerence (SMD) and
95% CI using the inverse variance method in Review Manager 5
(Review Manager 2014). For cluster RCTs, where the study reported
cluster-adjusted eQect estimates (e.g. RR, OR) or counts, these were
extracted.
Unit of analysis issues
We included both individually and cluster RCTs. Where cluster-
RCTs were included, in the first instance, we extracted eQect
estimates that were adjusted for within-cluster correlation by the
study authors. If no adjusted estimates were available in the study
report, we derived intracluster correlation coeQicients (ICCs) for
the outcomes of interest from other included studies or from a
paper by Pagel 2011 and calculated adjusted eQect estimates prior
to meta-analysis. We calculated a design eQect using these ICCs
and mean cluster size, which was used to calculate the eQective
number of events per control/intervention and eQective number
of participants per control/intervention (for methods see Higgins
2011).
Where we identified multiarm trials with more than one
relevant intervention arm but only one control arm, we pooled
the intervention arms for a single pair-wise comparison as
recommended by the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). We excluded intervention arms from
multi-arm trials that were not eligible for inclusion, but listed them
in the Characteristics of included studies table.
Dealing with missing data
We planned to contact investigators or study sponsors to obtain
missing data where possible (e.g. when a study was identified
as abstract only); however, we did not have the resources to
do so. Where a study was identified as abstract only (Kamau-
Mbuthia 2013; Kebaya 2014), we searched for associated full
reports. We commented on the potential impact of studies that
apparently measured outcomes but did not contribute usable
data in the EQects of interventions section. Where missing data
were considered a potential source of serious bias, we planned to
conduct a sensitivity analysis to explore the impact of including
such studies in the overall assessment of results.
For participant data, we planned, where possible, to conduct
analysis on an intention-to-treat basis; otherwise data were
analysed as reported. We reported loss to follow-up and assessed
this as a source of potential bias.
Assessment of heterogeneity
We carried out meta-analyses when we considered it meaningful
to do so. In order to be pooled, studies had to have been
conducted among the same population (i.e. we did not pool studies
across the three distinct populations as defined under Types of
participants), targeting and measuring the same outcome, and
comparing the intervention with similar control groups conditions
(i.e. pooling was carried out separately for the following three
comparisons: TCC delivered by mobile device versus 1. standard
care or no intervention, 2. non-digital TCC, or 3. digital non-targeted
communication. We assessed the degree of heterogeneity by visual
inspection of forest plots and by examining the Chi2 test for
heterogeneity. Heterogeneity was quantified using the I2 statistic
and interpreted by considering the size and direction of eQects
and the strength of the evidence for heterogeneity, based on the
P value from the Chi2 test (Higgins 2011). Where heterogeneity
was present in pooled eQect estimates, we intended to explore
possible reasons for variability by conducting our prespecified
subgroup analysis; however, there were an insuQicient number of
studies in the pooled analyses to conduct meaningful subgroup
analyses. Where we noted other potential explanations for high
heterogeneity (e.g. diQering baseline level of risk), and there was a
suQicient number of studies, we conducted subgroup analyses to
examine these.
Assessment of reporting biases
We assessed reporting bias qualitatively based on the
characteristics of the included studies. For example, if only
small studies that indicated positive findings were identified
for inclusion, or information that we obtained from contacting
experts and authors of studies suggested that there were relevant
unpublished studies, we would have considered this as potential
evidence of publishing bias and would have reported it as so. If we
had identified suQicient studies (at least 10) for inclusion in a meta-
analysis, we planned to construct a funnel plot to investigate small-
study eQects, which may indicate the presence of publication bias.
We also searched for trial registry entries and published protocols
of all included studies, and used this to assess the risk of bias due
to selective reporting.
Data synthesis
We decided whether to meta-analyse data based on whether
the included trials were similar enough in terms of participants,
settings, intervention, comparison, and outcome measures to
ensure meaningful conclusions from a statistically pooled result.
For studies which measured the same outcome at diQerent time
points, we extracted the outcome measured at the longest follow-
up time point. We had planned to categorise lengths of follow-up as
follows: short-term follow-up: less than three months; moderate-
term follow-up: three to 12 months; long-term follow-up: more
than 12 months. However, given the limited number of studies with
the same aim, comparison, and outcome measure that could be
pooled, we decided to pool outcomes across diQerent lengths of
follow-up.
Due to the anticipated variability in the interventions of included
studies, we used random-eQects models for meta-analysis. The
primary meta-analyses included all studies regardless of their score
on the risk of bias assessment.
For continuous outcomes, we calculated MDs with 95% CIs. If more
than one study measured the same continuous outcome using
diQerent tools, we calculated the SMD and 95% CI using the inverse
variance method in Review Manager 5 (Review Manager 2014). We
calculated RR or OR with 95% Cl for dichotomous outcomes. For
cluster-RCTs that presented adjusted eQect estimates (e.g. OR, RR),
we combined these estimates with using generic inverse variance
random-eQects (Higgins 2011).
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses for the
objectively measured outcomes of health status:
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• income region (by World Bank income group: lower income,
lower-middle income, upper-middle income, high income)
(World Bank 2017);
• delivery mechanisms (i.e. mobile phone messaging only, mobile
apps only, combined mobile phone messaging and apps,
combined apps and other).
However, there was an insuQicient number of studies reporting the
same health status outcomes to conduct these subgroup analyses.
Sensitivity analysis
We planned to carry out the following sensitivity analyses:
• only including studies with low risk of bias on the sequence
generation, allocation concealment, and incomplete outcome
data domains;
• only including studies with objectively measured outcomes.
However, there was only a suQicient number of studies to conduct
the first specified sensitivity analysis.
'Summary of findings' table
We prepared 'Summary of findings' tables to present the
results of meta-analyses or narrative synthesis (or both) for the
major comparisons of the review, for the following prespecified
outcomes.
Pregnant and up to six weeks postpartum women
• Maternal morbidity and mortality combined.
• Neonatal morbidity and mortality combined.
• Breastfeeding.
• Attendance for ANC.
• Birth in a health facility/occurring with a skilled attendant
present.
• Unintended consequences.
Pregnant and up to six weeks postpartum women living with
HIV
• Maternal morbidity and mortality combined.
• Neonatal morbidity and mortality combined.
• Attendance for ANC (including eMTCT care).
• Birth in a health facility.
• Unintended consequences.
• Neonate HIV status.
• Adherence to ARV therapy.
Parents and other carers of children under five years of age
• Child morbidity and mortality combined.
• Child nutritional status (including anthropometric measures).
• Breastfeeding.
• Clinic attendance for necessary healthcare (e.g. for vaccinations,
care for severe illness, HIV tests)
• Hygiene practices (e.g. handwashing).
• Correct treatment taken (e.g. correct treatment for diarrhoeal
disease, adherence to ARV therapy).
• Unintended consequences.
Two review authors independently used the GRADE criteria to
assess the certainty of the evidence based on the methods
described in Chapter 11 of the Cochrane Handbook for Systematic
Reviews of Interventions, using the GRADEprofiler (GRADEpro)
soIware (Schünemann 2011). Where meta-analyses were not
possible, we presented results in a narrative format.
Ensuring relevance to healthcare decisions
The protocol and review received input and feedback from
members of the WHO throughout the review process to ensure the
relevance of the review for health policy and practice decisions.
The review was also refereed by content experts and including
a consumer referee as part of the Cochrane Consumers and
Communication Group standard editorial processes.
R E S U L T S
Description of studies
Results of the search
The results of the search are shown in Figure 1. The search
of the databases retrieved 11,259 records, with a further 1726
records identified from clinical trial registries, and one additional
record from other sources. AIer deduplication, 10,332 records
remained for title and abstract screening, of which 9206 were
clearly irrelevant and excluded. We assessed 1126 full-text articles
for eligibility and 168 studies (including 64 ongoing studies) met the
inclusion criteria for either this review, or the linked review of TCC
via mobile devices for sexual and reproductive health (Palmer in
preparation).
For this review, the search identified 48 eligible studies, of which 21
were added to the Characteristics of studies awaiting classification
section. A total of 27 studies were included in the synthesis reported
below, 11 concerned pregnant and postpartum populations, three
related to pregnant and postpartum populations living with HIV,
and 13 related to parents of children under the age of five years.
Included studies
The Characteristics of included studies table presents details of
the design, methods, participants, intervention, comparison, and
outcome measures for the studies included in this review.
Participants and settings
In the 11 studies conducted among pregnant and postpartum
populations, the sample size ranged from 68 to 2637, totalling
7626 participants. The three studies concerned with pregnant and
postpartum women living with HIV had sample sizes varying from
150 to 550, resulting in 1088 women. All participants were recruited
from a mix of community and healthcare settings.
The 13 studies among parents of children aged under five years
were conducted with 8749 participants, with sample sizes ranging
from 57 to 2054. All trials recruited through healthcare settings or
community settings linked with healthcare facilities.
Table 1 presents details of the settings in which each trial
was carried out. Of the 11 trials concerned with pregnant
and postpartum women, four were conducted in high-income
countries, two in upper middle-income countries, four in lower
middle-income countries, and one in a low-income country. All
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three trials among pregnant and postpartum women living with HIV
were carried out in Kenya (a lower middle-income country). Of the
13 studies targeting parents of children under five years of age, five
were conducted in high-income countries, seven in lower middle-
income countries, and one in a low-income country.
Interventions
Details of the interventions are provided in the Characteristics of
included studies table and Table 2.
Of the 11 studies conducted among pregnant and postpartum
populations, nine evaluated interventions that aimed to provide
information, education, or support (Evans 2014; Jareethum 2008;
Joshi 2015; Kamau-Mbuthia 2013; Maslowsky 2016; McConnell
2016; Moniz 2013; Naughton 2017; Yudin 2017), and two
interventions also provided reminders alongside information/
education or support (Lund 2012; Omole 2018). Six trials delivered
the intervention by text messages only (Evans 2014; Kamau-
Mbuthia 2013; Lund 2012; Moniz 2013; Omole 2018; Yudin
2017); two delivered via voice calls only (Maslowsky 2016;
McConnell 2016); and the remaining three studies examined
interventions delivered by multiple mechanisms, such as text
messages, telephone calls, and email (Naughton 2017), texts
messages and telephone calls (Jareethum 2008), and multimedia
messaging including video and audiovisual messages, combined
with voice calls (Joshi 2015). Four studies did not report on
personalisation of the intervention (Jareethum 2008; Kamau-
Mbuthia 2013; Moniz 2013; Yudin 2017); and the rest reported
some extent of personalisation, such as messaging specific to the
baby's gestational age, choice of language in which to receive
intervention, and preferred time of receipt of messaging. In eight
of the trials among pregnant and postpartum women, the control
group received standard care/no intervention, and in two trials the
control group received digital non-targeted communication, both
in the form of text messages containing general health information
(Moniz 2013; Omole 2018). One trial had two control groups
contributing to this review; of which one was standard care, and
the other was non-digital targeted communication (which involved
delivering the content of the intervention through home visits by
community health workers) (McConnell 2016).
Of the trials conducted among pregnant and postpartum women
living with HIV, one tested an intervention providing reminders
(Kebaya 2014), and the other two provided information, education,
or support alongside reminders (Kassaye 2016; Odeny 2014). One
trial delivered the intervention through voice calls (Kebaya 2014),
and the other two via text messaging only (Kassaye 2016; Odeny
2014). One trial did not report if the intervention was personalised
(Kebaya 2014); one was tailored according to pregnancy stage
(Kassaye 2016); and one allowed participants to select their
preferred time of receipt of messaging and their preferred name
(Odeny 2014). Two of the trials among pregnant and postpartum
women living with HIV compared the intervention to a control
of standard care/no intervention (Kassaye 2016; Odeny 2014),
and, in one trial, the control group received digital non-targeted
communication in the form of standard healthcare text messages
(Kebaya 2014).
Most trials among parents of children aged under five years tested
interventions providing reminders only, as most of these studies
were concerned with eQorts to increase attendance for childhood
vaccinations (Ahlers-Schmidt 2012; Bangure 2015; Bigna 2015;
Domek 2016; Eze 2015; Gibson 2017; Haji 2016; Hofstetter 2015a;
Niederhauser 2015). Three trials evaluated interventions aiming
to provide both reminders and education, information, or support
(Brown 2016; Hannan 2016; Stockwell 2015); and one provided
education, information, or support without reminders (Sharma
2011). Ten interventions were delivered via text messages (Ahlers-
Schmidt 2012; Bangure 2015; Domek 2016; Eze 2015; Gibson 2017;
Haji 2016; Hofstetter 2015a; Niederhauser 2015; Sharma 2011;
Stockwell 2015), one through voice calls (Brown 2016), and two
through a combination of text messages and voice calls (Bigna
2015; Hannan 2016). Four studies did not report on whether the
intervention had any degree of personalisation (Ahlers-Schmidt
2012; Bigna 2015; Haji 2016; Hannan 2016); two studies reported
that the intervention was not personalised (Bangure 2015; Brown
2016); and the rest reported at least some degree of personalisation
such as use of the child's name or name of clinic at which the
appointment was due (or both), and delivery in preferred language.
In 10 of the trials among parents of children aged under five years,
the control group received standard care or no intervention, in
one trial the control received digital non-targeted communication
in the form of text messages about general infant health, without
the reminders for vaccination appointments that were received
by the intervention group (Niederhauser 2015); and in one trial
the control group received non-digital targeted communication in
the form of pamphlets (Sharma 2011). One trial among parents of
children had two control groups for the purposes of this review; one
received standard care and the other received non-digital targeted




Six trials among pregnant and postpartum women reported on at
least one health behaviour change outcome. Two trials recorded
smoking during pregnancy (Evans 2014; Naughton 2017), one
reported on alcohol consumption during pregnancy (Evans 2014),
three reported on breastfeeding (Kamau-Mbuthia 2013; Maslowsky
2016; McConnell 2016), one reported on uptake of postpartum
contraception (Maslowsky 2016), and one on adherence to iron/
folic acid tablets during the antenatal period (Joshi 2015).
Two of the three trials among pregnant and postpartum women
living with HIV reported on behaviour change – one in the form
of maternal utilisation and adherence to ARV therapy, infant ARV/
PMTCT, and infant HIV testing (Kassaye 2016); and one on recorded
adherence to newborn PMTCT treatment (nevirapine prophylaxis)
(Kebaya 2014).
Only one of the trials carried out with parents of children aged
under five years reported a behaviour change outcome, and this
was an indicator of hygiene practices for oral health (the Visible
Plaque Index (VPI) in children) (Sharma 2011).
Service utilisation
Seven of the trials among pregnant and postpartum women
reported on health service utilisation outcomes: one measured the
proportion of women attending more than four ANC appointments
(Lund 2012); two measured attendance for antenatal influenza
vaccine (Moniz 2013; Yudin 2017); three reported whether birth
occurred in a health facility or whether it was attended to by
a skilled birth assistant (Joshi 2015; Lund 2012; Omole 2018);
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and two measured attendance for postpartum care appointments
(Maslowsky 2016; McConnell 2016).
All three of the trials among pregnant and postpartum women
living with HIV recorded service utilisation outcomes. One recorded
the proportion of births occurring in a health facility, ANC, and
mean number of face-to-face or mobile communications with
healthcare workers (Kassaye 2016); two reported attendance for
postpartum care visits (Kebaya 2014; Odeny 2014).
Eleven of the trials targeting parents of children aged under
five years reported on health service utilisation outcomes, most
which related to attendance for childhood vaccinations (Ahlers-
Schmidt 2012; Bangure 2015; Brown 2016; Domek 2016; Eze
2015; Gibson 2017; Haji 2016; Hannan 2016; Hofstetter 2015a;
Niederhauser 2015; Stockwell 2015). Two studies reported on
other types of health service utilisation – one on attendance to
HIV medical appointments (among HIV-positive and HIV-exposed
infants) (Bigna 2015); and one reported on urgent care seeking
(Hannan 2016).
Health and well-being
Three trials among pregnant and postpartum women measured
health and well-being outcomes. One reported on neonatal
diarrhoeal disease and infant growth up to three months
postpartum (Kamau-Mbuthia 2013); one reported on preterm
delivery, birthweight, and gestational age at birth (Jareethum
2008); and one trial measured perinatal death and maternal
mortality (Lund 2012).
Two of three trials among pregnant and postpartum women living
with HIV recorded HIV status of the neonate (Kassaye 2016; Odeny
2014), and one trial reported neonatal deaths/stillbirths (Odeny
2014). None of trials among parents of children aged under five
years recorded health and well-being outcomes.
Unintended consequences
None of the trials carried out among the three populations of
interest reported data on unintended consequences or adverse
events.
Acceptability
Eight studies among pregnant and postpartum women recorded
at least one measure relating to acceptability/satisfaction with the
intervention (Jareethum 2008; Joshi 2015; Lund 2012; Maslowsky
2016; Moniz 2013; Naughton 2017; Omole 2018; Yudin 2017),
whereas as none of the studies among pregnant and postpartum
women living with HIV did so. Of the trials carried out with parents
of children aged under five years, six reported on indicators of
acceptability/satisfaction with the intervention (Ahlers-Schmidt
2012; Bangure 2015; Domek 2016; Gibson 2017; Hofstetter 2015a;
Stockwell 2015).
Resource use
One trial conducted among pregnant and postpartum women
reported on the costs associated with delivering the intervention
(Naughton 2017). No trials among pregnant and postpartum
women living with HIV reported on the intervention costs. Five of
the trials among parents of children aged under five years provided
information relating to intervention costs (Bangure 2015; Bigna
2015; Eze 2015; Haji 2016; Hannan 2016).
Funding
Of the trials conducted among pregnant and postpartum women,
nine were funded by non-commercial grants (Evans 2014; Joshi
2015; Kamau-Mbuthia 2013; Maslowsky 2016; McConnell 2016;
Moniz 2013; Naughton 2017; Omole 2018; Yudin 2017), and one did
not state the source of funding (Jareethum 2008).
Two of the trials conducted among pregnant and postpartum
women living with HIV reported non-commercial funding sources
(Kassaye 2016; Odeny 2014), and one did not report the source of
funding (Kebaya 2014).
Most trials conducted among parents of children aged under five
years reported non-commercial funding sources (Ahlers-Schmidt
2012; Bangure 2015; Bigna 2015; Domek 2016; Gibson 2017; Haji
2016; Hannan 2016; Hofstetter 2015a; Lund 2012; Stockwell 2015),
and four of the studies did not report their source of funding (Brown
2016; Eze 2015; Niederhauser 2015; Sharma 2011).
Excluded studies
Following full-text screening, we excluded 958 articles (Figure
1). The details of relevant excluded trials are provided in the
Characteristics of excluded studies table. Reasons for exclusion
included not having a randomised controlled design or enrolling an
irrelevant population (e.g. parents of older children/adolescents).
The most common reasons for exclusion were related to the
intervention being evaluated. In some cases, the intervention was
not considered to be TCC as per our definition, or the intervention
included a digital tracking component, or was used in conjunction
with other interventions (e.g. face-to-face interventions).
Studies awaiting classification
We updated the search in August 2019, and identified a further
21 studies, which are summarised in the Characteristics of studies
awaiting classification table.
Ongoing studies
We identified 32 ongoing studies, which are summarised in the
Characteristics of ongoing studies table.
Risk of bias in included studies
Details of the risk of bias assessments for each of the included
studies are presented in the 'Risk of bias' tables in the
Characteristics of included studies table, and in Figure 2.
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Ahlers-Schmidt 2012 + ? - + - + ? ?
Bangure 2015 + ? - ? - + + +
Bigna 2015 + + - + - + + ?
Brown 2016 ? ? ? - ? + ? -
Domek 2016 + + - ? - + + ?
Evans 2014 + ? - - - + ?
Eze 2015 + ? - + - ? ? -
Gibson 2017 + + - - + ? + + +
Haji 2016 ? ? - - - - ? + -
Hannan 2016 + ? - - - ? ?
Hofstetter 2015a + + + + + + ? +
Jareethum 2008 + ? - + - + + +
Joshi 2015 ? ? ? - - ? ? ?
Kamau-Mbuthia 2013 ? ? - - ? - ?
Kassaye 2016 ? ? ? - - - ? -
Kebaya 2014 ? ? - ? ? ? - ?
Lund 2012 ? ? + - ? + + +
Maslowsky 2016 + ? - - - ? +
McConnell 2016 + ? - - ? + ?
Moniz 2013 ? + ? + ? + + +
Naughton 2017 + ? - + - ? + ?
Niederhauser 2015 + ? - ? - - ? ?
Odeny 2014 + + - + + ? +
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Figure 2.   (Continued)
Niederhauser 2015 + ? - ? - - ? ?
Odeny 2014 + + - + + ? +
Omole 2018 ? ? - - ? ? - - ?
Sharma 2011 ? ? - + - ? +
Stockwell 2015 ? + - + - + + +
Yudin 2017 + + + + + + ?
 
Allocation
Pregnant and postpartum women
One trial demonstrated adequate random sequence generation
and allocation concealment, and so was at low risk of bias
for both domains (Yudin 2017). Five trials reported adequate
random sequence generation and were at low risk of bias on
this domain, but did not provide suQicient information on their
procedures relating to allocation concealment and therefore were
at unclear risk of bias for this domain (Evans 2014; Jareethum 2008;
Maslowsky 2016; McConnell 2016; Naughton 2017). One trial was
at unclear risk of bias for random sequence generation, and at low
risk of bias for allocation concealment (Moniz 2013). Four studies
were at unclear risk of bias for both random sequence generation
and allocation concealment domains as they provided insuQicient
information (Joshi 2015; Kamau-Mbuthia 2013; Lund 2012; Omole
2018).
Pregnant and postpartum women living with HIV
One trial demonstrated adequate random sequence generation
and allocation concealment, and so was at low risk of bias for both
domains (Odeny 2014). Two studies were at unclear risk of bias
for both random sequence generation and allocation concealment
domains as they provided insuQicient information (Kassaye 2016;
Kebaya 2014).
Parents and carers of children aged under five years
Four trials demonstrated adequate random sequence generation
and allocation concealment, and so were at low risk of bias for both
domains (Bigna 2015; Domek 2016; Gibson 2017; Hofstetter 2015a).
Five studies reported adequate random sequence generation and
were at low risk of bias on this domain, but did not provide
suQicient information on their procedures relating to allocation
concealment and therefore were at unclear risk of bias for this
domain (Ahlers-Schmidt 2012; Bangure 2015; Eze 2015; Hannan
2016; Niederhauser 2015). Three studies were at unclear risk of bias
for both random sequence generation and allocation concealment
domains as they provided insuQicient information (Brown 2016;
Haji 2016; Sharma 2011), and one study was at unclear risk of bias
for random sequence generation, but low risk of bias for allocation
concealment (Stockwell 2015).
Blinding
Pregnant and postpartum women
Nine trials were at high risk of bias for the blinding of participants
and personnel domain (Evans 2014; Jareethum 2008; Joshi 2015;
Kamau-Mbuthia 2013; Lund 2012; Maslowsky 2016; McConnell
2016; Naughton 2017; Omole 2018). One trial did not provide
suQicient information relating to blinding of participants and
personnel and so was at unclear risk of bias for this domain (Moniz
2013). One trial was at low risk of bias for blinding of participants
and personnel (Yudin 2017). Three studies demonstrated adequate
blinding for objective outcomes and were at low risk of bias on this
domain (Jareethum 2008; Moniz 2013; Naughton 2017), two studies
did not provide adequate information and so were at unclear risk
of bias on this domain (Lund 2012; Omole 2018), and six studies
did not record objective outcomes (Evans 2014; Joshi 2015; Kamau-
Mbuthia 2013; Maslowsky 2016; McConnell 2016; Yudin 2017). In
relation to blinding for subjective outcome assessment, one trial
was a low risk of bias (Yudin 2017), two were at unclear risk of
bias due to lack of information provided (Moniz 2013; Omole 2018),
seven were at high risk of bias (Evans 2014; Jareethum 2008;
Joshi 2015; Kamau-Mbuthia 2013; Maslowsky 2016; McConnell
2016; Naughton 2017), and the remaining study did not record any
subjective outcomes (Lund 2012).
Pregnant and postpartum women living with HIV
All three trials were at high risk of bias for the blinding of
participants and personnel domain (Kassaye 2016; Kebaya 2014;
Odeny 2014).
One study was at high risk of bias for subjective outcome
assessment, and did not record any objectively measured
outcomes (Kassaye 2016), one provided insuQicient information
and was considered to be at unclear risk of bias for blinding of both
objective and subjective outcomes (Kebaya 2014), and third study
was at low risk of bias for blinding of objective outcomes, and did
not record any subjective outcomes (Odeny 2014).
Parents of children aged under five years
With the exception on one trial which was at low risk of bias for
blinding of participants and personnel (Hofstetter 2015a), all trials
among parents of children aged under five years were at high risk of
bias for this domain. One study was at low risk of bias for blinding
of both objective and subjective outcome assessments (Hofstetter
2015a), one study was at low risk of bias for blinding of objective
outcome assessments, and did not record any subjective outcomes
(Sharma 2011), one study was at low risk of bias for objective
outcomes and unclear risk of bias for subjective outcomes (Gibson
2017), and four studies were at low risk of bias for blinding of
objective outcome assessments and high risk of bias for blinding
of subjective outcome assessments (Ahlers-Schmidt 2012; Bigna
2015; Eze 2015; Stockwell 2015). Three studies were at unclear risk
of bias for blinding of objective outcome assessment, and high
risk of bias for subjective outcome assessment (Bangure 2015;
Domek 2016; Niederhauser 2015). One study was at unclear risk
of bias for blinding of objective outcomes, and did not record
subjective outcomes (Brown 2016); one study did not record
objective outcomes, and was at high risk of bias for subjective
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outcome blinding (Hannan 2016); and one study was at high risk
of bias for blinding for both objective and subjective outcome
assessment (Haji 2016).
Incomplete outcome data
Pregnant and postpartum women
Four of the trials among pregnant and postpartum women were
at low risk of bias for incomplete outcome data (Jareethum 2008;
Lund 2012; Moniz 2013; Yudin 2017) and seven were at high or
unclear risk of bias for this domain (Evans 2014; Joshi 2015; Kamau-
Mbuthia 2013; Maslowsky 2016; McConnell 2016; Naughton 2017;
Omole 2018).
Pregnant and postpartum women living with HIV
For the incomplete outcome data domain, one trial among
pregnant and postpartum women living with HIV was at low risk of
bias (Odeny 2014), one was at unclear risk of bias (Kebaya 2014),
and one was at high risk of bias (Kassaye 2016).
Parents of children aged under five years
Eight of the trials among parents of children aged under five years
were at low risk of bias for incomplete outcome data (Ahlers-
Schmidt 2012; Bangure 2015; Bigna 2015; Brown 2016; Domek 2016;
Gibson 2017; Hofstetter 2015a; Stockwell 2015), two were at unclear
risk of bias (Eze 2015; Haji 2016), and three were at high risk of bias
for this domain (Hannan 2016; Niederhauser 2015; Sharma 2011).
Selective reporting
Pregnant and postpartum women
Seven studies were at low risk of bias for the selective outcome
reporting domain as their protocols or trial registry entries (or
both) could be identified and all expected outcomes were reported
(Evans 2014; Jareethum 2008; Lund 2012; McConnell 2016; Moniz
2013; Naughton 2017; Yudin 2017). Two studies were at unclear
risk of bias as their protocols could not be identified (Joshi
2015; Maslowsky 2016). Two studies were at high risk of bias on
the selective outcome reporting domain due to inconsistencies
between the prespecified and actual outcome reporting (Kamau-
Mbuthia 2013; Omole 2018).
Pregnant and postpartum women living with HIV
Two of the trials among pregnant and postpartum women living
with HIV were at unclear risk of bias for selective outcome reporting
as their protocols could not be identified (Kassaye 2016; Odeny
2014), and one was at high risk of bias due to inconsistency between
prespecified and actual outcome reporting (Kebaya 2014).
Parents of children aged under five years
Six studies among parents of children aged under five years were
at low risk of bias for the selective outcome reporting domain as
their protocols or trial registry entries (or both) could be identified
and all expected outcomes were reported (Bangure 2015; Bigna
2015; Domek 2016; Gibson 2017; Haji 2016; Stockwell 2015). Seven
studies were at unclear risk of bias as their protocols could not
be identified (Ahlers-Schmidt 2012; Brown 2016; Eze 2015; Hannan
2016; Hofstetter 2015a; Niederhauser 2015; Sharma 2011).
Other potential sources of bias
Pregnant and postpartum women
Four studies were at low risk of bias for the 'other bias' domain
(Jareethum 2008; Lund 2012; Maslowsky 2016; Moniz 2013), and
seven were at unclear risk of bias (Evans 2014; Joshi 2015; Kamau-
Mbuthia 2013; McConnell 2016; Naughton 2017; Omole 2018; Yudin
2017).
Pregnant and postpartum women living with HIV
For the 'other bias' domain, one trial among pregnant and
postpartum women living with HIV was at low risk of bias (Odeny
2014), one was at unclear risk of bias (Kebaya 2014), and one was at
high risk of bias as due to important baseline diQerences between
groups (Kassaye 2016).
Parents of children aged under five years
Five of the trials conducted among parents of children aged
under five years were at low risk of other bias (Bangure 2015;
Gibson 2017; Hofstetter 2015a; Sharma 2011; Stockwell 2015). Five
trials were at unclear risk of bias for this domain (Ahlers-Schmidt
2012; Bigna 2015; Domek 2016; Hannan 2016; Niederhauser 2015).
Three trials were at high risk of bias for this domain due to:
significant demographic diQerences between clusters in a clustered
RCT (Brown 2016); participants being swapped between the
intervention and control group when people who did not own a
mobile phone had been allocated to the intervention (Eze 2015);
and an issue whereby attending a diQerent facility may results in
misclassification of the outcome of vaccination (Haji 2016).
Selective cluster recruitment
Pregnant and postpartum women
Three of the 11 trials conducted among pregnant and postpartum
women were cluster RCTs and one was at low risk of bias for the
domain of selective cluster recruitment (Lund 2012), one was at
unclear risk of bias (Joshi 2015), and one was at high risk of bias due
to participant enrolment aIer cluster allocation had been made
(Omole 2018). The remaining trials were individually randomised
trials and so were not assessed regarding cluster recruitment.
Pregnant and postpartum women living with HIV
One of the three trials conducted among pregnant and postpartum
women living with HIV was a cluster RCT and at unclear risk of bias
for the domain of selective cluster recruitment (Kassaye 2016). The
other two trials were individually randomised trials and so were not
assessed regarding cluster recruitment.
Parents of children aged under five years
Three of the 13 trials conducted among parents of children aged
under five years were cluster RCTs. One was at unclear risk of
bias for the domain of selective cluster recruitment (Brown 2016),
and two were at high risk of bias due to convenient enrolment
of participants likely to have taken place aIer cluster allocation
to intervention arms (Haji 2016), and participant enrolment aIer
cluster allocation had been made (Gibson 2017). The remaining
trials were individually randomised trials and so were not assessed
regarding cluster recruitment.
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E>ects of interventions
See: Summary of findings 1 Digital targeted client communication
via mobile devices compared to standard care or no intervention
(pregnant and postpartum women) for improving maternal,
neonatal, and child health; Summary of findings 2 Digital targeted
client communication via mobile devices compared to non-digital
targeted client communication (pregnant and postpartum women)
for improving maternal, neonatal, and child health; Summary
of findings 3 Digital targeted client communication via mobile
devices compared to digital non-targeted client communication
(pregnant and postpartum women) for improving maternal,
neonatal, and child health; Summary of findings 4 Digital targeted
client communication via mobile devices compared to standard
care or no intervention (pregnant and postpartum women with
HIV) for improving maternal, neonatal, and child health; Summary
of findings 5 Digital targeted client communication via mobile
devices compared to non-digital targeted client communication
(pregnant and postpartum women with HIV) for improving
maternal, neonatal, and child health; Summary of findings 6
Digital targeted client communication via mobile devices compared
to digital non-targeted client communication (pregnant and
postpartum women with HIV) for improving maternal, neonatal,
and child health; Summary of findings 7 Digital targeted client
communication via mobile devices compared to standard care
or no intervention (parents of children aged under five years)
for improving maternal, neonatal, and child health; Summary
of findings 8 Digital targeted client communication via mobile
devices compared to non-digital targeted client communication
(parents of children aged under five years) for improving maternal,
neonatal, and child health; Summary of findings 9 Digital targeted
client communication via mobile devices compared to digital non-
targeted client communication (parents of children aged under five
years) for improving maternal, neonatal, and child health
Pregnant and postpartum women
Targeted client communication via mobile devices versus
standard care
Summary of findings 1 presents the evidence relating to the
eQect of TCC via mobile devices compared to standard care or
no intervention among pregnant and postpartum women for the
outcomes of maternal mortality and morbidity, neonatal mortality
and morbidity, breastfeeding, attendance for ANC, receipt of
intrapartum care, and unintended consequences.
Health behaviour change
There was at best moderate-certainty evidence relating to the eQect
of TCC via mobile devices on health behaviours when compared to
standard care.
One study carried out in Kenya provided low-certainty evidence
relating to the eQect of TCC via mobile devices for the promotion of
exclusive breastfeeding in a setting where all women in the control
group exclusively breastfed (exclusive breastfeeding at 9 weeks
postpartum: RR 0.92, 95% CI 0.79 to 1.08; n = 40; low-certainty
evidence – downgraded due to risk of bias and imprecision; Analysis
1.1) (McConnell 2016). Another study, conducted in Ecuador, which
had comparatively lower breastfeeding rates in the standard
care arm, suggests that the intervention may increase exclusive
breastfeeding at three months postpartum (RR 1.30, 95% CI 1.06
to 1.59; n = 135; low-certainty evidence – downgraded for risk of
bias (unclear risk of bias on the allocation concealment domain
and high rates of loss to follow-up) and imprecision; Analysis 1.1)
(Maslowsky 2016). A second RCT in Kenya found that mobile phone-
based support may increase the proportion of postpartum women
receiving help with breastfeeding (RR 2.15, 95% CI 1.78 to 2.58; n
= 332; low-certainty evidence – downgraded twice for risk of bias;
Analysis 1.2) (Kamau-Mbuthia 2013).
One study conducted among women living in rural villages in India
demonstrated that voice messages delivered to mobile devices
probably increased the proportion of participants who took iron
and folate tablets for 100 days during pregnancy (RR 1.71, 95% CI
1.42 to 2.07; n = 908; moderate-certainty evidence – downgraded
once due to unclear risk of bias for random sequence generation
and allocation concealment; Analysis 1.3) (Joshi 2015).
We are uncertain about the eQects of the intervention on
postpartum contraceptive use at three months (study in Ecuador)
and at nine weeks postpartum (study in Kenya) because the
certainty of the evidence was very low (RR 1.35, 95% CI 0.75 to 2.46;
n = 175; downgraded twice for risk of bias and once for imprecision;
Analysis 1.4) (Maslowsky 2016; McConnell 2016).
Two studies reported on smoking during pregnancy: one UK
trial among pregnant women who smoked suggested that
the intervention may increase objectively verified continuous
abstinence (RR 2.76, 95% CI 0.89 to 8.54; n = 407; low-certainty
evidence – downgraded due to risk of bias and imprecision; Analysis
1.6) (Naughton 2017). One trial in the USA among pregnant women
(who were not recruited based on smoking status) suggested that
the intervention may reduce the proportion of pregnant women
reporting having smoked in the last 30 days (RR 0.43, 95% CI
0.17 to 1.10; n = 459; low-certainty evidence – downgraded due
to risk of bias and imprecision; Analysis 1.5) (Evans 2014). The
USA study also found that the intervention may have little or no
impact on preventing alcohol consumption during pregnancy (RR
1.00, 95% CI 0.97 to 1.03; n = 459; low-certainty evidence – due to
risk of bias and indirectness based evidence from a single high-
income country; Analysis 1.7) (Evans 2014). However, over 97% of
participants across the intervention and control group reported no
alcohol consumption at baseline leaving little room for any change
to be observed postintervention. The eQect of the intervention may
be diQerent in populations with diQerent levels of baseline risk.
Service utilisation
Evidence for whether TCC via mobile devices increased service
utilisation was mixed. TCC via mobile devices may have a modest
eQect on increasing the proportion of women attending four or
more antenatal appointments (cluster-adjusted OR 1.54, 95% CI
0.80 to 2.96; n = 2550; low-certainty evidence – downgraded due
to risk of bias and imprecision, CI encompasses both benefit and
harm; Analysis 1.8) (Lund 2012). Based on pooled analyses of this
trial and another conducted in Canada, TCC via mobile devices
may increase attendance for antenatal vaccinations (influenza and
tetanus) (OR 1.36, 95% CI 0.90 to 2.06; n = 714; low-certainty
evidence – downgraded due to risk of bias and imprecision
(Analysis 1.9) (Lund 2012; Yudin 2017). The study by Lund 2012
also suggests that TCC via mobile devices may increase antenatal
attendance for preventive treatment for malaria (cluster adjusted
OR 1.69, 95% CI 0.82 to 3.48; low-certainty evidence – downgraded
for risk of bias and imprecision; Analysis 1.10).
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Two studies examined the eQect of TCC via mobile devices on
the proportion of births with a skilled attendant present The
intervention may make little or no diQerence in one low-risk
setting where 99% of both the control and intervention group had
a skilled attendant at birth (OR 1.00, 95% CI 0.34 to 2.94; n =
1743; low-certainty evidence – downgraded due to risk of bias and
imprecision; Analysis 1.11) (Joshi 2015). The second trial conducted
in a high-risk setting (Tanzanian urban and rural settings where
about 50% of all deliveries take place at home with unskilled
attendance) found that there may be benefit in urban populations
(cluster-adjusted OR 4.45, 95% CI 1.36 to 14.51; n = 1077), but not
rural populations (cluster adjusted OR 0.83, 95% CI 0.36 to 1.92; n =
1473) (low-certainty evidence – downgraded due to risk of bias and
imprecision; Analysis 1.11) (Lund 2012) (this study only reported
eQect estimates accounting for clustering separately by urban and
rural for this outcome).
Two studies examined the eQect of TCC via mobile devices on
utilisation of care for newborns. One trial conducted in Kenya
found that the intervention may make little or no diQerence to
care utilisation (RR 0.98, 95% CI 0.87 to 1.11; n = 56; low-certainty
evidence – downgraded for risk of bias and imprecision; Analysis
1.12). However, this was a low-risk setting where 96% of the control
group attended care for their newborn leaving little room for
demonstration of an improvement (McConnell 2016). Another trial,
conducted in Ecuador – a high risk setting where utilisation of care
for newborns was lower (53.3% attendance in the control group)
– reported that the intervention may increase the proportion of
women attending services for infant care within 10 days of delivery
(RR 1.35, 95% CI 1.02 to 1.78; n = 135; low-certainty evidence
– downgraded for risk of bias and imprecision; Analysis 1.12)
(Maslowsky 2016). Maslowsky 2016 also reported that "no eQect of
the intervention on attendance at maternal postpartum visits was
observed," without providing data for extraction.
One study in Kenya showed that TCC via mobile device may
increase attendance for a postpartum care appointment at 10 days
postpartum (RR 1.50, 95% CI 0.30 to 7.52; n = 56; low-certainty
evidence – downgraded due to risk of bias and imprecision; Analysis
1.13), and may have little or no eQect on newborn vaccination
(pentavalent and polio at up to nine weeks) (RR 1.08, 95% CI 0.89
to 1.32; n = 40; low-certainty evidence – downgraded due to risk of
bias and imprecision; Analysis 1.14) (McConnell 2016).
Health status and well-being
Based on very low-certainty evidence from one study in Tanzania,
we are uncertain as to whether TCC via mobile devices has an
eQect on maternal mortality (RR 2.86, 95% CI 0.30 to 27.40; n =
2637; downgraded due to risk of bias and twice for imprecision;
Analysis 1.15) (Lund 2012). While this eQect estimate is large, it is
based on very few events (four maternal deaths in the intervention
group and one in the control group), and the CI is very wide,
consistent with a decrease in mortality as well as a large increase;
therefore, we cannot be certain what the eQect might be. This
study also provided low-certainty evidence that the intervention
may slightly reduce severe obstetric complications up to six weeks
postpartum (RR 0.86, 95% CI 0.70 to 1.07; n = 2550; downgraded
due to risk of bias and imprecision; Analysis 1.15) (Lund 2012). The
trial conducted by McConnell 2016 provided low-certainty evidence
that TCC via mobile devices may reduce the likelihood of reporting
having experienced 'any maternal health problem' up to 10 days
postpartum (RR 0.50, 95% CI 0.90 to 2.76; n = 56; downgraded
due to risk of bias and imprecision; Analysis 1.15). There was
low-certainty evidence that TCC via mobile devices may reduce
self-reported breast pain and breast engorgement up to three
months postpartum (pain: RR 0.28, 95% CI 0.09 to 0.80; n = 332;
engorgement: RR 0.58, 95% CI 0.31 to 1.10; n = 332; Analysis 1.15)
(Kamau-Mbuthia 2013). There was low-certainty evidence that the
intervention may result in little or no diQerence to the number of
acute maternal episodes requiring a clinic visit up to three months
postpartum (MD 0.06, 95% CI –0.19 to 0.31; n = 135; downgraded
due to risk of bias and imprecision; Analysis 1.16) (Maslowsky 2016).
There was very low-certainty evidence relating to the eQect of
the intervention on neonatal mortality and morbidity based on
three trials (in Tanzania and Kenya) (OR 1.00, 95% CI 0.61 to
1.64; n = 2870; downgraded once due to risk of bias and twice
for imprecision; Analysis 1.17) (Kamau-Mbuthia 2013; Lund 2012;
McConnell 2016). There was moderate-certainty evidence that the
intervention may reduce the number of acute neonatal episodes
requiring a clinic visit up to three months postpartum (MD –0.53,
95% CI –0.92 to –0.14; n = 135; downgraded due to risk of bias;
Analysis 1.18) (Maslowsky 2016). One study reported on the eQect of
TCC via mobile devices on gestational age at birth and birth weight
(gestational age: MD 0.10 weeks, 95% CI –0.45 to 0.65; n = 61; birth
weight: MD –173 g, 95% CI –448.87 to 102.87; n = 61; low-certainty
evidence – downgraded due to risk of bias and imprecision; Analysis
1.19) (Jareethum 2008). Two studies conducted in Thailand and
Zanzibar reported preterm birth (RR 0.85, 95% CI 0.31 to 2.33;
n = 2557; low-certainty evidence – downgraded due to risk of
bias and an imprecise eQect estimate, which encompassed both
large potential benefit and harm of the intervention; Analysis
1.20) (Jareethum 2008; Lund 2012). A sensitivity analysis was also
conducted to examine the eQect of excluding the cluster RCT by
Lund 2012 from the analysis with preterm birth as the outcome.
This resulted in no substantive change in the findings; the point
estimate remained in the direction of intervention benefit (RR 0.18,
95% CI 0.01 to 3.64; Analysis 1.21), but the CI was considerably
wider, encompassing both benefit and harm.
Targeted client communication via mobile devices versus non-
digital targeted communication
Summary of findings 2 presents the evidence relating to the
eQect of TCC via mobile devices compared to non-digital targeted
communication among pregnant and postpartum women for the
outcomes of maternal mortality and morbidity, neonatal mortality
and morbidity, breastfeeding, attendance for ANC, receipt of
intrapartum care, and unintended consequences.
Health behaviour change
One study conducted in Kenya compared TCC via mobile devices to
non-digital targeted communication (in the form of home visits by
community health workers). This provided low-certainty evidence
relating to the eQect on exclusive breastfeeding at nine weeks
postpartum (RR 0.92, 95% CI 0.79 to 1.07; n = 42; Analysis 2.1;
downgraded due to risk of bias and imprecision) (this study
reported 100% of participants were breastfeeding in the control
arm, so there was no room for benefit to be observed and the
eQect of the intervention may be diQerent in populations with
diQerent levels of baseline risk) (McConnell 2016). The same study
also provided low-certainty evidence for the eQect on contraceptive
use at nine weeks postpartum (RR 1.45, 95% CI 0.78 to 2.69; n =
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42; downgraded due to risk of bias and imprecision; Analysis 2.2)
(McConnell 2016).
Service utilisation
The trial by McConnell 2016 provided moderate-certainty evidence
that the intervention made little or no diQerence to attendance for
newborn care at 10 days postpartum (RR 0.97, 95% CI 0.87 to 1.09; n
= 59; downgraded due to risk of bias; Analysis 2.3) or attendance for
newborn vaccination at nine weeks (pentavalent and polio vaccine)
(RR 1.01, 95% CI 0.88 to 1.16; n = 42; downgraded due to risk of
bias; Analysis 2.4). This trial also provided low-certainty evidence
relating to the intervention eQect on attendance for a maternal
care postpartum appointment (RR 0.56, 95% CI 0.18 to 1.79; n =
59; downgraded due to risk of bias and imprecision; Analysis 2.5)
(McConnell 2016).
Health status and well-being
Based on the McConnell 2016 trial, there was low-certainty
evidence that the intervention may reduce 'any maternal health
problem' reported up to 10 days postpartum (RR 0.19, 95% CI 0.04
to 0.79; n = 59; Analysis 2.6) and 'any newborn health problem'
reported up to 10 days postpartum (RR 0.52, 95% CI 0.25 to 1.06; n
= 59; Analysis 2.7). For both outcomes, the certainty of the evidence
was downgraded due to risk of bias and imprecision due to the
small number of events.
Targeted client communication via mobile devices versus digital
non-targeted communication
Summary of findings 3 presents the evidence relating to the
eQect of TCC via mobile devices compared to digital non-targeted
communication among pregnant and postpartum women for the
outcomes of maternal mortality and morbidity, neonatal mortality
and morbidity, breastfeeding, attendance for ANC, receipt of
intrapartum care, and unintended consequences.
Health behaviour change
No studies reported health behaviour outcomes for the comparison
of TCC via mobile devices compared with digital non-targeted
communication.
Service utilisation
Based on one study in the USA comparing TCC via mobile devices
with digital non-targeted communication, there was low-certainty
evidence that the intervention may have little or no eQect on
attendance for antenatal influenza vaccination (RR 1.05, 95%
CI 0.71 to 1.58; n = 204; downgraded due to risk of bias and
imprecision; Analysis 3.1) (Moniz 2013). Based on a single study
conducted in Nigeria we are uncertain as to whether TCC via
mobile devices has an eQect on the proportion of births occurring
with skilled attendant when compared with digital non-targeted
communication (RR 1.00, 95% CI 0.69 to 1.45; n = 16; very low-
certainty evidence – downgraded twice due to risk of bias and once
due to imprecision; Analysis 3.2) (Omole 2018).
Health status and well-being
No studies reported health status and well-being outcomes for the
comparison of TCC via mobile devices compared with digital non-
targeted communication.
Patient/client acceptability and satisfaction with the intervention
There was generally high rates of satisfaction with the interventions
received. One UK trial targeting smoking cessation in pregnancy
reported that 61.7% of intervention participants thought the
messages were helpful, and 80.8% would recommend the support,
while 14.2% reported that the messages were 'annoying' and 13.3%
discontinued the support by texting 'STOP' (Naughton 2017). One
study in Canada evaluating the eQect of text messages aiming to
increase influenza vaccine uptake during pregnancy found that
88% of intervention recipients were satisfied with the messages;
81% found the information in the messages useful; 65% thought
the messages were appropriately timed; and 60% thought that
the number of messages was right (received two messages per
week for four weeks) (Yudin 2017). About 99% of intervention
recipients in a trial conducted in Nigeria stated that they thought
the SMS reminders improved ANC attendance; over 95% stated the
messages influenced their decision to deliver in a health facility
and to attend a postnatal clinic; 77.8% stated that the messages
helped them to complete immunisations and preventive therapy
for malaria in pregnancy; and 96.6% agreed that they supported
the use of a SMS platform for informing ANC clients about
obstetric danger signs (Omole 2018). One trial in India reported
that 89.3% of the intervention group were satisfied with the
content of the voice messages and 97.4% with animations received
(Joshi 2015). One trial among pregnant women in Thailand who
received text messages about pregnancy and the early postpartum
period reported high levels of satisfaction (a mean score of 9.25,
based on a visual analogue scale of 1 to 10 points) (Jareethum
2008). The majority of participants receiving the SMS intervention
in one trial conducted Tanzania rated the messages positively.
About 59% stated that receiving text messages influenced the
number of times they attended ANC and 71% reported that the
messages helped them in various areas, including learning about
danger signs in pregnancy and feeling that the health system
cared for them (Lund 2012). The trial of an intervention delivered
through phone calls providing postpartum health education and
support in Ecuador reported almost universal satisfaction – 98%
of intervention participants agreed that they would like to have
access to the service at their next birth, and 100% that they
would recommend the service to a friend (Maslowsky 2016). Most
recipients of messages communicating the importance of influenza
vaccinations during pregnancy along with general health advice
(USA) reported that they liked the text messages (90%), found them
to be helpful (86%), wanted to receive text messages in the future
(82%), and thought they increased their satisfaction with their ANC
(80%) (Moniz 2013).
Resource use
Naughton 2017 reported that the total cost of delivering the 'MiQuit'
text messaging intervention was GBP 4.62 per participant, and,
based on the relevant incremental quit rate estimate of 3.46%, this
resulted in an incremental cost per additional quitter of GBP 133.53
(95% CI –395.78 to 843.62).
Unintended consequences
None of the trials among pregnant and postpartum women
collected or reported data on unintended consequences.
Equity considerations
The three trials concerned with breastfeeding were conducted
in upper-middle and lower-middle income countries, and two
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of which specifically highlighted their inclusion of low-income
participants (Kamau-Mbuthia 2013; McConnell 2016). Both trials
of interventions aiming to reduce harmful behaviour during
pregnancy (smoking and alcohol consumption) were conducted in
high-income countries, and it is not possible to assess whether
the results are applicable to low-income settings (Evans 2014;
Naughton 2017). The two trials of TCC via mobile devices for
promoting attendance for antenatal influenza vaccination were
also from high-income countries: one primarily included unmarried
participants with low levels of education (Moniz 2013), while
the other study population was made up of mostly married
or partnered women with higher levels of education (Yudin
2017); despite the apparent socioeconomic diQerences in these
populations, both studies demonstrated no benefit.
Of note for consideration of issues relating to equity, is that more
than half of the trials applied a language-based criteria in their
inclusion/exclusion criteria. Given the nature of the intervention, it
is likely that those studies not explicitly stating the need to speak
the native language to partake in the study, will have also excluded
those lacking such fluency in a particular language. This raises the
issue of exclusion of illiterate populations and recent migrants,
who are known to be a particularly vulnerable population, but are
unable to provide consent to take part in studies that rely on phone-
based communications in a specific language.
Pregnant and postpartum women living with HIV
Targeted client communication via mobile devices versus
standard care
Summary of findings 4 presents the evidence relating to the
eQect of TCC via mobile devices compared to standard care or no
intervention among pregnant and postpartum women living with
HIV for the outcomes of maternal mortality and morbidity, neonatal
mortality and morbidity, attendance for ANC (including eMTCT
care), receipt of intrapartum care, unintended consequences,
neonate HIV status, and adherence to ARV therapy.
Health behaviours
One study reported the eQect of TCC via mobile devices on
whether mothers took any type of ARVs antenatally and postnatally
compared to standard care in Kenya (Kassaye 2016). There was low-
certainty evidence suggesting the intervention may make little or
no diQerence to maternal antenatal ARV usage (RR 1.04, 95% CI
0.91 to 1.19; n = 503; downgraded twice due to risk of bias; Analysis
4.1). The same study also provided very low-certainty evidence
relating to the eQect of the intervention on maternal postnatal ARV
usage (RR 0.87, 95% CI 0.61 to 1.24; n = 471; downgraded twice for
risk of bias and once for imprecision; Analysis 4.2). This study also
reported infant ARV/PMTCT treatment adherence as an outcome,
providing low-certainty evidence that the intervention may have
little or no eQect (RR 1.01, 95% CI 0.98 to 1.04; n = 223; downgraded
twice due to risk of bias; Analysis 4.3).
Pooled analyses of two studies carried out in Kenya provided low-
certainty evidence that TCC via mobile devices may have little or
no eQect on increasing rates of infant HIV testing in comparison to
standard care (RR 1.04, 95% CI 0.95 to 1.13; n = 838; downgraded
twice due to risk of bias; Analysis 4.4) (Kassaye 2016; Odeny 2014).
Repeating this analysis excluding the cluster RCT (Kassaye 2016),
resulted in very little change from the original pooled estimate (RR
1.08, 95% CI 1.00 to 1.16; n = 378).
Service utilisation
One trial conducted in Kenya provided very low-certainty evidence
relating to the eQect of a text messaging intervention on
the proportion of births occurring in health facilities, with CI
encompassing both potential intervention benefit and harm (RR
0.85, 95% CI 0. 62 to 1.15; n = 134; downgraded twice due to risk
of bias and once due to imprecision; Analysis 4.6) (Kassaye 2016).
This trial also provided low-certainty evidence that the intervention
may result in a slight increase in the mean number of face-to-face or
mobile communications with a healthcare worker during ANC (MD
1.50, 95% CI –0.36 to 3.36; n = 297; downgraded twice due to risk of
bias; Analysis 4.7).
One trial carried out among pregnant women living with HIV in
Kenya found that a text messaging intervention may increase
attendance to appointments for postpartum care (RR 1.66, 95% CI
1.02 to 2.70; n = 381; moderate-certainty evidence – downgraded
due to the low number of events recorded; Analysis 4.5) (Odeny
2014).
Health status and well-being
Based on low-certainty evidence from a single trial in Kenya, TCC via
mobile devices may make little or no diQerence to neonatal health
(RR for neonatal death or stillbirth: 1.12, 95% CI 0.39 to 3.28; n =
381; downgraded twice for imprecision; Analysis 4.8) (Odeny 2014).
Given the wide CI consistent with both benefit and harm, there is
uncertainty about what the true eQect might be. Pooled analyses
of two trials in Kenya also provided very low-certainty evidence,
meaning we are uncertain as to whether TCC via mobile devices
has an eQect on the proportion of infants testing HIV positive (RR
0.54, 95% CI 0.11 to 2.56; n = 852; downgraded one level due to
risk of bias and two levels due to imprecision; Analysis 4.9). The
CI encompassed both benefit and harm, meaning we are uncertain
as to what the true eQect might be (Kassaye 2016; Odeny 2014).
Repeating this analysis excluding the cluster RCT (Kassaye 2016),
resulted in very little change from the original pooled estimate (RR
0.64, 95% CI 0.11 to 3.80; n = 378).
Targeted client communication via mobile devices versus non-
digital targeted communication
Summary of findings 5 presents the evidence relating to the
eQect of TCC via mobile devices compared to non-digital targeted
communication among pregnant and postpartum women living
with HIV for the outcomes of maternal mortality and morbidity,
neonatal and morbidity, attendance for ANC (including eMTCT
care), receipt of intrapartum care, unintended consequences,
neonate HIV status, and adherence to ARV therapy.
Health behaviours
No studies reported health behaviour outcomes for the comparison
of TCC via mobile devices compared with non-digital targeted
communication among pregnant and postpartum women living
with HIV.
Service utilisation
No studies reported service utilisation outcomes for the
comparison of TCC via mobile devices compared with non-digital
targeted communication among pregnant and postpartum women
living with HIV.
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
Health and well-being
No studies reported health and well-being outcomes for the
comparison of TCC via mobile devices compared with non-digital
targeted communication among pregnant and postpartum women
living with HIV.
Targeted client communication via mobile devices versus digital
non-targeted communication
Summary of findings 6 presents the evidence relating to the
eQect of TCC via mobile devices compared to digital non-targeted
communication among pregnant and postpartum women living
with HIV for the outcomes of maternal mortality and morbidity
combined, neonatal and morbidity combined, attendance for ANC
(including eMTCT care), receipt of intrapartum care, unintended
consequences, neonate HIV status, and adherence to ARV therapy.
Health behaviour
One trial conducted in Kenya among women living with HIV
recruited within 24 hours of birth examined the eQect of a
two-weekly phone calls about PMTCT compared with standard
healthcare messages. Based on this study, TCC via mobile devices
may be beneficial for infant ARV/PMTCT treatment adherence
at six weeks postpartum compared with digital non-targeted
communication (RR 1.26, 95% CI 1.07 to 1.48; n = 150; low-certainty
evidence – downgraded twice due to risk of bias with the trial at
unclear or high risk of bias across all applicable domains; Analysis
5.1) (Kebaya 2014).
Service utilisation
One trial provided low-certainty evidence that the intervention may
increase attendance to appointments for postpartum care at 10
weeks (RR 1.86, 95% CI 1.34 to 2.58; n = 150; downgraded twice for
risk of bias; Analysis 5.2) (Kebaya 2014).
Health and well-being
No studies reported health status and well-being outcomes for the
comparison of TCC via mobile devices compared with digital non-
targeted communication among pregnant and postpartum women
living with HIV.
Acceptability
No studies among pregnant and postpartum women living with HIV
reported measures of acceptability.
Resource use
No studies among pregnant and postpartum women living with HIV
reported on resource use.
Unintended consequences
No studies among pregnant and postpartum women living with HIV
reported on unintended consequences or adverse outcomes.
Equity considerations
All three trials were conducted in Kenya (a lower-middle income
country), and it is not possible to assess the applicability of these
findings to other settings. One study specifically stated that it
excluded women without a phone, who did not receive ANC, and
who could not read or did not have someone to read, making it
highly likely that particularly vulnerable women were unable to
take part in this trial (Odeny 2014). The other two studies provided
little information on exclusion criteria, however, all trials recruited
from healthcare facilities, meaning that those not accessing care
will not have had the opportunity for inclusion.
Parents or carers of children aged less than five years
Targeted client communication via mobile devices versus
standard care
Summary of findings 7 presents the evidence relating to the
eQect of TCC via mobile devices compared to standard care or no
intervention among parents of children aged under five years for
the outcomes of child morbidity and mortality, child nutritional
status, breastfeeding, clinic attendance for necessary healthcare,
hygiene practices, correct treatment taken, and unintended
consequences.
Health behaviours
No studies reported health behaviour outcomes for the comparison
of TCC via mobile devices compared with standard care among
parents of children under five years of age.
Service utilisation
Overall, for the outcome of attendance to services for necessary
health care, we found low-certainty evidence for a modest
intervention benefit based on the pooled results of 10 studies
concerned with attendance for childhood vaccinations at six to 12
months and attendance for HIV medical appointments (among HIV-
positive and HIV-exposed infants) (RR 1.21, 95% CI 1.08 to 1.34;
n = 5660; downgraded for risk of bias and inconsistency; Analysis
6.1) (Ahlers-Schmidt 2012; Bangure 2015; Bigna 2015; Brown 2016;
Domek 2016; Gibson 2017; Haji 2016; Hannan 2016; Hofstetter
2015a; Stockwell 2015). Given the very high degree of inconsistency
indicated by the I2 value (I2 = 91%), we also present subgroup
analyses by type of service and timing of vaccination, described
below.
Pooled analyses of five studies (conducted in the USA, Zimbabwe,
Guatemala, and Kenya) indicated that TCC via mobile devices may
result in a slight increase in attendance for vaccinations at six
months (RR 1.14, 95% CI 1.01 to 1.28; n = 1586; low-certainty
evidence – downgraded due to risk of bias and inconsistency;
Analysis 6.1) (Ahlers-Schmidt 2012; Bangure 2015; Domek 2016;
Haji 2016; Hannan 2016). The I2 value was 63%, with one study
reporting an point estimate indicative of reduced vaccination rates
in the intervention arm (Ahlers-Schmidt 2012), and the other four
studies reporting eQect estimates indicative of benefit. Excluding
the cluster RCT (Haji 2016) from this analysis resulted in a negligible
change in the pooled eQect estimate (RR 1.13, 95% CI 0.96 to 1.32).
Four studies (conducted in Nigeria, Kenya, USA) provided low-
certainty evidence that TCC via mobile devices may increase
attendance for vaccinations at 12 months (RR 1.24, 95% CI
1.02 to 1.52; n = 3832) (Brown 2016; Gibson 2017; Hofstetter
2015a; Stockwell 2015) (Analysis 6.1). This body of evidence
was downgraded due to risk of bias and inconsistency between
individual eQect estimates (I2 = 92%), with two trials reporting
eQect estimates consistent with intervention benefit (Brown 2016;
Stockwell 2015), and two trials reporting little or no diQerence
with CI encompassing no eQect (Gibson 2017; Hofstetter 2015a).
Repeating this analysis without including the cluster RCTs (Brown
2016; Gibson 2017), resulted in little change to the eQect estimate,
but a widening of the CI (RR 1.28, 95% CI 0.82 to 2.01).
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Pooled analyses of four RCTs (conducted in the USA, Nigeria, and
Kenya) provided moderate-certainty evidence that TCC via mobile
devices probably has a modest eQect on increasing 'timeliness
of vaccination' (vaccine receipt within a certain time period)
compared with standard care (RR 1.18, 95% CI 1.04 to 1.34; n = 2400;
downgraded due to risk of bias; Analysis 6.2) (Ahlers-Schmidt 2012;
Eze 2015; Gibson 2017; Stockwell 2015). Excluding the cluster RCT
from this analysis (Gibson 2017) resulted in a negligible change in
the pooled eQect estimate (RR 1.19, 95% CI 0.96 to 1.46).
One trial indicated that TCC via mobile devices probably increases
the attendance of HIV-positive and HIV-exposed children to medical
appointments in Cameroon (RR 1.63, 95% CI 1.26 to 2.11; n = 242;
moderate-certainty evidence – downgraded due to imprecision
given the small number of events; Analysis 6.1) (Bigna 2015).
One study conducted in the USA provided very low-certainty
evidence meaning we are uncertain as to whether the two-way
communication phone and texting intervention had an eQect on
attendance to the emergency department in the six months aIer
birth (no attendance: RR 1.32, 95% CI 1.03 to 1.70; n = 129;
downgraded due to risk of bias, imprecision resulting from a small
number of events, and indirectness (a single study conducted in a
high-income country; Analysis 6.3) (Hannan 2016).
Health and well-being
No studies reported health and well-being outcomes for the
comparison of TCC via mobile devices compared with standard care
among parents of children under five years of age.
Targeted client communication via mobile devices versus non-
digital targeted communication
Summary of findings 8 presents the evidence relating to the
eQect of TCC via mobile devices compared to non-digital targeted
communication among parents of children under five years of age
for the outcomes of child morbidity and mortality, child nutritional
status, breastfeeding, clinic attendance for necessary healthcare,
hygiene practices, correct treatment taken, and unintended
consequences.
Health behaviours
One trial carried out in India comparing the eQect of providing oral
health education via text messages with the provision of the same
information via pamphlets suggests that the intervention may have
little or no eQect on children's oral health at four weeks, measured
with the VPI (MD –2.10, 95% CI –7.54 to 3.34; n = 143; low-certainty
evidence – downgraded due to risk of bias and imprecision; Analysis
7.1) (Sharma 2011).
Service utilisation
Based on one study, there was low-certainty evidence that TCC via
mobile devices might result in a slight increase in attendance for
vaccinations compared with non-digital targeted communication
(in the form of stickers) (RR 1.13, 95% CI 1.00 to 1.28; n = 744;
downgraded twice due to risk of bias; Analysis 7.2) (Haji 2016).
Health and well-being
No studies reported health and well-being outcomes for the
comparison of TCC via mobile device compared with non-digital
targeted communication among parents of children under five
years of age.
Targeted client communication via mobile devices versus digital
non-targeted communication
Summary of findings 9 presents the evidence relating to the
eQect of TCC via mobile devices compared to digital non-targeted
communication among parents of children under five years of age
for the outcomes of child morbidity and mortality, child nutritional
status, breastfeeding, clinic attendance for necessary healthcare,
hygiene practices, correct treatment taken, and unintended
consequences.
Health behaviour
No studies reported health behaviour outcomes for the comparison
of TCC via mobile device compared with digital non-targeted
communication among parents of children under five years of age.
Service utilisation
One trial in Hawaii compared vaccination reminders delivered via
SMS with the control arm receiving general health information for
their babies. This study found that SMS reminders may reduce
attendance for vaccinations at seven months; however, the CI
encompassed both benefit and harm (RR 0.63, 95% CI 0.33 to 1.20;
n = 40; low-certainty evidence – downgraded due to risk of bias and
imprecision; Analysis 8.1) (Niederhauser 2015).
Health status and well-being
No studies reported health status and well-being outcomes for
the comparison of TCC via mobile device compared with digital
non-targeted communication among parents of children under five
years of age.
Acceptability and satisfaction
There was generally a high level of acceptability and satisfaction
with the interventions assessed among parents of children aged
under five years. One trial in the USA of text message reminders for
childhood vaccinations interviewed 18/50 participants randomised
to the intervention group, all of whom reported that they found
the messages 'helpful' or 'somewhat helpful' and that they
would be willing to receive text message reminders in the future
(Ahlers-Schmidt 2012). Most (93%) intervention recipients in one
trial of SMS immunisation reminders in Zimbabwe perceived the
use of SMS as 'very beneficial' (Bangure 2015). One study of
SMS vaccination reminders in Guatemala reported that 99.1%
of intervention parents agreed that they would be interested in
receiving text message reminders in the future and 67.5% said
that they would be willing to pay for future SMS reminders
(Domek 2016). One study in Kenya reported that 97.5% of
participants thought the number of reminders was 'just right' (SMS
vaccination reminders were sent three days and the day before
each scheduled immunisation visits) (Gibson 2017). Another study
involving reminders for the measles, mumps, and rubella (MMR)
vaccination in the USA reported that 86.8% of participants liked
the messages and 9.3% did not like them (Hofstetter 2015a). Finally
another US study reported that nearly all intervention recipients
(98.0%) were very satisfied or satisfied with the messages which
sought to increase attendance for childhood influenza vaccination
(Stockwell 2015).
Resource use
Five studies reported on the resource use of the interventions. One
study reported a cost of USD 59.22 for all the messages (n = 1368)
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(Bangure 2015). Another reported a cost of USD 0.27 per child for
the project (Haji 2016). One study reported that the intervention
was estimated to save between USD 51,030 and USD 104,277 in
healthcare costs (Hannan 2016). Another study did not report the
total costs but noted that text messaging was the most eQicient
intervention when both the direct costs of the intervention and
staQ working time were considered (Bigna 2015). Only one study
reported on a cost-eQectiveness analysis and found that projected
cost of using SMS reminders was about 25% what it would cost
to use Junior Community Health Extension Workers (CHEWs) for
functional home visits in one year (Eze 2015).
Unintended consequences
No studies among parents of children aged under five years
reported on unintended consequences.
Equity considerations
The trials targeting childhood immunisations were conducted
in a range of high-, lower-middle-, and low-income countries.
Two studies specifically included low-income families (Hannan
2016; Stockwell 2015), for example, the intervention examined
by Hannan 2016 targeted low-income first-time mothers. A third
study assessing text message reminders for immunisation recruited
from two public health clinics in Guatemala City serving a
publicly insured and low-income population (Domek 2016). Of
the participants involved in the text messaging trial conducted in
Kenya, 77% were unemployed and 49% had only primary level
education (Haji 2016).
Sensitivity analyses
We planned to conduct a sensitivity analysis only including studies
at low risk of bias (those scored at low risk of bias for the sequence
generation, allocation concealment, and incomplete outcome data
domains). The following trials had a low risk of bias: Yudin 2017
(pregnant and postpartum women); Odeny 2014 (pregnant and
postpartum women living with HIV); and Bigna 2015; Domek 2016;
Gibson 2017; Hofstetter 2015a (parents of children aged under five
years). Therefore, only the comparison of TCC via mobile devices
and standard care for outcome of uptake of childhood vaccinations
at 12 months could undergo sensitivity analyses. As reported
above, the pooled results of four studies was RR 1.28 (95% CI 0.82 to
2.01) (Brown 2016; Gibson 2017; Hofstetter 2015a; Stockwell 2015).
However, when repeating this analysis pooling only the two studies
at low risk of bias, the eQect estimate was attenuated to RR 1.03
(95% CI 0.98 to 1.09; n = 2802) (Gibson 2017; Hofstetter 2015a).
Studies not contributing usable data
All included studies provided data that could be analysed
using meta-analyses for examining the intervention eQect on
health behaviour, service utilisation, health and well-being, or
a combination of these, meaning that conclusions relating to
eQectiveness have been made based on all available data from
included studies.
D I S C U S S I O N
Summary of main results
We included 27 studies in our review. For pregnant and postpartum
women and parents of children aged under five years, trials were
conducted in a range of low- to high-income countries. All trials
among pregnant women living with HIV were conducted in one
lower-middle income country.
Pregnant and postpartum women
See Summary of findings 1; Summary of findings 2; and Summary
of findings 3.
Targeted client communication delivered by mobile device
versus standard care
Women receiving TCC via mobile devices may breastfeed more in
settings where breastfeeding is less common. They may go to more
ANC appointments, and may use skilled birth attendants more in
settings where this is less common. We do not know if TCC via
mobile devices aQects women's or infant morbidity or mortality
because the evidence is of very low certainty.
Targeted client communication via mobile devices compared
to non-digital targeted client communication or digital non-
targeted communication
When compared to non-digital TCC, TCC via mobile devices may
have little or no eQect on breastfeeding, and may improve maternal
and newborn health. We do not know what the eQect is on health
service use because the evidence is missing.
We do not know what the eQect of TCC via mobile devices is on
women's use of a skilled birth attendant when compared to digital
non-targeted communication because the evidence is of very low
certainty. TCC via mobile devices may make little or no diQerence to
whether women attendance appointments for vaccination during
pregnancy when compared to digital non-targeted communication.
We do not know what the eQect of TCC via mobile devices is
on women's or babies' morbidity or mortality or breastfeeding
when compared to digital non-targeted communication because
the evidence is missing.
The eQects of TCC via mobile devices on unintended consequences
is unknown due to lack of studies. Only one study reported
on resource use associated with the intervention. Satisfaction
with the intervention was generally high when assessed, but few
studies conducted in low-income settings reported on measures of
satisfaction.
Pregnant and postpartum women living with HIV
See Summary of findings 4; Summary of findings 5; and Summary
of findings 6.
Targeted client communication delivered by mobile device
versus standard care
Women who receive TCC via mobile devices may go to slightly
more ANC appointments. We do not know what the eQect of TCC
via mobile devices is on whether women give birth in a health
facility because the evidence was of very low certainty. We do
not know what the eQect of TCC via mobile devices is on babies'
health or mortality because the evidence is of very low certainty.
No studies reported on maternal mortality or morbidity. TCC via
mobile devices may make little or no diQerence to maternal and
infant adherence to ARV therapy.
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Targeted client communication via mobile devices compared
to non-digital targeted client communication or digital non-
targeted communication
We do not know what the eQect of TCC via mobile devices is on
women's or babies' health or mortality, use of healthcare services
during pregnancy, or whether women use skilled attendants at
birth because the evidence is missing. Women who receive TCC via
mobile devices may follow their baby's ARV treatment better than
women who receive digital non-targeted communication.
For pregnant and postpartum women living with HIV, we are
uncertain of the satisfaction and resource use associated with
receiving TCC via mobile devices, or the eQects on unintended
consequences, due to lack of evidence.
Parents or carers of children aged under five years
See Summary of findings 7; Summary of findings 8; and Summary
of findings 9.
Targeted client communication delivered by mobile device
versus standard care
We do not know what the eQect of parental receipt of TCC via
mobile devices is on breastfeeding, children's health or nutrition,
whether they received the right treatments, or parents' hygiene
practices because the evidence is missing. Parents who receive
TCC via mobile devices may take their children to more healthcare
services, such as vaccination appointments; however, the results
varied widely between studies.
Targeted client communication via mobile devices compared
to non-digital targeted client communication or digital non-
targeted communication
We do not know what the eQect of TCC via mobile devices
is on breastfeeding, children's health or nutrition, or whether
they received the correct treatments, because the evidence in
missing. Parents who receive TCC via mobile devices may take
their children to more vaccination appointments compared to
parents who receive non-digital targeted communication although
the eQects vary. There is little or no diQerence observed between
these groups in terms of oral hygiene practices. Parents who
receive TCC via mobile devices may take their children to fewer
vaccination appointments than parents who receive digital non-
targeted communication, but it is possible that the intervention
makes little or no diQerence.
The eQects of TCC via mobile devices on unintended consequences
is unknown due to lack of studies. Acceptability and satisfaction
with the intervention was high in the six studies that reported
these outcomes. Costs were low in the five studies that reported on
intervention costs.
Overall completeness and applicability of evidence
This review includes evidence from 27 studies, 11 of which were
conducted among pregnant and postpartum women, three among
pregnant and postpartum women living with HIV, and 13 among
parents of children aged under five years. In collating those trials
relating to the same population, employing the same comparison
groups, and measuring the same outcomes, these specific bodies of
evidence were generally made up of only a small number of studies,
thereby limiting the extent to which conclusions can be made.
With the exception of trials among pregnant and postpartum
women living with HIV, all of which were carried out in Kenya, there
was generally a varied geographical spread for where studies were
conducted, with representation of low- to high-income countries.
Furthermore, the trials recruited from a mix of community and
healthcare settings.
No trials targeted or measured correct treatment of childhood
illness or child nutritional outcomes. No trials reported measuring
unintended consequences or adverse events. However, HIV and
reproduction can be sensitive topics and there is the potential for
harm resulting from interventions concerned with these issues.
In the accompanying review focusing on reproductive and sexual
health, one trial among women living with HIV reported one
participant withdrew due to her undisclosed HIV status being
compromised (Palmer in preparation).
Quality of the evidence
Using GRADE methodology, we assessed the certainty of the
evidence for all outcomes. Among the pregnant and postpartum
population, there was low or very low-certainty evidence relating
to the eQect of TCC via mobile devices for most outcomes. There
was moderate-certainty evidence for only three outcomes among
this population, generally based on the results of a single trial.
For pregnant and postpartum women living with HIV, the evidence
for all outcomes except one were considered of low or very low
certainty. Based on trials conducted among parents of children
aged under five years, for most outcomes the evidence was of
low or very low certainty. Across all three populations, the most
common reasons for downgrading were risk of bias of the studies
and imprecision of the eQect estimates.
Given the nature of the interventions, participant blinding was
generally unfeasible. The trials among pregnant and postpartum
women primarily depended on self-reported outcome measures.
Therefore, among these studies there is risk of response bias which
could result in an overestimation of intervention benefit. Most
trials among parents of children aged under five years concerned
with increasing uptake of childhood vaccination were able to use
objective outcome measures based on clinic attendance recording
systems, meaning that for these studies, having unblinded
intervention recipients would be unlikely to bias the eQect
estimates recorded. Few other trials used objective outcomes,
which would be less subject to bias than self-reported measures.
Potential biases in the review process
There were limited resources to follow-up with authors of reports
that did not provide suQicient information for data extraction/risk
of bias assessments. Furthermore, publication bias, whereby trials
with positive findings are more likely to be published, may have
biased the selection of included studies in this review. However,
eQorts were made to overcome this through searching clinical trial
registries for prospectively registered trials.
Agreements and disagreements with other studies or
reviews
As with other communication and behaviour change interventions,
a challenge in synthesising the results of TCC interventions
delivered by mobile device is the heterogeneity of interventions,
ranging from reminders to educational and more complex
behaviour change support. As evidenced by the heterogeneity
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of some pooled estimates in our review and similar reviews
(Amankwaa 2018; McFadden 2017), this can result in real
diQerences in eQects of interventions even when they use the same
delivery mechanisms and target the same outcomes.
There was uncertain evidence relating to the eQect of TCC via
mobile devices for improving postpartum contraception use. The
CI was wide so modest benefits similar to those reported in
other Cochrane Reviews of contraception interventions delivered
by mobile phone for general populations of women or women
postabortion cannot be excluded (Palmer in preparation; Smith
2015).
Our finding that TCC delivered by mobile devices may improve
exclusive breastfeeding at three months in settings where
exclusive breastfeeding rates are modest is consistent with one
Cochrane Review which found that breastfeeding support is
eQective in increasing exclusive breastfeeding and the duration of
breastfeeding. We note, however, that the trial of TCC included in
our review was delivered by mobile phone calls and the Cochrane
Review found that face-to-face support was more eQective than
telephone support (McFadden 2017).
This review showed TCC delivered by mobile devices may increase
abstinence from smoking in pregnancy, but evidence is low
certainty. These findings are consistent with the eQects of TCC
delivered by mobile phone which doubles continuous abstinence
from smoking among general populations of smokers willing
to make a quit attempt (Free 2011; Palmer 2018b; Whittaker
2016). EQective smoking cessation support delivered by mobile
phone includes a range of behavioural change techniques, and
the behaviour change techniques found in eQective psychosocial
support for smoking cessation in pregnant women have also been
described (Lorencatto 2012). Since our search was completed, one
trial of TCC by mobile phone for smoking cessation in pregnant
women compared to digital non-targeted communication reported
an increase in validated no smoking in the last seven days at
three months (OR 1.47, 95% CI 1.21 to 1.78) (Abroms 2017a)
and one recent systematic review including the Abroms 2017a
trial reported an increase in smoking cessation during pregnancy
(pooled OR 1.59, 95% CI 1.07 to 2.38) (GriQiths 2018). Our review
findings are also consistent with the findings of one systematic
review of health education and psychosocial interventions, not
specifically delivered by mobile devices, for smoking cessation
during pregnancy which found evidence of a beneficial intervention
eQect (Chamberlain 2017).
Our finding of a lack of eQect of TCC via mobile devices for alcohol
reduction in pregnancy is consistent with one Cochrane Review
of psychological and education interventions for reducing alcohol
intake, not specifically delivered by mobile devices, which found no
intervention eQects for most outcomes (Stade 2009).
The eQect of TCC via mobile devices for improving antenatal and
postnatal adherence to ARV therapy among women living with HIV
was uncertain. The eQects on ARV/PMTCT adherence in infants were
mixed. One previous Cochrane Review examining text messaging
for adherence to ARV therapy in populations of all ages reported
evidence of beneficial eQects from two trials (Horvath 2012), but
further trials of ARV therapy adherence interventions delivered by
mobile phone have been published since 2012, with mixed results
reported in more recent systematic reviews (Quintana 2018; Shah
2019). One systematic review reported an increase in adherence
for adults based on a pooled analysis of interventions delivered
by SMS, but uncertain eQects of interventions delivered by voice
message (Amankwaa 2018).
The finding that TCC via mobile devices may improve service
utilisation, such as attendance to antenatal and postnatal
care appoints among pregnant and postpartum women, and
attendance for infant HIV medical appointments, is in accordance
with our findings relating to other populations (Palmer in
preparation), and previous research findings that mobile phone-
based reminders improve healthcare appointment attendance
(Free 2013b; Gurol-Urganci 2013).
Some feasibility studies have shown promise for TCC delivered by
mobile devices altering nutrition in infants or children (Singh 2014).
However, we did not identify any RCTs of nutritional interventions
or trials reporting infant or child nutrition outcomes that met our
inclusion criteria.
Our findings that TCC via mobile devices among parents of children
aged under five years may have modest eQects on increasing
attendance for childhood immunisations and necessary health care
is consistent with the findings of a previous review of mobile
phone-based interventions (Free 2013a),  and a Cochrane Review
examining face-to-face interventions for parents about childhood
vaccinations, which also found evidence for small intervention
benefits (Kaufman 2018). However, in our review, the eQects varied
in diQerent studies. This could  be due to bias, as  both of the
trials that found a positive eQect were at unclear risk of bias for
random sequence generation. It is also possible that there was
a ceiling eQect  in the Gibson 2017 trial due to the high uptake
of vaccination in the control arm (82%) leaving less scope  for
extra improvement to be demonstrated. It may also be that for
some vaccinations remembering an appointment is not the main
barrier to uptake, so simple reminders would not be expected to
improve attendance. The  Hofstetter 2015a trial in the USA was
targeting MMR, which in the context of vaccine concerns  might
be intractable to improvement using reminder messages only.
Educational messages targeting parental concerns about the MMR
vaccine could be more relevant.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
We cannot make strong recommendations for implementation of
targeted client communication (TCC) delivered by mobile devices
on the basis of this review as the certainty of the evidence was
primarily very low or low.
TCC interventions delivered by mobile devices, such as
appointment reminders have already been implemented in many
settings. Where healthcare providers and policy makers are
considering implementation, we suggest prioritising interventions
for which evidence is suggestive of an improvement in outcomes,
such as TCC delivered by mobile devices for general populations
of pregnant women for antenatal care attendance, skilled
attendance at birth, and for childhood vaccinations. However,
careful consideration should be given to the costs and resources
needed in conjunction with the limited strength of evidence
for gains in service use and health behaviours. Few studies in
this review reported on costs, but those that did so generally
indicated costs to be low. Furthermore, the interventions delivered
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in trials which observed evidence for a small increase in attendance
for vaccinations (parents of children aged under five years)
compared to standard care, consisted of simple reminders which
may be more straightforward to implement than more complex
interventions. The text messaging intervention evaluated by Odeny
2014 consisted of just 14 messages sent to pregnant women living
with HIV from 28 weeks' gestation to six weeks postdelivery,
but seemed to result in gains in relation to attendance for the
postpartum appointment, and infant HIV testing. In other areas
of health behaviour change, such as smoking cessation, eQective
TCC delivered by mobile devices has been shown to be highly
cost eQective (Guerriero 2013). The majority of TCC interventions
in this review were delivered by text message (SMS). The World
Health Organization and the International Telecommunication
Union have developed guidance on implementing SMS-based
smoking cessation support at scale, and much of this guidance
would apply to implementing any SMS health platform (WHO/
ITU 2015). Nonetheless, setting up, maintaining and monitoring
SMS platforms, and delivery requires resources and incurs
ongoing costs, which can represent a considerable burden and
challenge in some settings. Furthermore, the findings of one
complementary synthesis of qualitative research which explored
clients' perceptions and experiences of targeted communication
via mobile devices on topics related to reproductive, maternal,
newborn, child, and adolescent health (RMNCAH) (Ames 2019),
highlights continuing barriers to the widespread implementation
of TCC via mobile devices. Despite the high rate of mobile phone
ownership globally, use of these devices can still be limited by poor
access to mobile networks and the internet, phones breaking, the
inability to aQord airtime, and the inability to charge the device.
Given that there are contexts in which uninterrupted access to
mobile devices cannot be guaranteed, it may be premature to roll
out TCC via mobile devices if it is at the expense of other channels
of communication.
For some outcomes, the findings suggested intervention benefits
may be gained only in settings where the behaviour targeted is
relatively uncommon and there is greater scope for improvement.
For example, while TCC via mobile devices had little or no eQect
in a low-risk setting where the majority of births already occurred
with a skilled attendant present, there was evidence that the
intervention increased skilled birth attendance in a moderate-
risk urban setting where two-thirds of births occurred with skilled
attendance (but not in the rural area included in the same study).
Therefore, background levels of health service use and behaviours
(and existing health facility infrastructure), should be considered
prior to implementation. While the majority of comparisons in
the review were between TCC via mobiles devices and standard
care/no intervention, consideration should also be given to the
apparent lack of intervention benefit when the comparison group
is in receipt of something quite similar to the intervention. For
example. the trial by Niederhauser 2015 examined the eQect of
a TCC mobile device-delivered intervention involving childhood
vaccination reminders at four weeks and two weeks prior to
the routine vaccination appointments, compared with the control
group who received well baby messages. However, the study report
states that the participants in both groups were also receiving
the "routine reminders that they receive from their healthcare
providers," therefore, the finding of no additional benefit of the
reminder messaging intervention, and perhaps even a slight
negative eQect, might be considered unsurprising. This highlights
that an understanding of what is delivered as part of existing
medical practice, which may vary between contexts, is important to
prevent misplaced interventions which result in few or no gains.
Healthcare providers and policy makers should be especially
cautious regarding the implementation of interventions
specifically targeting pregnant women living with HIV. While the
evidence is of low or very low certainty, the confidence intervals
around the eQect estimates suggest that TCC delivered by mobile
devices may have little benefit or no eQect. Due to the sensitivity
and stigma associated with HIV status, it is essential that such
interventions are designed so that content and delivery ensures
confidentiality of sensitive material. In contexts where women's
access to phones is controlled by others, or where phones are
shared, it may not be feasible for content to remain private. In such
circumstances it may be better to include HIV-positive pregnant
women in mobile phone interventions for general populations
of pregnant women, such as for attendance for antenatal care,
rather than targeting them in isolation on the basis of their HIV
status. This is consistent with the findings of one synthesis of
qualitative research concerned with perceptions and experiences
of TCC via mobile devices on topics related to RMNCAH (Ames 2019).
Practical considerations for messaging concerned with stigmatised
or personal health conditions included the use of neutral language,
and tailoring the content, timing, and frequency of the messages
(Ames 2019).
No studies across the three populations in this review reported
on unintended consequences or adverse events. However, given
that reproduction can be a sensitive topic and HIV is subject to
considerable stigma, there is the potential for harm resulting from
interventions concerned with these issues. For example, in the
accompanying review focusing on reproductive and sexual health,
a trial among women living with HIV reported that one participant
withdrew due to her undisclosed HIV status being compromised.
Furthermore, globally one in three women has experienced
intimate partner violence in their lifetime and pregnancy is a
time when domestic violence can escalate (WHO 2013). There
is the potential that TCC on sensitive topics could result in
further escalations in abuse for women in abusive relationships.
Consequently, those implementing interventions should consider
how the risks of such potential unintended consequences can
minimised and monitored.
Issues relating to language and literacy have been highlighted
in this review as potential barriers in achieving equity of access
and benefit from communication-based interventions. This is
also a finding of the qualitative synthesis of clients' perceptions
experiences with such interventions (Ames 2019), in which
language, literacy, techno-literacy, or a combination of these
were raised as potential limiting factors for accessing these types
of interventions. Based on this, some participants reported a
preference for voice calls in which they could request clarifying
information. Where interventions are being implemented, this
should be accompanied by monitoring and evaluation of impact
(including both benefits and harms), equity, and associated costs.
Implications for research
• The eQect of TCC delivered by mobile devices on health
service use (antenatal care, delivery in a health facility)
and vaccinations at six and 12 months requires further
assessment. The vaccination interventions in this review
primarily provided reminders. Further TCC interventions, which
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also target attitudinal barriers to childhood vaccinations, should
be evaluated.
• Given the somewhat equivocal evidence relating to the eQects of
TCC delivered by mobile devices for pregnant women living with
HIV, future research should explore whether carefully designed
interventions can improve outcomes in this population, and the
contexts in which this can occur.
• We found no trials of TCC delivered by mobile devices that
targeted treatment of childhood illness, and infant and child
nutrition. Therefore, research is needed to evaluate whether
well-designed TCC interventions targeting these behaviours can
be eQective.
• Future research should ensure potential unintended
consequences and adverse events are considered in the design
of the intervention and evaluation, so that risks are minimised
and any such events that do occur are adequately captured.
• Researchers should ensure that interventions are adequately
described in suQicient detail for them to be replicated, for
example, with reference to guidance on reporting interventions
(Agarwal 2016; HoQmann 2014).
• Both trials and implementation research should evaluate equity
in access to, and the eQects of, TCC delivered by mobile devices
for maternal, neonatal, and child health.
• Where interventions have been shown to be eQective, cost-
eQectiveness analysis of TCC delivered by mobile device for
maternal, neonatal, and child health is needed.
• Further high-quality trials are warranted to evaluate the eQects
of TCC by mobile devices on behaviours such as postpartum
contraception use and breastfeeding. Given that lay support is
associated with increased exclusive breastfeeding and duration
of breastfeeding, trials of lay support for breastfeeding delivered
by mobile devices could be considered (McFadden 2017).
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Aim: to evaluate feasibility, stability of mobile service, and effect size.
Study design: parallel individual RCT
Recruitment: parents of newborns being discharged from a local hospital who intended to seek
child health care at the university resident and faculty clinic. Parents enrolled in the study by texting
"TRICKs" to the research phone number.
Study duration: up to 1 year
Study dates: January 2011 to February 2011
Participants Inclusion criteria: English- and Spanish-speaking parents of newborns were eligible if they owned a
mobile phone with text messaging capability.
Sample size (n): 90 (intervention: 50; standard care: 40)
Ahlers-Schmidt 2012 
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Age (mean): intervention: 26 (SD 5) years; control: 26 (SD 6) years
Sex (female): intervention: 84%; control: 83%
County: USA (high-income)
Setting: local hospital, university resident and faculty clinic in a Midwestern metropolitan area
Interventions Intervention: reminder text messages 7 days before their child's immunisations which were due at 2,
4, and 6 months of age.
Content: reminder and request to respond to query whether their child was immunised.
Frequency and intensity: 7 days before immunisations at 2, 4, and 6 months, assumed to be single
text messages.
Control: standard care/no intervention: parents in the control arm received standard notification (an
appointment card) of immunisations due only.
Co-interventions: none reported
Outcomes 1. Attendance for vaccinations; 2. Timely attendance for vaccinations; 3. Satisfaction with the service
(time point not reported)
Outcome assessment time point: 2, 4, 6 months – we included the longest time point (6 months).
Funding/declarations of
interest
Funding: funded by a Wichita Center for Graduate Medical Education and Kansas Bioscience Authority
Level III grant.
Conflicts of interest: none
Notes Trial ID: NCT01396902
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation scheme.
Allocation concealment
(selection bias)





High risk Not possible to blind participants or personnel.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Vaccination results were abstracted from immunisation registry records and
were considered low risk of detection bias.
Blinding of subjective out-
come assessment (detec-
tion bias)





Low risk 2 participants excluded from analysis, reason provided.
Ahlers-Schmidt 2012  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk All relevant outcomes appear to be reported but there was no protocol or on-
line trial registration.
Other bias Unclear risk Intervention and control arm participants differ significantly on income, with
28% (11/40) of control parents having an income level ≥ USD 25,000 annually





Methods Aim: to assess whether immunisation coverage among those receiving short message reminders and
routine immunisation health education differ from those receiving routine immunisation health educa-
tions only.
Study design: parallel individual RCT
Recruitment: mother or carer soon after delivery or at third or seventh day visit after delivery
Study duration: 14 weeks
Study dates: 1 January 2013 to 31 August 2013
Participants Inclusion criteria: mother or carer soon after delivery or at third or seventh day visit after delivery,
must have mobile phone and be a resident of Kadoma City.
Sample size (n): 304 (intervention: 152; control: 152)
Age (median): intervention: 26 (Q1 21, Q3 30); control: 27 (Q1 23, Q3 32)
Sex: not reported
Country: Zimbabwe (low-income)
Setting: city clinics and general hospital
Interventions Intervention: 3 automatic text message reminders. First message sent 7 days before due date for im-
munisation, second message sent 3 days before, last message sent 1 day before immunisation appoint-
ment.
Content: appointment reminder
Frequency and intensity: 3 text message reminders before the 6-, 10-, and 14-week appointments
Control: standard care/no intervention: informed about next scheduled visit
Co-interventions: all participants received routine health education.
Outcomes 1. Attendance for vaccinations (6, 10, 14 weeks – we included the longest time point, 14 weeks); 3. opin-
ion of SMS; 4. Cost of SMS service
Outcomes reported but not included in the review:
2. Age of child when immunised (outcome not eligible for inclusion)
Outcome assessment time point: 6, 10, 14 weeks
Funding/declarations of
interest
Funding: Center for Disease Control and Prevention, Zimbabwe
Conflicts of interest: none declared
Bangure 2015 
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Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Study participants assigned by computer-generated random numbers.
Allocation concealment
(selection bias)





High risk Not possible to blind participants or personnel.
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Not reported.
Blinding of subjective out-
come assessment (detec-
tion bias)





Low risk 0 lost.
Selective reporting (re-
porting bias)
Low risk Only outcome reported in registration is immunisation coverage at 6, 10, and
14 weeks.





Methods Aim: to determine 1. if reminders sent by text message, phone call, or concomitant text and phone calls
most increase the presence at medical appointments of HIV-infected or HIV-exposed children, and 2.
which is the most efficient related to working time and financial cost.
Study design: parallel individual RCT
Recruitment: adult–child (carer–patient) pairs were recruited for HIV-infected or exposed children
aged < 15 years attending HIV care.
Study duration: not reported
Study dates: January 2013 to May 2013
Participants Inclusion criteria: people aged ≥ 18 years accompanying an HIV-infected or HIV-exposed child aged <
15 years for HIV care
Sample size (n): 242 (text message: 60; text message + call: 61; call: 60; control: 61)
Bigna 2015 
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Age: children: age range up to 15 years, although we could not confirm that ≥ 70% of included children
were ≤ 5 years we decided to include this study since the weighted mean age of children was 2.8 years.
Carers (mean): text message + call group: 36.5 (SD 12.4) years; text message group: 41.4 (SD 12.8) years;
call group: 50.5 (SD 13.2) years; control group: 42.6 (SD 12.6)
Sex: carers – men: text message + call group: 20%; text message group: 13%; call group: 15%; control
group: 13%; children – boys: text message + call group: 52%; text message group: 47%; call group: 47%;
control group: 49%
Country: Cameroon (lower middle-income)
Setting: 3 hospitals serving urban (Essos), semi-urban (Kousséri), and rural (Goulfey) settings
Interventions Intervention: appointment reminders via text message; voice call; or text message + voice call
Content: appointment reminder
Frequency and intensity: 1 call, or 1 text message then 1 call 2–3 days before appointment
Control: standard care/no intervention. No reminder (usual practice), all participants attended stan-
dard HIV care appointments
Co-interventions: HIV care (to all participants)
Outcomes 1. Attendance at HIV medical appointments; 2. Direct costs; 3. StaQ working time
Outcome assessment time point: 2 days
Funding/declarations of
interest
Funding: no external funding, done as part of an academic degree financed from the personal funds of
the corresponding author Jean Joel R Bigna.
Conflicts of interest: authors declare no competing interests
Notes Trial ID: PACTR201304000528276
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Quote: "Randomisation and allocation were done centrally with WinPepi ver-
sion 11.25. Eligible participants (adult–child pairs) were randomly assigned in




Low risk Central allocation.
Quote: "Randomisation and allocation were done centrally with WinPepi ver-
sion 11.25. Eligible participants (adult–child pairs) were randomly assigned in






High risk Personnel were blinded. Not possible to blind participants.
Quote: "The treating physician, the medical administrative assistant responsi-
ble for contacting participants in the intervention groups 2, 3, and 4 via mobile
phone … were all masked to group assignments."
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Outcome assessors and analysts were blinded.
Bigna 2015  (Continued)
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Quote: "the nurse (outcome assessor) responsible for recording the patient's
presence or absence at the appointment, and the data analysts were all
masked to group assignments."
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Self-reported measures would have been at high risk of detection bias since




Low risk All randomised participants, whether or not they received the intervention,
were included in the ITT analysis.
Selective reporting (re-
porting bias)
Low risk All outcomes listed in the protocol were fully reported.
Other bias Unclear risk Some baseline characteristics (ages of children and carers, carers' education,





Methods Aim: to assess the effect of reminder/recall system and primary healthcare immunisation providers'
training intervention on routine immunisation.
Study design: cluster RCT
Recruitment: children aged 0–12 weeks at their first immunisation appointment
Study duration: until child was 12 months old
Study dates: August 2012 to September 2013
Participants Inclusion criteria: children aged 0–12 weeks at their first immunisation visits, parents living in study
communities
Sample size: 595 (reminder: 153 participants, 1 cluster; usual care: 152 participants, 1 cluster; re-
minder + HCP training: 149 participants, 1 cluster – not eligible or included in review; HCP training: 141
participants, 1 cluster – not eligible or included in review)
Age: children: 0–12 months; parents: not reported
Sex (female): children: 51.4%
Country: Nigeria (lower middle-income)
Setting: community/health facility
Interventions Intervention: mobile phone calls for the reminder/recall interventions sessions, reminder of immuni-
sation appointment, recall for missed appointment
Content: appointment reminder and recall for missed appointments
Frequency and intensity: 2 telephone reminders to the contact person whose mobile phone number
was provided by the mother – 2 days before and 1 day before the appointment.
Control: standard care/no intervention: usual care
Co-interventions: 2-day refresher training conducted for primary healthcare immunisation providers
Brown 2016 
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Outcomes 1. "immunization completed" = receipt of all scheduled routine childhood immunisation = 1 dose of
BCG vaccine, at ≥ 4 doses of OPV, 3 doses of DPT vaccine, 3 doses of hepatitis B vaccines, and 1 dose
each of measles and yellow fever vaccine by age of 12 months




Conflicts of interest: not reported
Notes 2 arms that included primary healthcare training were not extracted.
Trial ID: not reported
Cluster features: 4 local government authorities were randomised. Mean cluster size: 152.5 (for the 2
study arms included in the review). The study did not adjust for clustering effect; we used ICC 0.0487
(derived from k = 0.089 reported in Gibson 2017) to adjust for cluster effect in the analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "Using ballot system, the four randomly selected LGAs [local govern-
ment association] were then allocated into three intervention groups and one
control group."
Comment: no further details reported.
Allocation concealment
(selection bias)
Unclear risk Not reported.
Selective cluster recruit-
ment
Unclear risk Quote: "A total of 605 eligible children aged 0–12 weeks at their first immuniza-
tion visits having their parents living in the study communities were consec-
utively recruited into four different study groups from August to November
2012."






High risk Not possible to blind participants or personnel since interventions were active
and different.
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Outcome data collected using a standard instrument to extract data from








Unclear risk Reports the outcome described in methods, but no protocol or online trial
record.
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Study characteristics
Methods Aim: 1. to test the feasibility and acceptance of SMS vaccination reminders sent to parents of chil-
dren presenting for their infant primary immunisation series, and 2. to evaluate the potential of a larg-
er-scale programme to optimise immunisation delivery in a LMIC.
Study design: parallel individual RCT
Recruitment: parents of infants aged 8–14 weeks recruited when presenting for the first dose of the 3-
dose infant primary immunisation series
Study duration: 6 months
Study dates: March 2013 to October 2013 (6 months after last enrolment April 2013)
Participants Inclusion criteria: parents of infants aged 8–14 weeks, presenting for the first dose of the 3-dose infant
primary immunisation series, owned a mobile phone with SMS text messaging capability, ≥ 1 parent
had to be literate and able to use SMS technology.
Sample size (n): 321 (intervention: 160; control: 161)
Age (mean): parents: not reported; infants: intervention: 9.7 (SD 9.1) months; control: 9.4 (SD 9.0
months)
Sex (male): intervention: 52.5%; control: 44.4%
Country: Guatemala (lower middle-income)
Setting: community, served by 2 public health clinics in Guatemala City
Interventions Intervention: SMS reminders for infant immunisation
Content: appointment reminders
Frequency and intensity: SMS text messages at 6, 4, and 2 days before scheduled vaccination visits 2
and 3 (at 4 and 6 months of age)
Control: standard care/no intervention
Co-interventions: all participants received written reminders in the child's immunisation card for the
next dose of vaccines at the time of each vaccination based on the usual standard of care at both clin-
ics.
Outcomes 1. Attendance for vaccinations: completing all vaccinations (6 months); 2. Client satisfaction
Outcomes reported but not included in review:
1. Completing any vaccination (6 months) – instead, we included completion of all vaccinations (see
above); 2. Attendance for vaccinations at second (4 months) and third visit (6 months) – instead, we in-
cluded completion of all vaccinations (see above); 3. Completing pentavalent (3 doses)/pneumococcal
(2 doses)/poliomyelitis (3 doses)/rotavirus (2 doses) vaccination; 4. Age at visits 2 and 3 (outcome not
eligible for inclusion); 5. Proportion of parents sent SMS messages (outcome not eligible for inclusion)
Outcome assessment time point: 4, 6 months
Funding/declarations of
interest
Funding: Bill & Melinda Gates Foundation Grand Challenges Explorations grant and a small operational
grant from the Pan American Health Organization
Conflicts of interest: none declared
Notes Trial ID: NCT01663636
Domek 2016 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Participants were allocated to either an intervention or usual care
group using a computer-generated randomization scheme."
Allocation concealment
(selection bias)
Low risk Quote: "Participants were allocated to either an intervention or usual care





High risk Not possible to blind participants. Personnel blind to allocation, but unclear
whether this blinding was sustained.
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Not reported whether research nurses that collected data were blinded. Im-
munisation records were able to be confirmed only for children who returned
to either of the 2 study sites.
Blinding of subjective out-
come assessment (detec-
tion bias)





Low risk 17.4% were lost to follow-up but analyses were ITT.
Selective reporting (re-
porting bias)
Low risk Outcomes listed in online trial record were reported.
Other bias Unclear risk Parents in the usual care group had significantly higher income with more fa-
thers working; otherwise, there were no significant differences between the






Methods Aim: to evaluate initial outcomes of the Text4baby intervention at 4 weeks postbaseline.
Study design: parallel individual RCT
Recruitment: women recruited at the end of their initial ANC visit to the Madigan Obstetrics and Gyne-
cology clinic.
Study duration: 4 weeks (intervention planned to continue for whole pregnancy)
Study dates: December 2011 (recruitment) to January 2013 (recruitment)
Participants Inclusion criteria: women military healthcare beneficiaries (both active duty and family members),
aged 18–45 years, presented for ANC prior to 14 weeks' gestation, working mobile phone, speaking,
and reading fluent English
Sample size (n): 943 (completers (number randomised per arm not reported): intervention: 229; con-
trol: 230)
Age (mean): 26.53 years
Evans 2014 
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Sex: 100% women
Country: USA (high-income)
Setting: community (military) served by a large tertiary-care army medical centre
Interventions Intervention: SMS messages
Content: 135 distinct antenatal text messages aimed at promoting ways to live a satisfying lifestyle
while reducing risk and promoting maternal and child health
Frequency and intensity: 3 messages per week for 4 weeks in this report (intervention intended for
whole pregnancy)
Control: standard care/no intervention. No SMS messages
Co-interventions: not reported
Outcomes 1. Self-reported consumption of alcohol since becoming aware of pregnancy; 2. Smoking in last 30 days
(self-report)
Outcomes reported but not included in the review:
1. Attitudes and knowledge on pregnancy risks, self-report (outcome not eligible for inclusion)
Outcome assessment time point: 4 weeks
Funding/declarations of
interest
Funding: Telemedicine and Advanced Technology Research Center (TATRC), US Army Medical and Ma-
teriel Command
Conflicts of interest: none declared
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Using an algorithm that generated a randomized list of individual as-
signments to treatment or control condition …"
Allocation concealment
(selection bias)





High risk Not possible to blind participants. Clinicians who met with participants were
blinded – the randomisation occurred outside the actual clinical visit and the
trial data were not accessed by the clinicians during the study.
Blinding of subjective out-
come assessment (detec-
tion bias)




High risk High level of attrition – 459/943 (48.7%) completed a 4-week follow-up survey.
Selective reporting (re-
porting bias)
Low risk Expected outcomes reported, as per methods in the protocol/early results pa-
per.
Evans 2014  (Continued)
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Other bias Unclear risk Control group reported a larger, statistically significant percent smoking in the






Methods Aim: 1. To provide evidence validating the need for development and deployment of automated client
reminder-recall systems for the Nigerian National Routine Immunisation Program and 2. to compare its
projected cost with the cost of a health personnel-based defaulter tracking system.
Study design: parallel individual RCT
Recruitment: carers were selected using multistage sampling method from 8 health facilities in Egor
local government area of Edo State.
Study duration: each child recruited into the study at its first immunisation session (BCG) was fol-
lowed up for 18 weeks while those who were recruited at their second session (DPT1) were followed up
for 12 weeks to allow for 4 extra weeks after the recommended dates of receipt of DPT3.
Study dates: June 2010 to June 2011
Participants Inclusion criteria: bringing child for routine immunisation for the first or second schedules
Sample size (n): 1001 (intervention: 500; control: 501)
Age (mean): carers: 29.35 (SD 5.3) years
Sex: 895 (89%) mothers, and 10 classed as 'other' but sex not stated
Country: Nigeria (lower middle-income)
Setting: facilities included 1 tertiary hospital, 2 primary health centres, and 5 privately owned health
facilities all of which provided routine immunisation services.
Interventions Intervention: reminder and recall text messages
Authors also report that (quote), "All text messages were by internet-based web-to-SMS (Bulk SMS) ser-
vice and were tagged the name of client's health facility for easy recognition." Messages sent the day
before an immunisation appointment. There were 4 immunisation time points for BCG, DPT1, DPT2,
and DPT3.
Content: short reminder text message, and recall messages to those who missed appointments
Frequency and intensity: reminder messages sent 1 day before the appointment, the number of re-
minder messages received depended the time point at which the participant was recruited. Recall mes-
sages were sent to defaulters. The total number of these messages was not reported.
Control: standard care/no intervention, details not reported
Co-interventions: none reported
Outcomes 1. Timeliness of receipt of DPT3; 2. Cost and cost-effectiveness (compared to estimated cost of home
visits)
Outcomes reported but not included in the review:
1. Barriers to receiving text message reminders (outcome not eligible for inclusion)
Eze 2015 
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Conflicts of interest: not reported
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Participants recruited per facility were randomized into 2 equal
groups: intervention and Control groups using the RANDOM. EXE function of
the Programme for Epidemiologists (PEPI) version 4.0."
Allocation concealment
(selection bias)





High risk Not possible to blind participants or personnel.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Quote: "Data collectors could not tell if a client was in the intervention or con-
trol group."
Blinding of subjective out-
come assessment (detec-
tion bias)




Unclear risk Available-case analysis with 9.6% (96 carers) attrition. Reasons for dropping
out were provided and dropouts were balanced between groups.
Selective reporting (re-
porting bias)
Unclear risk All expected outcomes and outcomes listed in the methods section were re-
ported in the results, but no protocol or online trial record was identified to
check against.
Other bias High risk Some participants switched groups after randomisation. Authors stated that,
"Some respondents, who did not have mobile phones but were randomized in-
to the Interventional group initially, were eventually matched for age and sex
and swapped with persons who own mobile phones and were randomized in-
to the Control group."
Comment: in addition, carers provided answers to questions by recall; this





Methods Aim: to assess whether SMS reminders, with or without mobile money incentives, improve the propor-
tion of children fully immunised by their first birthday.
Study design: cluster RCT
Gibson 2017 
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Recruitment: the Health and Demographic Surveillance System village reporters identified eligible
carers and their infants. Village reporters used mobile phones to send birth notification text messages.
Birth notifications were relayed to field-based community interviewers who then screened carers of
newborns for eligibility into the study.
Study duration: 12 months
Study dates: October 2013 (start date of recruitment) to October 2014 (end date of recruitment)
Participants Inclusion criteria: mothers/carers of infants aged 0–34 days during the study period, current resident
of 1 of the participating study villages, willing to sign informed consent for the study
Sample size: 2018 (intervention: 476 participants, 38 clusters; control: 489 participants, 38 clusters)*
Age: mothers aged ≤ 25 years: 52% (n = 825); aged > 25 years 48% (n = 769); infants: mean 14 (SD 8) days
Sex: 100% female (mothers)
Country: Kenya (lower middle-income)
Setting: community-based (villages)
Interventions Intervention: SMS reminders composed of a core text and a motivational saying
Frequency and intensity: 3 days and the day before scheduled immunisation visits at ages 6 weeks, 10
weeks, and 14 weeks for the 3 doses of pentavalent vaccine and age 9 months for measles vaccine
Control: standard care/no intervention, did not receive SMS reminders or incentives
Co-interventions: all carers received a single text message at enrolment welcoming them to the study
Outcomes 1. Fully immunised child by 12 months of age, defined as receiving BCG, 3 doses of OPV, 3 doses of pen-
tavalent vaccine, and measles vaccine; 2. Timely fully immunised child defined as being fully immu-
nised within 2 weeks of the measles EPI due date; 3. Carer's opinion on number of SMS reminders per
vaccine and about the influence of SMS reminder on decision to vaccinate the child
Outcomes reported but not included in the review:
1. Timely vaccinations for individual vaccines defined as receiving pentavalent 1, 2, and 3 vaccine;
OPV; or measles vaccines within 2 weeks (we included overall measure instead of individual mea-
sures per vaccine); 2. Receiving all timely vaccines (children who received pentavalent 1, 2, and 3, and
measles vaccines within 2 weeks of their respective EPI due date) (we included fully immunised child
by measles due date instead (see above))
Outcome assessment time point: 12 months (1 time point for all outcomes)
Funding/declarations of
interest
Funding: Bill & Melinda Gates Foundation
Conflicts of interest: none declared
Notes *SMS plus incentives (KES 75 or KES 200) groups were not considered relevant for this systematic re-
view and were not extracted.
Trial ID: NCT01878435
Cluster features: 152 villages were randomised. The study adjusted outcomes for cluster effect using
coefficient of variation (k) = 0.089 in the control group; k = 0.069 in the SMS only group.
Risk of bias
Bias Authors' judgement Support for judgement
Gibson 2017  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Computer generated.
Quote: "A constrained randomisation was done with GAUSS Mathematical and




Low risk The 1000 sequences were labelled with 3-digit numbers, 000 to 999, each 1
assigning 38 villages to each of the 4 groupings (A–D). At a public randomisa-
tion ceremony on 12 September 2013, village chiefs determined the final ran-
domisation outcome by picking numbered balls from a cloth sack to select 1 of
these 1000 sequences, then picking labelled (study group) balls to assign the
interventions to the chosen allocation.
Selective cluster recruit-
ment
High risk Enrolment of participants took place after cluster allocation had been made.
Quote: "Birth notifications were relayed to field-based community interview-
ers who then screened caregivers of newborns for eligibility into the study."
Quote: "Participants provided written informed consent and were enrolled






High risk Due to nature of intervention and study design, study participants were not
blinded to their study group allocation. Field staQ were not informed of a vil-
lage's allocation, but this could be inferred from some enrolment and fol-
low-up survey questions.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Data cleaning was performed by a statistician blinded to the allocation.
Blinding of subjective out-
come assessment (detec-
tion bias)
Unclear risk Field staQ were not informed of a village's allocation, but this could be inferred




Low risk 14% in the SMS only arm and 19% in the control arm were lost to follow-up
(out-migration and death), 4.4% in the SMS only arm and 7.4% in the control
arm reported immunisation verbally (no vaccination booklet) and were ex-
cluded.
Primary analyses were performed with modified ITT analyses at the partici-
pant level so that participants' outcomes were analysed regardless of the de-
gree of exposure to study interventions. The term modified refers to the re-
quirement of being able to determine the 12-month immunisation outcomes.
Selective reporting (re-
porting bias)
Low risk Table and figures reporting all outcomes stated in the paper and online trial
registration (NCT0187843).






Methods Aim: to assess the impact of SMS and sticker reminders to reduce dropout rates for routine childhood
vaccinations, and determined factors associated with missed vaccination in selected districts in Kenya.
Haji 2016 
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Study design: cluster RCT
Recruitment: children aged < 12 months who were brought to the selected vaccinating health facilities
in the 3 districts for their first dose of pentavalent vaccine were recruited on a first-come basis until the
strategy-level target sample sizes was reached.
Study duration: 8 weeks
Study dates: February 2014 to December 2014 (enrolment ceased October 2014)
Participants Inclusion criteria: children aged < 12 months attending for first dose of pentavalent vaccine
Sample size: 1116 (SMS: 372 participants, 3 clusters; targeted non-digital communication (stickers):
372 participants, 3 clusters; usual care: 372 participants, 3 clusters)
Age (mean): carers: 26 (range 14–45) years
Sex (male): infants = 51%
Country: Kenya (lower middle-income)
Setting: community-based, linked to 9 vaccinating health facilities in 3 districts (Machakos, Langata,
and Njoro), 3 facilities in each district
Interventions Intervention: SMS reminders sent from an automated web-based system in Kiswahili and English, sent
2 days before (reminding the date of next vaccine and which health facility to attend) and on the day of
the scheduled vaccination for the second and third doses of pentavalent vaccine.
Content: SMS reminders
Frequency and intensity: 4 reminders (2 days before and on day of both second and third dose), re-
minders were at 10 weeks (–2 days) until 14 weeks
Control: 1. standard care/no intervention. 2. targeted non-digital communication: reminder sticker
Co-interventions: scheduled vaccination due date was indicated on the child's health booklet as per
routine procedures. All groups received routine health education and advice on vaccination.
Outcomes 1. Receipt of pentavalent vaccine (at 10 and 14 weeks of age); 2. Costs
Outcomes reported but not included in the review:
1. Mean days delay in receiving vaccine doses (at 10 and 14 weeks of age) (outcome not eligible for in-
clusion); 2. Factors associated with missed vaccination (not included in review, results were not report-
ed per group; 3. Did not return for vaccinations (not included in review, those receiving vaccinations
were extracted)
Outcome assessment time point: 10 and 14 weeks of age corresponding to the second and third dos-
es of the pentavalent vaccine
Funding/declarations of
interest
Funding: US Center for Disease Control and Prevention
Conflicts of interest: authors declared no competing interests.
Notes Districts were selected that had > 10% dropout rate for third dose of pentavalent vaccine.
Trial ID: not reported
Cluster features: 9 health facilities were randomised. Mean cluster size: 124. The study did not adjust
for clustering effect for any of the relevant outcomes; we used ICC 0.0487 (derived from k = 0.089 re-
ported in Gibson 2017) to adjust for cluster effect in the analyses.
Risk of bias
Haji 2016  (Continued)
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "We selected three health facilities in each district, and randomly allo-
cated each facility …"
Comment: no further details reported.
Allocation concealment
(selection bias)
Unclear risk No information on allocation concealment.
Selective cluster recruit-
ment
High risk Convenient enrolment of participants likely to have taken place after cluster
allocation to intervention arms.
Quote: "We selected three health facilities in each district, and randomly allo-
cated each facility to one of the two interventions … or to serve as the control
group … Participants were conveniently enrolled in the selected health facili-





High risk Not possible to blind; participants and personnel were aware of cluster alloca-
tions for data collection purposes.
Blinding of objective out-
come assessment (detec-
tion bias)
High risk Personnel were aware of cluster allocations for data collection purposes.
Blinding of subjective out-
come assessment (detec-
tion bias)





Unclear risk Flow of participants and clusters through the study was not clearly reported.
Selective reporting (re-
porting bias)
Low risk Outcomes are reported exhaustively, including for acknowledged limitations.
Other bias High risk Contamination: acknowledged limitation was that (quote) "If a care giver took
the child to another facility for second or third pentavalent dose, the system
considered the child unvaccinated."
Follow-up phone-calls determined that 35 infants had been taken to other
centres. Baseline differences: there were no statistical differences in demo-






Methods Aim: to test the effects of a NP 2-way communication mobile phone and texting follow-up intervention
for the first 6 months postbirth in low-income first-time mothers and their healthy full-term infants.
Study design: parallel individual RCT
Hannan 2016 
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Recruitment: first-time low-income mothers were enrolled from the Mother Baby Unit at Jackson
Memorial Hospital in Miami, FL.
Study duration: 6 months
Study dates: not reported
Participants Inclusion criteria: first-time mothers, aged 18 years, any racial/ethnic group, low-income, understood
spoken English or Spanish, access to a mobile phone, delivered a singleton healthy full-term infant, on-
ly infants with limited access to health care were included.
Sample size (n): 141 (intervention: 63; control: 66)
Age (mean): mothers: 25.3 (SD 5.6) years
Sex (male): infants: 55%
Country: USA (high-income)
Setting: community, linked to hospital mother and baby unit
Interventions Intervention: 2-way NP mobile phone intervention that included calls and SMS messages
Content: calls and text messages assessing health problems or concerns regarding the infant
Frequency and intensity: mobile phone contact and texting on posthospital discharge days 3, 7, 14,
21, then monthly for 6 months. Additionally, intervention group mothers were able to contact the NPs
by mobile phone or texting Monday to Saturday
Control: standard care/no intervention. Routine hospital discharge care
Co-interventions: if a healthcare concern was stated, the NP followed US paediatric protocols to im-
plement care. If the mother voiced a serious infant complaint such as fever, excessive crying, vomit-
ing, lethargy, or seizure-like activity, the mother was instructed to contact the 911 emergency systems.
Backup paediatricians were available to the NPs for consultation on infant health concerns.
Outcomes 1. Immunisations up to date (at 2, 4, 6 months – we included data for the longest time point (6
months)); 2. Infant emergency room attendance (6 months)
Outcomes reported but not included in review:
1. Infant hospitalisations (6 months) (outcome not included, for healthcare attendance we included im-
munisations and emergency department visits); 2. Infant urgent care seeking (6 months) (outcome not
included, for healthcare attendance we included immunisations and emergency department visits);
3. Time in days to first well visit (postnatal care appointment) – outcome not eligible for inclusion; 4.
Mothers' perceived stress (posthospital discharge) – outcome not eligible for inclusion; 5. Mothers' per-
ceived social support (posthospital discharge) – outcome not eligible for inclusion; 6. Infant well visits
received late (first visit, month 1, month 2, month 4, month 6) – outcome not eligible for inclusion
Outcome assessment time point: specified above after each outcome
Funding/declarations of
interest
Funding: funded by MBRS Score National Institute of Health; Eunice Kennedy Shriver National Institute
of Child Health & Human Development.
Conflicts of interest: author(s) declared no potential conflicts of interest.
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Hannan 2016  (Continued)
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
Random sequence genera-
tion (selection bias)
Low risk Quote: "mothers were randomized to a control or intervention group using a
table of random numbers."
Allocation concealment
(selection bias)





High risk Not possible to blind participants, no information on blinding of study person-
nel.
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Measures collected from mothers were at high risk of detection bias since the




High risk 12 mothers were lost to contact postdischarge due to disconnected mobile
phones. It is not reported how many from each group.
Selective reporting (re-
porting bias)
Unclear risk All expected outcomes and all outcomes listed in the methods section were re-
ported, but no protocol or online trial record available to check against.
Other bias Unclear risk There were no significant differences in the demographic characteristics be-





Methods Aim: assessed the impact of text message reminders to parents on timely MMR vaccination.
Study design: parallel individual RCT
Recruitment: parents/children identified through the hospital registration system and its immuni-
sation registry. The registration system included demographic and visit data for participants, and all
vaccine doses administered to participants at the hospital and affiliated clinics through the electronic
health record.
Study duration: 2.5–3.5 months
Study dates: June 2011 to October 2012
Participants Inclusion criteria: parents were eligible for participation if their child: was age 9.5–10.5 months, had a
participating clinic visit in the past 6 months, had a mobile phone number listed in the hospital regis-
tration system.
Sample size (n): 2054 (SMS only: 686; scheduling + SMS: 686; usual care: 682)
Age: parents' age not reported, children: 9.5–10.5 months at enrolment
Sex (female): SMS only: 48.1%; scheduling + SMS: 49.4%; usual care: 49.0%
Country: USA (high-income)
Setting: community, linked to 4 paediatric practices in an ambulatory care network affiliated with a
large academic medical centre in New York City.
Hofstetter 2015a 
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Interventions Intervention: reminder SMS message 2 days before scheduled appointment. Scheduled SMS messages
not sent if a previously arranged appointment was detected in the system.
Content: SMS message reminded parents 2 days before a scheduled 1-year appointment, informed
them that doctor would discuss needed vaccines, and asked them to remember to bring the child's
vaccination card. SMS messages included the clinic contact information and mentioned the child's
need for important vaccines such as measles following the first birthday.
Frequency and intensity: 1 reminder SMS 2 days before child's 1-year vaccination. Up to 3 weekly SMS
after randomisation (at child age of 9.5–10.5 months) followed by 1 reminder 2 days before child's 1-
year vaccination.
Control: standard care/no intervention. The usual care arm received no text message reminders.
Co-interventions: children in all arms received "usual care," which included a routine automated tele-
phone appointment reminder provided directly from the clinic network 1 day before existing appoint-
ments.
Outcomes 1. Child receives MMR vaccine between 361 days and 13 months of age; 2. Client satisfaction (13
months)
Outcomes reported but not included in the review:
1. 1-year preventive care visit scheduled at 11–13 months of age (outcome not eligible for inclusion); 2.
1-year preventive care visit attended 11–13 months of age (outcome not eligible for inclusion); 3. MMR
vaccination by 16 months of age (only overall proportion and P value were reported – not included in
review, 13-month time point was included)
Outcome assessment time point: 13 months
Funding/declarations of
interest
Funding: supported by National Center for Immunization and Respiratory Diseases of the Centers for
Disease Control and Prevention.
Conflicts of interest: unclear: under 'Funding' the authors have listed personal research funding, ap-
parently linked to a different study: quote: "Dr. Hofstetter receives research support for an investigator
initiated study funded by the Pfizer Medical Education Group."
Notes Trial ID: NCT01199666
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomised (quote): "Using a random sample algorithm
generator in SPSS 19.0."
Allocation concealment
(selection bias)
Low risk Randomisation and delivery of intervention automated and integrated within





Low risk Participants were not aware that they were in a study.
Quote: "The study was approved by the Columbia University Medical Center
Institutional Review Board with a waiver of consent."
Intervention delivered by an automated "text messaging platform integrated
with the hospital registration system and its immunization registry."
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Data were retrieved electronically from hospital and registry records.
Quote: "Study analysts were blinded to group assignments."
Hofstetter 2015a  (Continued)
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Blinding of subjective out-
come assessment (detec-
tion bias)




Low risk Medical and vaccination records available for all participants.
Selective reporting (re-
porting bias)
Unclear risk Online trial record available, but all outcomes listed in methods were report-
ed.





Methods Aim: to compare the satisfaction levels of ANC between healthy pregnant women who received SMS via
mobile phone for antenatal support, and those who did not.
Study design: parallel individual RCT
Recruitment: all pregnant women who received ANC and planned to give birth at the study site.
Study duration: from 28 weeks of gestation until delivery
Study dates: May 2007 to October 2007
Participants Inclusion criteria: aged > 18 years, no medical diseases or obstetric complications, singleton pregnan-
cy, gestational age < 28 weeks (confirmed by ultrasound) when enrolled in the present study, owner of
a mobile phone, able to receive and understand SMS messages
Sample size (n): 68 (intervention: 34; standard care: 34)
Age (mean): intervention: 28.72 (SD 4.9) years; standard care: 25.97 (SD 6.1) years
Sex (female): 100%
Country: Thailand (upper middle-income)
Setting: Siriraj Hospital, Bangkok
Interventions Intervention: SMS messages appropriate to the women's gestational age
Content: information and warnings relating to abnormal symptoms
Frequency and intensity: twice a week (Mondays and Thursdays during the daytime)
Control: standard care/no intervention
Co-interventions: all participants received phone calls at 32 weeks' gestation to check both groups
were still contacted by the Siriraj antenatal clinic and to confirm that participants could receive and un-
derstand SMS messages. All participants received routine antenatal and perinatal care.
Outcomes 1. Preterm delivery; 2. Birth weight; 3. Gestational age at birth; 4. Patient satisfaction with intervention
(antenatal and perinatal periods)
Outcomes reported but not included in the review:
Jareethum 2008 
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1. Self-reported level of confidence (outcome not eligible for inclusion); 2. Anxiety (scale not verified,
not eligible for inclusion); 3. Route of delivery (vaginal or Caesarean) (outcome not eligible for inclu-
sion)




Conflicts of interest: not reported
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The pregnant women who participated were randomly allocated into 2 groups
using a table of random numbers.
Allocation concealment
(selection bias)





High risk No attempts to blind the participants or personnel were reported. Not possible
to blind participants due to the nature of the intervention.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk It was not reported whether outcome assessors were blinded, but objective
pregnancy outcomes (preterm delivery, birth weight, route of delivery, etc.)
were collected from the obstetric records at the postpartum ward and were
thus considered at low risk of bias.
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Subjective outcomes (client satisfaction, confidence, anxiety) were self-report-




Low risk Available-case analysis with low attrition (10%). 2 (6.3%) women in study
group and 2 (6.9%) women in control group changed to deliver at another hos-
pital. 2 (6.9%) women were lost during the follow-up and 1 (3.4%) woman had
her pregnancy aborted before 28 weeks of gestation. The remaining 32 women
in study group and 29 in control group were included in analyses.
Selective reporting (re-
porting bias)
Low risk All relevant outcomes in the method section were reported in the results sec-
tion.





Methods Aim: to conduct an RCT to test and document the effectiveness of 2 mHealth interventions provided to
target women.
Study design: cluster RCT
Joshi 2015 
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
Recruitment: a list of all villages in Osmanabad, Solapur, and Washim districts was sent to biostatisti-
cians to randomly select 100 villages each from Osmanabad and Solapur (being larger districts) and 50
villages from Washim district. Then 1743 pregnant women from the 250 villages were enrolled and di-
vided into 2 groups.
Study duration: 11–39 weeks of pregnancy
Study dates: not reported
Participants Inclusion criteria: women in project area were enrolled from the third or fourth month of pregnancy.
Sample size: 1743 (intervention: 1162 participants, 166 clusters; control: 581 participants, 84 clusters*)
Age: not reported
Sex (female): 100%
Country: India (lower middle-income)
Setting: home-based care
Interventions Intervention: twice-a-week mobile phone voice messaging service in local dialect that disseminates
targeted, timely, and culturally sensitive preventive information directly to the pregnant women. Con-
tent of voice messages as well as animation films were culturally appropriate; timed and targeted as
per beneficiary's gestational age; sent in a user specified language and time slot. The range of functions
served by mHealth tools included: client education and counselling; diagnostic alerts; information giv-
ing; actionable tips to pregnant women for self-care and foetal health; and encouragement to clients
for behaviour change.
Content: the voice messaging service was supported by short educational animation film clips dis-
played on mobile phones for reinforcement of preventive health information.
Frequency and intensity: twice a week from 11–39 weeks of pregnancy
Control: standard care/no intervention.
Co-interventions: none reported
Outcomes 1. Proportion of pregnant women who took iron and folic acid tablets for 100 days; 2. Proportion of
births attended by skilled birth assistant/skilled health personnel; 3. Client satisfaction
Outcomes reported but not included in the review:
1. Knowledge gain (outcome not eligible for inclusion)
Outcome assessment timepoint: not reported
Funding/declarations of
interest
Funding: Department for International Development (DFID), UK
Conflicts of interest: not reported
Notes *number of clusters in the control group was not reported but we assumed 84 since the total was 250
and there were 166 intervention clusters.
Trial ID: not reported
Cluster features: 250 villages were randomised. Mean cluster size: 6.97. The study did not adjust for
clustering effect; we used ICC 0.041 for skilled birth attendance and ICC 0.154 for iron and folate tablet
adherence (reported in Pagel 2011) to adjust for cluster effects in the analyses.
Risk of bias
Bias Authors' judgement Support for judgement
Joshi 2015  (Continued)
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Random sequence genera-
tion (selection bias)




Unclear risk Not reported.
Selective cluster recruit-
ment
Unclear risk Unclear whether participants were enrolled before or after clusters had been
randomised.
Quote: "In the next step, 1743 pregnant women from 250 villages enrolled in





High risk Not possible to blind participants.
Blinding of subjective out-
come assessment (detec-
tion bias)









Unclear risk No protocol or trial registration was mentioned and few details were reported
in the paper to determine the risk of reporting bias.





Methods Aim: to investigate pathways through which mobile phone-based support may promote exclusive
breastfeeding.
Study design: parallel individual RCT
Recruitment: women in third trimester attending ANC
Study duration: up to 3 months postpartum
Study dates: not reported
Participants Inclusion criteria: low-income women in the third trimester attending ANC at a large hospital
Sample size (n): 505 (intervention: 153; control: 179)*
Age: not reported
Sex (female): 100%
Country: Kenya (lower middle-income)
Setting: facility based
Interventions Intervention: mobile phone-based peer support provided by trained peer leaders
Kamau-Mbuthia 2013 
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
Content: not reported
Frequency and intensity: not reported
Control: standard care/no intervention. existing facility-based standard of care
Co-interventions: not reported
Outcomes 1. Receiving postpartum help with breastfeeding; 2. Neonatal morbidity: infant diarrhoeal disease; 3.
Infant length and weight (no SD reported); 4. Mastitis: breast pain and engorgement
Outcomes reported but not included in the review:
1. Any infant illness (outcome not included, for neonatal morbidity we included 'infant diarrhoeal dis-
ease' (see above)); 2. Receiving infant feeding advice from HCWs or others (outcome not included, we
included 'receiving postpartum help with breastfeeding' (see above)); 3. Give medicines, vitamins, and
minerals (outcome not eligible for inclusion); 5. Return to work by 3 months postpartum (results were
not reported)
Outcome assessment time point: 3 months postpartum (1 time point for all outcomes)
Funding/declarations of
interest
Funding: Bill & Melinda Gates Foundation through the Alive and Thrive small grants programme
Conflicts of interest: not reported
Notes Trial ID: not reported
*1 study arm (peer support group) was not eligible for inclusion in the review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "Randomized", no further details reported.
Allocation concealment
(selection bias)





High risk Not possible to blind participants.
Blinding of subjective out-
come assessment (detec-
tion bias)




Unclear risk Not reported.
Selective reporting (re-
porting bias)
High risk Not all outcomes were reported (return to work by 3 months postpartum).
Other bias Unclear risk The study was reported in 2 conference abstracts with limited information to
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Study characteristics
Methods Aim: to determine the utility of text messages to improve uptake of antenatal and PMTCT service.
Study design: cluster RCT
Recruitment: HIV-positive women presenting for ANC
Study duration: from enrolment (< 32 weeks' gestation) to 6–8 weeks postpartum
Study dates: June 2012 to June 2013
Participants Inclusion criteria: HIV-positive pregnant women, < 32 weeks' gestational age, were not currently re-
ceiving ARV therapy, were planning to remain in the area for the duration of the study period, and
agreed to follow-up of their infants until 6 weeks following delivery
Sample size: 550 (intervention: 280 participants, 13 clusters; control: 270 participants, 13 clusters)
Age (median): intervention: 25.5 (IQR 21–29) years; control: 25.6 (IQR 22–29) years
Sex (female): 100%
Country: Kenya (lower middle-income)
Setting: community, health facilities
Interventions Intervention: automated text messages
Content: PMTCT services including appointment reminders and adherence support, motivational mes-
sages, male-partner involvement and engagement in delivery planning and essential child health mes-
sages including warning signs and nutrition
Frequency and intensity: 3–6 text messages each week (< 32 weeks' gestation to 6–8 weeks postpar-
tum)
Control: standard care/no intervention
Co-interventions: none
Outcomes 1. ARV adherence – any maternal missed doses in the past week (6–8 weeks postpartum, we did not in-
clude earlier time points 36 weeks of gestation and at delivery); 2. Birth in health facility; 3. infant ARV
treatment adherence (6 weeks postpartum); 4. infant HIV test (6 weeks postpartum); 5. infant HIV DNA
PCR test positive (6 weeks postpartum); 6. number of face-to-face or mobile phone communications
(delivery)
Outcomes reported but not included in the review:
1. Mother on combination ARV therapy (time points: 34–36 weeks' gestation, 7 days, and 6–8 weeks
postpartum, outcome not eligible for inclusion)
Outcome assessment time point: see above
Funding/declarations of
interest
Funding: WHO through a grant to the Elizabeth Glaser Pediatric AIDS foundation and the Elizabeth
Glaser Pediatric AIDS Foundation.
Conflicts of interest: no competing interests to report
Notes Trial ID: NCT01645865
Cluster features: 26 healthcare facilities were randomised. Mean cluster size: 21.15. The study adjust-
ed some outcomes (mother taking antenatal and postnatal ARV) for cluster effect and confounding
variables (participant age, gestational age, whether the woman was newly diagnosed with HIV, and dis-
closure of HIV status to her partner and family). For the remaining outcomes, we used ICCs reported in
Kassaye 2016 
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Pagel 2011: ICC 0.127 (birth in health facility), ICC 0.055 (infant ARV, infant HIV test uptake, infant HIV
test positive), and ICC 0.030 (communications between HCW and participant) to adjust for cluster effect
in the analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "All health facilities were randomly allocated to be an intervention or
control site, stratified by high volume (hospitals) and medium and low vol-
umes (health centers and dispensaries)."
Comment: information on sequence generation were not reported.
Allocation concealment
(selection bias)
Unclear risk Not reported.
Selective cluster recruit-
ment
Unclear risk Unclear whether participants were enrolled before or after clusters were allo-
cated to intervention arms.
Quote: "Consecutive eligible HIV-positive pregnant women presenting for ANC





High risk Unable to blind participants.
Blinding of subjective out-
come assessment (detec-
tion bias)








Unclear risk Trial registry includes an additional secondary outcome that was not report-
ed in the publication – time to initiation of ARV (clinicaltrials.gov/ct2/show/
NCT01645865).





Methods Aim: to compare self-reported adherence to infant nevirapine prophylaxis and retention in care in HIV-
exposed infants randomised to 2-weekly mobile phone call vs control (no phone calls).
Study design: parallel individual RCT
Recruitment: recruited from postnatal wards of 3 health facilities and randomised within 24 hours of
birth
Study duration: not reported
Study dates: not reported
Kebaya 2014 
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Participants Inclusion criteria: HIV-positive women and their infants
Sample size (n): 150 (intervention: 75; control: 75)
Age: not reported
Sex (female): 100%
Country: Kenya (lower middle-income)
Setting: recruited from postnatal wards of 3 health facilities in Kisumu, treatment was home based.
Interventions Intervention: mobile phone calls
Content: reminders on PMTCT messages
Frequency and intensity: fortnightly
Control: digital, non-targeted communication: "standard health care messages (no calls)"
Co-interventions: infants received nevirapine prophylaxis for PMTCT
Outcomes 1. Attendance for postpartum care appointment (10 weeks); 2. Adherence to newborn PMTCT treat-
ment (nevirapine) (6 weeks)
Outcomes reported but not included in the review:
1. Mode of infant feeding (mother report) (results were not reported); 2. Early HIV testing (results were
not reported)




Conflicts of interest: not reported
Notes Limited information reported in 2 abstracts, no author contact details in abstracts.
Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Report states the study was randomised but no further details provided.
Allocation concealment
(selection bias)





High risk Open-label RCT.
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Limited information reported in 2 abstracts.
Kebaya 2014  (Continued)
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Blinding of subjective out-
come assessment (detec-
tion bias)




Unclear risk Limited information reported in 2 abstracts.
Selective reporting (re-
porting bias)
High risk Limited information reported in 2 abstracts. However, safe infant feeding and
HIV testing were outcome measures mentioned for which results were not re-
ported in any of the abstracts.
Other bias Unclear risk The study was reported in 2 conference abstracts with limited information to





Methods Aim: to examine the effect of the wired mothers' intervention on ANC, skilled delivery attendance, ac-
cess to emergency obstetric care, and perinatal mortality.
Study design: cluster RCT
Recruitment: women who attended ANC at 1 of the 24 selected healthcare facilities were included in
their first ANC visit and followed until 42 days after delivery.
Study duration: until 6 weeks after delivery
Study dates: March 2009 to March 2010
Participants Inclusion criteria: 1. Clusters: health facilities with the highest number of ANC clients in 2008; avail-
ability of ≥ 1 midwife in the facility; mobile phone network coverage; 2. Participants: women aged 14–
45 years; pregnant women attending ANC at 1 of 24 selected primary healthcare facilities
Sample size: 2637 (intervention: 1351 participants, 12 clusters; control: 1286 participants, 12 clusters)
Age group: < 19 years: intervention: 9%; control: 10%; 20–24 years: intervention: 25%; control: 26%;
25–29 years: intervention: 29%; control: 26%; 30–34 years: intervention: 20%; control: 22%; ≥ 35 years:
intervention: 18%; control: 17%
Sex (female): 100%
Country: Tanzania (low-income)
Setting: primary healthcare facilities
Interventions Intervention: SMS + voucher. The frequency of the messages varied depending on the stage of the
pregnancy.
Content: simple health education and appointment reminders to encourage attendance to routine
ANC, skilled delivery attendance, and postnatal care
Frequency and intensity: early in the pregnancy, women received 2 messages a month, after gesta-
tional week 36, the intensity increased to 2 a week, until 6 weeks after delivery
Control: standard care/no intervention. Standard antenatal, delivery, and postnatal services consisted
of ≥ 4 ANC visits, skilled attendance at delivery, and a postnatal visit within the first 48 hours for deliver-
ies taking place outside healthcare facilities.
Lund 2012 
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Co-interventions: if the women could not provide a phone number, they received only the mobile
phone voucher component. All enrolled women were offered the standard antenatal, delivery, and
postnatal services.
Outcomes 1. Maternal deaths; 2. Skilled attendant at birth (adjusted ORs split by rural and urban populations); 3.
Neonatal death; 4. Attendance ≥ 4 ANC appointments (outcome was selected among attendance at 0
to > 5 appointments because it is the local and global WHO recommendation); 5. Antenatal antitetanus
vaccinations; 6. Antenatal preventive treatment for malaria; 7. Premature deliveries; 8. Severe obstetric
complications (mother); 9. Client satisfaction with intervention (only reported in intervention group)
Outcomes reported but not included in the review:
1. Gestational age at last ANC visit (outcome not eligible for inclusion); 2. Antepartum referrals (out-
come not eligible for inclusion); 3. Timing of the mentioned services (outcome not eligible for inclu-
sion); 4. Caesarean section (outcome not eligible for inclusion); 5. Perinatal death (combination of
neonatal death and stillbirth) (outcome not eligible for inclusion, we included neonatal deaths)
Outcome assessment time point: 6 weeks after delivery (1 time point for all outcomes)
Funding/declarations of
interest
Funding: Danish International Development Cooperation
Conflicts of interest: none declared
Notes Trial ID: NCT01821222
Cluster features: 24 primary healthcare facilities were randomised. Mean cluster size: 110. The study
adjusted some outcomes (skilled attendant at birth, attendance at > 4 ANC appointments, perina-
tal death, antenatal antitetanus vaccinations, antenatal preventive treatment for malaria) for cluster
design effect. For the remaining outcomes, we used ICCs reported in Pagel 2011: ICC 0.003 (maternal
deaths, premature delivery, severe maternal complications) to adjust for cluster effect in the analyses.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Primary healthcare facilities were assigned by simple random allocation to the
mobile phone intervention. Method not described.
Allocation concealment
(selection bias)
Unclear risk No details on allocation concealment reported.
Selective cluster recruit-
ment
Low risk All eligible women from the selected clusters were included.
Quote: "Women who attended antenatal care at one of the 24 selected health-
care facilities were included on their first antenatal care visit and followed un-
til 42 days after delivery. Women were eligible for study participation irrespec-





High risk Neither study participants nor clinic staQ blinded because of the nature of the
intervention requiring overt participation.
Blinding of objective out-
come assessment (detec-
tion bias)




Low risk No clusters were lost to follow-up and rate of participant loss to follow-up was
low: 3.0% (40/1351) participants in the intervention group and 3.7% (47/1286)
in the control group were lost to follow-up.
Lund 2012  (Continued)
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Selective reporting (re-
porting bias)
Low risk All outcomes stated in the online trial register were reported in 3 different pub-
lications.
Other bias Low risk No significant differences between intervention and control groups with re-
gard to baseline characteristics. Cluster sizes were reported and some analy-





Methods Aim: to evaluate the effects of a mobile phone-based intervention, providing postpartum health edu-
cation and support + 30 days of telephone access to a dedicated on-call nurse, on postnatal maternal
health behaviour, and maternal and infant health.
Study design: parallel individual RCT
Recruitment: study enrolled consecutive inpatient mothers after delivery of their newborn at a large
public hospital or a community clinic with a birthing centre
Study duration: 1 call + 30-day access to call nurse
Study dates: 1 June 2012 (start of recruitment) to 31 August 2012 (end of recruitment)
Participants Inclusion criteria: mothers aged ≥ 15 years, spoke Spanish, newborn not admitted to neonatal inten-
sive care unit
Sample size (n): 178 (intervention: 102; control: 76)
Age (mean): intervention: 27.0 (SD 5.4) years; control: 25.5 (SD 6.2) years
Sex (female): 100%
Country: Ecuador (upper middle-income)
Setting: community served by a large public hospital or a community clinic with a birthing centre.
Interventions Intervention: telephone-based education intervention in 2 parts: 1. educational session administered
by nurse via phone within 48 hours of hospital discharge; 2. Access to a nurse on-call during the first 30
days of the newborn's life
Content: initial session: advice on newborn feeding, safe sleeping, environment, health red flags, rec-
ommended appointments, and excessive crying + advice on mother recognising/preventing infection,
bleeding, pain, voiding, contraception, and mood. Second part: mothers could call the nurse to ask
questions regarding their own or their newborn's health and care, as needed.
Frequency and intensity: 1 call and 30 days of telephone access to receive support from a nurse
Control: standard care/no intervention. Brief discharge instructions delivered by a nurse at the time
of hospital or clinic discharge, typically including a newborn check-up within 1 week, a maternal fol-
low-up visit within 6 weeks, and initiation of a family planning regimen. If mothers required additional
support during the postnatal period, they were instructed to attend a local health centre or emergency
department.
Co-interventions: none
Outcomes 1. Self-reported breastfeeding; 2. Self-reported use of contraception; 3. Infant attended newborn
check-up (reported by mother); 4. Self-reported attendance for postpartum care appointment (narra-
tive result); 5. Acute episodes of illness in infants and mothers (reported by mother); 6. Client satisfac-
tion (only intervention group)
Maslowsky 2016 
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Outcomes reported but not included in the review:
1. Infant attended 2-month check-up (outcome not eligible for inclusion)
Outcome assessment time point: 3 months (1 time point for all outcomes)
Funding/declarations of
interest
Funding: pilot grant from the University of Michigan Center for Global Health; 2 authors' salaries sup-
ported by Eunice Kennedy Shriver National Institute of Child Health and Human Development; 1 author
supported in part by grants from the Breast Cancer Research Foundation and the National Cancer Insti-
tute.
Conflicts of interest: none.
Notes Trial ID: not reported.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "… participants were assigned via a random number generator to ei-
ther the intervention or the control group."
Allocation concealment
(selection bias)





High risk Blinding of participants not possible, no information on blinding of personnel.
Blinding of subjective out-
come assessment (detec-
tion bias)
High risk Outcomes were self-reported by unblinded participants. No information on




High risk High attrition rate: intervention: 27/102 (26%); control: 16/76 (21%).
Selective reporting (re-
porting bias)
Unclear risk All outcomes in methods reported, but no protocol available.
Other bias Low risk Intervention and control groups did not significantly differ in any demographic





Methods Aim: to pilot a programme implemented 3 days after delivery in which a checklist was used by a CHW
to assess the health of mother and newborn and targeted health education was offered.
Study design: parallel individual RCT
Recruitment: women attending selected health facilities were approached by a CHW for recruitment
after a normal delivery just prior to their discharge home.
Study duration: 1 week (at day 7 after birth)
McConnell 2016 
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Study dates: April 2014 to October 2014
Participants Inclusion criteria: women aged 18–40 years, safe normal delivery of a live infant at a Jacaranda Health
facility, reside within a 20 km radius from the Jacaranda Health's hospital facility in peri-urban Nairobi,
provide 2 phone numbers
Sample size (n): 104 (phone call: 41; home visit: 32; standard care: 31)
Age (mean): phone call: 25.6 years; home visit: 25.9 years; standard care: 26.7 years
Sex (female): 100%
Country: Kenya (lower middle-income)
Setting: facility-based, i.e. at Jacaranda Health's 10-inpatient bed hospital in a peri-urban setting just
outside Nairobi
Interventions Intervention: phone/mobile call
Content: CHWs call to screen for maternal and newborn danger signs, to deliver targeted postnatal
health education, and to refer mothers and their newborns to facility-based care if necessary using a
checklist to guide them through the process that was available in English and Kiswahili.
Frequency and intensity: once (at day 3 after delivery)
Control: 1. Standard care/no intervention. Standard care from Jacaranda clinic and did not receive any
additional postpartum check-in from CHW. 2. Home visit. Same health screening and education as the
intervention, but during CHW house calls
Co-interventions: none
Outcomes 1. Exclusive breastfeeding (9 weeks postpartum, the study also reported on this outcome at 10 days
postpartum, but we only included the longest follow-up); 2. Newborn postpartum care sought (10 days
postpartum); 3. Maternal postpartum care sought (10 days postpartum); 4. Newborn health problems
(10 days postpartum); 5. Maternal health problems (10 days postpartum); 6. Use of family planning
method (9 weeks postpartum); 7. Newborn vaccination: ≥ 1 dose of OPV and pentavalent vaccines (9
weeks postpartum)
Outcomes reported but not included in review:
1. Days postpartum maternal care sought, among maternal care-seekers, mean (no SD was reported,
outcome not eligible for inclusion) (10 days postpartum); 2. Days postpartum newborn care sought,
among maternal care-seekers, mean (no SD was reported, outcome not eligible for inclusion) (10 days
postpartum); 3. Postnatal knowledge (10 days postpartum, outcome not eligible for inclusion); 4.
Breastfed ≥ 3 times in past 8 hours (10 days postpartum, 9 weeks postpartum) – outcome not included,
we included exclusive breastfeeding (see above); 5. Combined outcome of health knowledge (10 days
postdelivery, outcome not eligible for inclusion); 6. Combined outcome of health practices (10 days'
and 9 weeks postdelivery, outcome not eligible for inclusion)
Outcome assessment time point: 10 days and 9 weeks postpartum
Funding/declarations of
interest
Funding: Grand Challenges Canada
Conflicts of interest: none declared
Notes Trial ID: NCT02104635
Risk of bias
Bias Authors' judgement Support for judgement
McConnell 2016  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Random assignment of patient identifiers was done using a randomisation se-
quence generated by the principal investigators.
Allocation concealment
(selection bias)
Unclear risk Participants were individually randomised prior to enrolment using numeric
patient identifiers assigned by Jacaranda Health. A unique identifier was given
to each Jacaranda Health client seeking any service (including ANC, delivery,
postnatal care, and child wellness care) during the client's first visit to Jacaran-





High risk Not possible to blind participants to phone call, home visit, or no intervention.
Blinding of subjective out-
come assessment (detec-
tion bias)





Unclear risk Quote: "We test for differences in outcomes across study arms on an inten-
tion-to-treat basis, with the treatment arms defined as participants' random-
ized treatment assignment and the sample including all respondents where
data is available (not just those reached by a day 3 intervention)."
Many participants could not be reached for outcome surveys, 16–22% for 10-
day survey and 41–45% for 9-week survey.
Selective reporting (re-
porting bias)
Low risk All study outcomes were explained and reported. See also ClinicalTrials.gov
Identifier: NCT02104635.
Other bias Unclear risk There were some baseline differences.
Quote: "Most of the differences in characteristics across arms are small and
not statistically significant, except for a somewhat lower rate of marriage in
the call arm (85 % (35/41) vs. 97 % (30/31) and 97 % (30/31) in the standard of
care and home visit arms, respectively) and a lower employment rate in the





Methods Aim: to estimate whether text messages encouraging influenza vaccination sent to an ambulatory ob-
stetric population could improve influenza vaccination rates among women unsure about or unwilling
to receive the vaccine.
Study design: parallel individual RCT
Recruitment: participants recruited and enrolled at routine obstetric visits to a Women's Hospital's
outpatient clinic
Study duration: 12 weeks
Study dates: September 2010 (recruitment) to February 2012 (recruitment)
Participants Inclusion criteria: pregnant women, < 28 weeks' gestation, aged 14–50 years, owned a personal mo-
bile phone with text messaging capabilities, reported not receiving that season's influenza vaccine,
electronic record lacked documentation of influenza vaccine administration in that season
Moniz 2013 
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Sample size (n): 216 (intervention SMS: 104; control SMS: 100)
Age group: 13–17 years: control/general: 2 (2%), intervention/influenza: 3 (3%); 18–25 years: con-




Setting: community, served by a single women's hospital
Interventions Intervention: SMS messages
Content: SMS messages regarding general preventive health in pregnancy plus the importance of in-
fluenza vaccination during pregnancy
Frequency and intensity: 12 weekly messages
Control: non-targeted, client communication: participants received 12 weekly text messages regard-
ing general preventive health in pregnancy. General preventive health messages received by all partici-
pants covered topics such as the importance of antenatal vitamins, nutritional foods, and seat belt use
during pregnancy
Co-interventions: participants in both groups received usual ANC in the outpatient clinic, where ANC
providers (nurses, midlevel HCPs, physicians) verbally recommend and offer influenza vaccination at
each antenatal visit.
Outcomes 1. Attendance for antenatal influenza vaccination; 2. Acceptability of text messaging
Outcomes reported but not included in the review:
1. Self-reported reasons for declining influenza vaccination (outcome not eligible for inclusion)
Outcome assessment time point: 12 weeks
Funding/declarations of
interest
Funding: grant from the Amy Roberts Health Promotion Foundation
Conflicts of interest: authors did not report any potential conflicts of interest.
Notes Trial ID: NCT01248520
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Participants were randomised to the 2 study arms with equal frequency using
a permuted block design with random block sizes of 2, 4, and 6. A researcher




Low risk A researcher uninvolved in participant recruitment or clinical care generated
the randomisation sequence and placed group assignments in sequentially





Unclear risk Both groups received SMS messages, but only 1 group's messages contained
information about influenza vaccination. Uncertain to what extent women
were cognisant that the influenza vaccine content was the intervention. HCPs
were blind to the groups to which participants were randomised.
Moniz 2013  (Continued)
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Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Vaccine receipt was verified by review of the clinic's electronic medical record,
which automatically documents date of vaccination at the time of vaccine ad-
ministration. Record review was conducted after exit surveys were completed
by a researcher unaware of participants' randomisation allocation.
Blinding of subjective out-
come assessment (detec-
tion bias)
Unclear risk Unclear whether participants were blinded, thus unclear whether self-report-








Low risk No reason to suspect selective reporting, online trial record was available and
results for listed outcomes were reported.





Methods Aim: to 1. estimate the effectiveness of pregnancy smoking cessation support delivered by SMS text
message, and 2. key parameters needed to plan a definitive trial.
Study design: parallel individual RCT
Recruitment: research midwives identified potential participants in antenatal clinics via their clinic
notes or a screening questionnaire, and interested women were provided with participant information
sheets.
Study duration: 12 weeks
Study dates: February 2014 (start of recruitment) to September 2014 (end recruitment)
Participants Inclusion criteria: pregnant and < 25 weeks' gestation, smoking ≥ 5 cigarettes per day prepregnancy,
smoking ≥ 1 cigarette on a typical day during pregnancy, aged ≥ 16 years, agreed to accept information
to assist cessation, had own or had primary use of a mobile phone, familiar with sending and receiving
text messages, able to understand written English, able to give informed consent
Sample size (n): 407 (intervention: 2013; control: 204)
Age (mean): intervention: 26.6 (SD 5.7) years; control: 26.4 (SD 5.7) years
Sex (female): 100%
Country: England (high-income)
Setting: English NHS hospital antenatal clinics
Interventions Intervention: SMS (MiQuit)
Content: motivational messages, advice about preparing for a quit attempt, how to manage cravings
and withdrawal, dealing with trigger situations, information about how smoking affects babies, and
general encouragement
Frequency and intensity: daily, according to a delivery schedule (0, 1, or 2 daily texts). Women were
able to alter support frequency by texting the keywords MORE or LESS
Naughton 2017 
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Control: standard care/no intervention
Co-interventions: all participants were given a standard NHS booklet on smoking cessation for moth-
ers-to-be and could access smoking cessation information, advice, or support for stopping smoking of-
fered as part of routine ANC.
Outcomes 1. Continuous abstinence (i.e. no more than 5 cigarettes in total) between 4 weeks postrandomisation
until late pregnancy (approximately 36 weeks' gestation) (both self-report and objectively verified, we
only included the objectively verified measure); 2. Client acceptability (SMS quite or extremely useful,
SMS quite or extremely annoying); 3. Economic analysis: total per participant cost (of intervention); 4.
Economic analysis: incremental cost per additional quitter
Outcomes reported but not included in the review:
1. 7-day point abstinence at 4 weeks postrandomisation and 36 weeks' gestation (both self-report and
objectively verified) – we excluded these measures and included the long-term continuous abstinence
outcome instead (see above); 2. Use of smoking cessation support during the trial period (outcome not
eligible for inclusion); 3. Number of quit smoking attempts between baseline and late pregnancy (we
excluded this smoking cessation outcome and included the long-term continuous abstinence outcome
instead (see above))




Funding: National Institute for Health Research (NIHR) under the Programme Grants for Applied Re-
search programme; the British Heart Foundation, Cancer Research UK, Economic and Social Research
Council, Medical Research Council, and the Department of Health, under the auspices of the UK Clinical
Research Collaboration.
Conflicts of interest: on 2 occasions since 2008, TC paid to attend and present at symposia arranged
by Pierre Fabre Laboratories (PFL); PFL is a manufacturer of nicotine replacement therapy. All other au-
thors had no competing interests.
Notes Trial ID: NCT02043509
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants were randomised individually to usual care or the MiQuit inter-




Unclear risk Randomisation used a computer-generated pseudo-random code with ran-
dom permuted blocks of randomly varying size, and stratification was by study
site and gestation (< 16 vs ≥ 16 weeks).
Following randomisation, unblinded trial team members sent arm-specific in-





High risk Not possible to blind participants.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Trial staQ involved in follow-up remained unaware of participants' treatments
until questions on the intervention were asked at the end of the study, after
smoking outcome data had been collected.
Naughton 2017  (Continued)
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Blinding of subjective out-
come assessment (detec-
tion bias)




Unclear risk ITT analysis used. Participants lost to follow-up or with missing outcome data
(around 30–40% depending on outcome and time point) were assumed to be
smoking.
Quote: "At 4 weeks, 295 (72%) participants provided smoking outcome data
(68% MiQuit, 77% usual care). Further attrition in late pregnancy was fairly
minimal, with 261 (64%) participants providing these outcome data (64% MiQ-
uit, 65% usual care). Two hundred and thirty (57%) provided smoking outcome
data at both time-points (55% MiQuit, 58% usual care) and 254 (62%) gave da-
ta used for smoking outcome 1 on abstinence between 4 weeks and late preg-
nancy (61% MiQuit, 64% usual care)."
Selective reporting (re-
porting bias)
Low risk No evidence that outcomes were selectively reported.
Other bias Unclear risk Quote: "Participants' characteristics were similar in both groups, apart from
that women randomized into the usual care group were more likely to reside
in the most deprived (e.g. lower income) areas and have a non-smoking part-
ner."
Comment: for the main smoking cessation outcome.
Quote: "We obtained validation samples for 37 of 64 (58%) of participants who
reported abstinence at 36 weeks gestation (56% MiQuit, 61% usual care); with






Methods Aim: to examine the effect text messages immunisation reminders have on immunisation rates in the
first 7 months of life.
Study design: parallel individual RCT
Recruitment: enrolment at health facilities
Study duration: 5 months
Study dates: not reported
Participants Inclusion criteria: parent of a child aged 1–28 days, able to speak and read English, having a mobile
telephone with text message capabilities, willingness to participate in study for 6 months
Sample size (n): 57 (intervention: 30; control: 27)
Age (mean): intervention: 31.5 (SD 6.9) years; control: 30.7 (SD 5.7) years
Sex: 98% females (mothers). Just 1 father was included in the study.
Country: USA (high-income)
Setting: 4 health facilities: 1 large federally qualified health centre, 1 women/infants and children clin-
ic, 1 private paediatric clinic, and the Honolulu Baby Expo, Hawaii
Niederhauser 2015 
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Interventions Intervention: SMS
Content: child immunisation reminders
Frequency and intensity: 4 and 2 weeks prior to the due date for the infant's 2, 4, and 6-month vacci-
nations. From 2 to 7 months of age, i.e. 5 months' duration
Control: digital, non-targeted communication. Messages were age-appropriate and based on well-ba-
by information found in Bright Futures in addition to their routine reminders that they received from
their HCPs.
Co-interventions: 10% of the parents were randomly selected to receive phone calls verifying the re-
ceiving of the messages.
Outcomes 1. Immunisation compliance with 5 vaccines (DTaP; hepatitis B; haemophilus influenzae type B; pneu-
mococcal conjugate vaccine; and polio) at 7 months of age
Outcomes reported but not included in the review:
1. Barriers to immunisation Survey (SHOTS survey), total score and subscales (outcome not eligible for
inclusion)
Outcome assessment time point: 2 months and 7 days, 2 months and 14 days, 4 months and 7 days,
4 months and 14 days, 6 months and 7 days, 6 months and 14 days, and 7 months of age – we reported




Conflicts of interest: none declared
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk After obtaining a written consent and contact information, using a random









High risk Blinding of participants and personnel not reported.
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Not reported.
Blinding of subjective out-
come assessment (detec-
tion bias)





High risk The loss to follow-up of 39% of the intervention group compared to a loss of
10% of the control group, only per-protocol analysis was done.
Niederhauser 2015  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk All outcomes described in the Measures section were included in the Results
section, but no protocol or online trial record was available.
Other bias Unclear risk In comparing the 2 groups, the only difference in the 2 groups that nearly
reached significance (P = 0.07), was a higher percentage of intervention (58%)





Methods Aim: evaluated effect of an interactive, individually tailored, 2-way text messaging system informed by
behavioural theory on maternal postpartum clinic attendance and infant HIV testing within 8 weeks af-
ter birth.
Study design: parallel individual RCT
Recruitment: not reported
Study duration: from pregnancy to 6 weeks after delivery
Study dates: April 2012 to March 2013
Participants Inclusion criteria: aged ≥ 18 years, between 28 weeks' gestation and delivery, enrolled in PMTCT, plan-
ning to remain in study area, access to a mobile phone, and reported ability to read or had someone
who read SMS on their behalf. Women who shared phones were eligible only if they had disclosed their
HIV status to the person with whom the phone was shared.
Sample size (n): 388 (intervention: 195; standard care: 193)
Age (n): 18–24 years: intervention: 60 (30.8%); control: 65 (33.7%); 25–34 years: intervention: 111
(56.9%); control: 111 (57.5%); ≥ 35 years: intervention: 24 (12.3%); control: 17 (8.8%)
Sex (female): 100%
Country: Kenya (lower middle-income)
Setting: ANC or HIV clinics at 5 health facilities, including a mix of rural and urban settings
Interventions Intervention: text messages
Content: educational or motivational messages tailored to gestation week or newborn age
Frequency and intensity: 14 messages. Up to 8 were sent during pregnancy (weeks 28, 30, 32, 34, 36,
38, 39, and 40). Additional messages were sent weekly for the first 6 weeks after delivery.
Control: standard care/no intervention
Co-interventions: participants in both arms were allowed to call or send SMS to the study nurse at any
time. Baseline treatments (n): on ART for own health: 101 (51.8%); 102 (52.8%); received ZDV prophy-
laxis: 85 (43.6%); 81 (42.0%); received ZDV + 3TC + nevirapine (delivery pack): 60 (30.8%); 53 (27.5%); re-
ceived ZDV + 3TC (postdelivery pack): 60 (30.8%); 51 (26.4%); nevirapine prophylaxis for baby issued:
139 (71.3%); 133 (68.9%)
Outcomes 1. Infant HIV testing; 2. Infant positive virological HIV test results; 3. Maternal postnatal appointment at-
tendance within 8 weeks; 4. Neonatal death/stillbirth
Outcome assessment time point: 8 weeks postpartum
Odeny 2014 
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Funding/declarations of
interest
Funding: the National Institutes of Health Office of the Director, Fogarty International Center, Office of
AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Insti-
tute, National Institute of Dental and Craniofacial Research, National Institute On Drug Abuse, National
Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institutes
of Health Office of Women's Health and Research through the Fogarty International Clinical Research
Scholars and Fellows Program at Vanderbilt University and the American Relief and Recovery Act. TAO
was a Fogarty International Clinical Research Fellow. CSC was supported by a Research Scientist De-
velopment Award from the National Institute of Mental Health, KY was supported by the University of
Washington Center for AIDS Research (CFAR), an NIH funded programme.
Conflicts of interest: financial competing interests include but are not limited to paid employment or
consultancy: CRC served as a paid consultant for CerMed Inc. to help them develop a barrier contracep-
tive/HIV prevention device. This consultancy ended in 2012. Research grants (from any source, restrict-
ed or unrestricted): CRC has active grants from the US NIH, CDC, and Bill & Melinda Gates Foundation.
RSM has active grants from the US NIH and Hologic/Gen-Probe. Travel grants and honoraria for speak-
ing or participation at meetings: CRC received a travel grant to consult with Gynuity on a study they
conducted to investigate infections following medical abortion in the United States. Nonfinancial (pro-
fessional): acting as an expert witness – CRC has served as an expert witness on a case in New York City
involving a malpractice suit of a woman who died after delivery due to infectious complications. Mem-
bership in a government or other advisory board: CRC was a non-paid consultant on a WHO panel to as-
sess the risk of hormonal contraception and HIV acquisition in women. RSM has received a donation of
study product for treatment of vaginal infections from Embil Pharmaceutical Company.
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Block randomisation scheme with variable block sizes. Investigators and study
staQ were unaware of block numbers, sizes, or sequences.
Allocation concealment
(selection bias)





High risk Labelled as unblinded.
Blinding of objective out-
come assessment (detec-
tion bias)




Low risk Analyses were ITT. There were few withdrawals or losses to follow-up.
Selective reporting (re-
porting bias)
Unclear risk Expected outcomes reported, but no protocol or online trial register to check
against.
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Methods Aim: to determine the impact of pregnancy information and appointment reminder SMSs on maternal
health behaviour.
Study design: cluster RCT
Recruitment: public launch of the project to sensitise health workers and select stakeholders followed
by recruitment of random selection of pregnant women in their first trimester who were attending an-
tenatal clinics in selected health facilities in the Ife-Ijesa zone.
Study duration: participants followed up to delivery and completion of immunisation for their chil-
dren
Study dates: December 2013 (start of enrolment) to December 2014 (end of enrolment)
Participants Inclusion criteria: pregnant women residing in Ife-Ijesa zone, owner of a mobile phone, able to read
and write in English or Yoruba (local dialect) language
Sample size: 508 (targeted SMS: 260 participants, 2 clusters; non-targeted SMS: 248 participants, 2
clusters)
Age group: 15–24 years: 27.8%; 25–34 years: 59.3%; > 35 years: 13%
Sex (female): 100%
Country: Nigeria (lower middle-income)
Setting: public health facilities in Ife-Ijesa area, Osun State, south-west Nigeria. These are secondary
health facilities with the highest number of ANC attendees and delivery within the zone.
Interventions Intervention: pregnancy information and appointment reminder text messages
Content: messages for the intervention group included pregnancy-related information such as birth
preparedness, complication readiness, and reminders of antenatal visits. Study participants in the in-
tervention group also had the opportunity of sending text messages to the project team to seek for
health information.
Frequency and intensity: once a week
Control: digital, non-targeted communication. General health tips, which excluded pregnancy-related
health information and clinic schedule reminders
Co-interventions: none
Outcomes 1. Place of birth (health facility); 2. Opinion of respondents about SMS intervention (only intervention
group)




Funding: The Madiro Fund: Gillian and Adrian Schauer Foundation, Montreal, Canada.
Conflicts of interest: none declared
Notes Trial ID: not reported
Cluster features: 4 government health facilities were randomised. Mean cluster size: 127. Study did not
adjust for clustering effect for the relevant outcome; we used ICC 0.127 (reported in Pagel 2011) to ad-
just for cluster effect in the analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Omole 2018  (Continued)
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Random sequence genera-
tion (selection bias)
Unclear risk Random sequence generation not mentioned.
Allocation concealment
(selection bias)
Unclear risk Allocation concealment not mentioned/reported.
Selective cluster recruit-
ment
High risk Participants were enrolled after clusters had been allocated to intervention
arms.
Quote: "This phase started with the public launch of the project to sensitize






High risk Not possible to blind participants.
Blinding of objective out-
come assessment (detec-
tion bias)
Unclear risk Blinding of objective outcome assessment not mentioned/reported.
Blinding of subjective out-
come assessment (detec-
tion bias)




High risk Table 4 shows primary outcome with high attrition.
Selective reporting (re-
porting bias)
High risk Primary outcome of study was complete ANC defined as "attendance of at
least 4 antenatal clinic visits and delivery in a health facility." The authors on-
ly reported on the proportions of delivery in a health facility for a subgroup of
pregnant women.
Other bias Unclear risk Groups differed significantly in their occupational distribution, occupational
category of spouses, proportion that had delivered in a health facility in their





Methods Aim: to evaluate the effect of providing oral health education by 2 different modes (text messages and
pamphlets), on the knowledge, attitude, and practices of mothers of preschool children and plaque
scores of their children.
Study design: parallel individual RCT
Recruitment: not reported
Study duration: 4 weeks
Study dates: not reported
Participants Inclusion criteria: mothers proficient in English, owners of a personal mobile phone, familiar with text
messaging
Sharma 2011 
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Sample size: 150 children enrolled, 143 completed study (SMS: 71; control: 72 at completion, numbers
per group at enrolment not reported)
Age (mean): mothers: not reported; children: text messages: 3.6 (SD 0.5) years; pamphlet: 3.3. (SD 0.5)
years
Sex: mothers: not reported; children: 83 boys/60 girls (among those who completed the study)
Country: India (lower middle-income)
Setting: not reported
Interventions Intervention: SMS
Content: messages covered topics that would help the mothers to maintain an optimum oral health
for their children and themselves
Frequency and intensity: total of 21 messages, either in the form of text messages or pamphlets, were
sent in 7 days (3 messages per day). Messages repeated every week for 4 weeks
Control: non-digital, targeted communication. Pamphlets sent daily to the mothers through the chil-
dren; 3 messages printed on the pamphlet and attached to the daily work diary of each child belonging
to the pamphlet group
Co-interventions: not reported
Outcomes 1. Visible Plaque Index in children
Outcomes reported but not included in the review:
1. Knowledge, attitude, and practices of the mothers (outcome not eligible for inclusion)




Conflicts of interest: not reported
Notes Trial ID: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Participants were randomly allocated to the text message group or the pam-
phlets group. Method of generating sequence not described.
Allocation concealment
(selection bias)





High risk Given nature of intervention, participants could not be blinded. The examiner
and statistician who analysed data were blinded.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Examiner and statistician who analysed the data were blinded.
Incomplete outcome data
(attrition bias)
High risk 143/150 preschool children and their mothers completed the study. It was not
reported which groups the dropouts belonged to.
Sharma 2011  (Continued)
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Unclear risk All outcomes described in the Measures section were included in the Results
section, but no protocol or online trial record was available.





Methods Aim: to compare the effectiveness of text message vaccine reminders with and without vaccine educa-
tion vs written reminder-only on receipt of second dose of influenza vaccine in young, low-income chil-
dren.
Study design: parallel individual RCT
Recruitment: study sites were part of an ambulatory-care network staQed by 1 centrally administered
paediatric group practice, all eligible children seen when research assistants were on-site were ap-
proached.
Study duration: 42 days
Study dates: August 2012 to March 2013
Participants Inclusion criteria: parenting adult of child age 6 months to 8 years, child received care at study site
(visit in last 12 months), child received 1 dose influenza vaccine and was in need of a second dose in
same season season*, parent had mobile phone with text message capability, parent spoke English or
Spanish and could read text messages
Sample size (n): 660 (conventional SMS: 225; educational SMS: 216; usual care: 219)
Age: parents: not reported; children: age group: < 5 years: 83% (550/660); 5–8 years: 17% (110/660)
Sex (female): children: 49.5%
Country: USA (high-income)
Setting: 3 community-based paediatric clinics affiliated with New York-Presbyterian Hospital/Colum-
bia University Medical Center in Northern Manhattan in New York City
Interventions Intervention: 1. SMS vaccine reminders only; 2. SMS vaccine reminders and educational messages
Content: SMS reminders contained the date after which the next dose was due and clinic-specific walk-
in hours. Those in the educational text message arm additionally received educational information that
included that the child was not protected until he or she received the second dose, that reaching full
protection could take 2 weeks after second dose administration, and that doctors recommended a sec-
ond dose. In addition, in 1 interactive message, parents could select to receive more information via
text message. Messages were sent in English or Spanish based on the participant's request at enrol-
ment.
Frequency and intensity: 5 messages – 3 dates before dose was due (day 7, day 21, and day 25 after
first influenza vaccine dose), on the day it was due (day 28), and 2 weeks after it was due (day 42)
Control: standard care/no intervention. Parents of children randomly assigned to receive usual care
did not receive any further intervention beyond the written reminder.
Co-interventions: all families received a written reminder with the date the next influenza vaccine
dose was due (routine practice)
Stockwell 2015 
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Outcomes 1. Attendance for second vaccination before end of influenza season; 2. Receipt of a second influenza
vaccine dose by 42 days postvaccination (i.e. on time); 3. Client satisfaction
Outcome assessment time point: see above
Funding/declarations of
interest
Funding: institutional career development grant funded by the National Institutes of Health.
Conflicts of interest: Dr Hofstetter received support from the Pfizer Medical Education Group for a dif-
ferent investigator-initiated study; Dr Stockwell is a co-investigator but received no financial support;
Dr Hofstetter also received support through the Investigator-Initiate.
Notes Trial ID: NCT01662583
*Children in need of a second dose were those who had not received 2 doses of vaccine since July 2010
(the first season the 2009 H1N1-strain was included in the seasonal vaccine) or those who had not re-
ceived 2 previous seasonal influenza vaccinations + ≥ 1 × 2009 H1N1-containing vaccination, either as a
seasonal or monovalent pandemic vaccine.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No information on sequence generation.
Quote: "Subjects were randomly assigned centrally with a 1:1:1 allocation at
an individual level by using a permuted block design with a block size of 9,
stratified by age and clinic site."
Allocation concealment
(selection bias)
Low risk Central allocation.
Quote: "Subjects were randomly assigned centrally with a 1:1:1 allocation at
an individual level by using a permuted block design with a block size of 9,





High risk Blinding of participants and personnel not reported/mentioned. However, due
to the nature of the intervention participants (at least) could not be blinded to
the intervention.
Blinding of objective out-
come assessment (detec-
tion bias)
Low risk Vaccination status retrieved from medical records and study analyst was blind-
ed to individual group assignment.
Blinding of subjective out-
come assessment (detec-
tion bias)





Low risk Analyses were ITT, there was only 2 exclusions after randomisation but this
was before the launching of the interventions.
Selective reporting (re-
porting bias)
Low risk All outcomes listed in the online trial record (NCT01662583) were reported.
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Study characteristics
Methods Aim: to evaluate if text message reminders increase the likelihood of receiving the influenza vaccine
among pregnant women.
Study design: parallel individual RCT
Recruitment: women were approached in the waiting room by research personnel who were not part
of the clinical care team and were asked if they were interested in enrolling in a study investigating the
use of text messages in pregnancy. Women were told the messages would be about health-related be-
haviour in pregnancy, but no mention was made of influenza or vaccination at the time of recruitment.
Study duration: 4 weeks
Study dates: November 2014 (start recruitment) to March 2014 (end recruitment)
Participants Inclusion criteria: pregnant woman, aged ≥ 18 years, working mobile phone with ability to receive text
messages, ability to speak or understand English
Sample size (n): 317 (SMS: 153; standard care: 164)
Age (mean): intervention: 32.2 (SD 4.5) years; control: 32.4 (SD 4.9) years
Sex (female): 100%
Country: Canada (high-income)
Setting: hospital-based antenatal clinic at St Michael's Hospital, which is a women's health ambulatory
care clinic in downtown Toronto
Interventions Intervention: SMS
Content: SMS messages reinforcing that the influenza vaccine is recommended for all pregnant
women and safe during pregnancy and breastfeeding
Frequency and intensity: weekly (2 SMS/week)
Control: standard care/no intervention. All women attending the clinic were given a pamphlet contain-
ing information about the risks of influenza during pregnancy, the importance of the vaccine for preg-
nant women, and the fact that the vaccine is safe in pregnancy and breastfeeding.
Co-interventions: all women received usual ANC, including the verbal recommendation for influenza
vaccination.
Outcomes 1. Attendance for influenza vaccination; 2. Satisfaction with receiving SMS and opinion on timing and
number of SMS received
Outcomes reported but not included in the review:
Outcome assessment time point: 6 weeks postpartum (1 time point for all outcomes)
Funding/declarations of
interest
Funding: St Michael's Hospital Innovation Fund Grant
Conflicts of interest: not reported
Notes Trial ID: NCT02428738 (registered as a case control study)
Risk of bias
Bias Authors' judgement Support for judgement
Yudin 2017 
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Random sequence genera-
tion (selection bias)
Low risk Computerised random number generator.
Allocation concealment
(selection bias)
Low risk Group allocation was assigned using sequentially numbered, sealed, opaque





Low risk Women were told the messages would be about health-related behaviour in
pregnancy, but no mention was made of influenza or vaccination at the time of
recruitment.
Medical and nursing staQ caring for the women were blinded to study group al-
location and were not involved in any aspects of the study.
Blinding of subjective out-
come assessment (detec-
tion bias)




Low risk The final analysis was based on the actual treatment received and included
281/317 randomised participants.
All analyses using ITT groupings were repeated and there were no changes




Low risk Outcomes listed in the online trial registration were reported.
Other bias Unclear risk No significant baseline differences.
Yudin 2017  (Continued)
3TC: lamivudine; ANC: antenatal care; ART: antiretroviral therapy; ARV: antiretroviral; BCG: Bacillus Calmette-Guérin; CHW: community
health worker; DPT: diphtheria, pertussis (whooping cough), and tetanus; DTaP: diphtheria, tetanus, and whooping cough (pertussis); EPI:
Expanded Programme on Immunisations; HCP: healthcare provider; HCW: healthcare worker; ICC: intracluster correlation coeQicient; IQR:
interquartile range; ITT: intention to treat; KES: Kenyan shilling; LMIC: low- to middle-income country; n: number of participants; NHS:
National Health Service; NP: nurse practitioner; OPV: oral polio vaccine; OR: odds ratio; PCR: polymerase chain reaction; PMTCT: prevention
of mother-to-child transmission; RCT: randomised controlled trial; SD: standard deviation; SMS: short message service; WHO: World Health
Organization; ZDV: zidovudine.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Atukunda 2017 Irrelevant intervention – including digital tracking component.
Bracken 2014 Irrelevant intervention – not exclusively using mobile device.
Broberg 2013 Irrelevant intervention – not exclusively using mobile device.
Carlsen 2013 Irrelevant intervention – not exclusively using mobile device.
Collier 2005 Irrelevant intervention – not exclusively using mobile device.
Gallegos 2014 Irrelevant study design – not randomised controlled trial.
Haberer 2016 Irrelevant intervention – including digital tracking component.
Hashemian 2015 Irrelevant intervention – targeted communication used in conjunction with other interventions.
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Study Reason for exclusion
Herring 2016 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Hofstetter 2015b Irrelevant population – parents of children older than 5 years.
Irons 2015 Irrelevant study design – not randomised controlled trial.
Jimenez 2017 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Kofinas 2014 Irrelevant intervention – not targeted client communication.
Lau 2013 Irrelevant study design – not randomised controlled trial.
Lau 2014 Irrelevant study design – not randomised controlled trial.
Lewis 2012 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Maduka 2013 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Mauriello 2016 Irrelevant intervention – not exclusively using mobile device.
Milani 2015 Irrelevant intervention – not exclusively using mobile device.
Moore 2013 Irrelevant intervention – including digital tracking component.
Moore 2015 Irrelevant intervention – including digital tracking component.
Murthy 2019 Quasi-randomised study.
Mwapasa 2017 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Oakley-Girvan 2016 Irrelevant study design – not randomised controlled trial.
Patel 2014 Irrelevant intervention – not exclusively using mobile device.
Peitzmeier 2016 Irrelevant intervention – not exclusively using mobile device.
Pollak 2014 Irrelevant intervention – including digital tracking component.
Prieto 2016 Irrelevant study design – not randomised controlled trial.
Pérez-Ferre 2010 Irrelevant intervention – including digital tracking component.
Rampersaud 2016 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Rand 2015 Irrelevant population – parents of adolescents receiving vaccination reminders.
Rand 2017 Irrelevant population – parents of adolescents receiving vaccination reminders.
Reeder 2014 Irrelevant intervention – not exclusively using mobile device.
Reid 2014 Irrelevant study design – not randomised controlled trial.
Richman 2016 Irrelevant intervention – not exclusively using mobile device.
Robbins 2013 Irrelevant intervention – not exclusively using mobile device.
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Study Reason for exclusion
Sridhar 2013 Irrelevant intervention – not exclusively using mobile device.
Sridhar 2014 Irrelevant intervention – not targeted communication.
Stern 2013 Irrelevant intervention – not exclusively using mobile device.
Stockwell 2012 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Szilagyi 2013 Irrelevant intervention – not exclusively using mobile device.
Takeuchi 2016 Irrelevant intervention – targeted communication used in conjunction with other interventions.
Tarrant 2014 Irrelevant intervention – not exclusively using mobile device.
Trent 2013 Irrelevant study design – not randomised controlled trial.
Trent 2015 Irrelevant study design – not randomised controlled trial.
Van Ryswyk 2015 Irrelevant comparison group – control group also received targeted communication.
Wright 2012 Irrelevant intervention – not exclusively using mobile device.
Young 2013 Irrelevant intervention – not targeted communication.
Young 2014 Irrelevant intervention – not targeted communication.
 
Characteristics of studies awaiting classification [ordered by study ID]
 
Methods Aim: to test whether an interactive and intensive text messaging programme, Quit4baby, can pro-
mote smoking cessation for pregnant women already enrolled in a health text messaging pro-
gramme, Text4baby.
Study design: randomised controlled trial
Study dates: July 2015 to February 2016
Participants 497 pregnant smokers recruited among 'Text4baby' subscribers in the USA (except CA, OK, OH, and
LA)
Interventions TCC: Quit4baby text messages + Text4baby text messages
Control: Text4baby text messages
Outcomes Smoking cessation outcomes




Methods Aim: to test the acceptability and feasibility of SmokefreeMOM, a national smoking cessation text-
messaging programme for pregnant smokers.
Abroms 2017b 
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Study design: randomised controlled trial
Study dates: September 2014 to May 2016 (recruitment)
Participants 99 pregnant smokers recruited from obstetrics-gynaecology clinics in Washington DC, USA.
Interventions TCC: SmokefreeMOM text messaging programme
Control: mailed self-help materials on quitting smoking while pregnant + 1 text message referring
to telephone quit line
Outcomes 1. Programme acceptability and feasibility; 2. Use of treatments and resources for quitting at 1
month; 3. Smoking-related outcomes




Methods Aim: to assess the effect of a behavioural intervention targeting excess gestational weight gain.
Study design: randomised controlled trial.
Study dates: February 2013 to October 2015
Participants 54 pregnant women who were overweight or obese recruited through advertisements and targeted
emails and referrals from local obstetricians in Baton Rouge, LA, USA.
Interventions TCC 1: SmartMoms through mobile application
TCC 2: SmartMoms in person
Control: usual care
Outcomes 1. Weight; 2. Mood; 3. Quality of life




Methods Aim: to assess the influence of mobile communication between health facility and pregnant
women on utilisation and outcome of maternal health services.
Study design: randomised controlled trial
Study dates: not reported
Participants 400 pregnant women in India (region not reported)
Interventions TCC: mobile phone calls as reminders about next visit and SMS on maternal health
Control: usual care
Outcomes 1. Antenatal care visits; 2. Institutional deliveries, 3. Perinatal mortality; 4. Complications during
pregnancy; 5. Postnatal follow-up
Bangal 2018 
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Methods Randomised controlled trial
Participants Carers of children aged 6 weeks to 6 months who received first dose of primary vaccination series
Interventions TCC: SMS message reminders 1 week before scheduled vaccination
Control: usual care
Outcomes 1. Completion of vaccine primary series; 2. Factors associated with immunisation delays; 3. Accept-
ability of SMS vaccine reminders; 4. Timeliness of immunisation




Methods Aim: to evaluate the impact of text messaging on smoking cessation rates among pregnant women.
Study design: randomised controlled trial
Study dates: May 2014 to January 2016
Participants 49 pregnant women in the preparation stage of quitting smoking recruited from a maternal foetal
care centre in Saint Louis, USA
Interventions TCC: text messaging
Control: usual care
Outcomes 1. Self-reported cessation rates at 1 month, as verified by exhaled carbon monoxide levels




Methods Aim: to determine if text message reminders, with or without mobile phone-based incentives, can
improve measles immunisation coverage and timeliness in rural western Kenya.
Study design: randomised controlled trial
Study dates: enrolment to March 2017
Participants 537 carers of infants aged 6–8 months in Siaya County, Kenya
Interventions TCC 1: SMS reminders for measles vaccine
TCC 2: SMS reminders plus a KES 150 incentive
Control: usual care
Gibson 2019 
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Outcomes 1. Measles vaccination coverage; 2. Time to measles vaccination




Methods Aim: to test the acceptability and feasibility of the Lactation Advice thru Texting Can Help interven-
tion.
Study design: randomised controlled trial
Study dates: not reported
Participants 58 pregnant women that intended to breastfeed recruited from 2 women, infants, and children
breastfeeding peer counselling programmes in CT, USA
Interventions TCC: peer counselling support with texting (breastfeeding education and support from peer coun-
sellors)
Control: peer counselling support without texting
Outcomes 1. Breastfeeding status; 2. Early postpartum contact; 3. Feasibility and acceptability




Methods Aim: to assess the effect of 2-way SMS with a nurse on postpartum contraceptive use among indi-
vidual women and couples.
Study design: randomised controlled trial
Study dates: July 2016 to September 2017
Participants 260 pregnant women (with the option to include male partners) recruited from 2 public hospitals in
western Kenya
Interventions TCC: automated family planning-focused SMS messages
Control: usual care
Outcomes Contraceptive use




Methods Aim: to implement a breastfeeding promotion intervention using mobile phone text messages in
Yangon, Myanmar, and evaluate its impact on breastfeeding practices.
Study design: randomised controlled trial
Study dates: January to March 2015 (recruitment)
Hmone 2017 
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Participants 358 pregnant women of 28–34 weeks' gestation recruited from the Central Women's Hospital in
Yangon, Myanmar
Interventions TCC: breastfeeding promotional SMS messages 3 times a week
Control: maternal and child healthcare messages (excluding breastfeeding-related messages) once
a week
Outcomes 1. Breastfeeding outcomes; 2. Other infant feeding practices; 3. Client satisfaction




Methods Aim: to investigate the impact of extended parallel process model (EPPM)-based SMS on protective
behaviours of pregnant women in reducing diseases caused by air pollution.
Study design: randomised controlled trial
Study dates: May 2015 to March 2016
Participants 130 pregnant women in Ahvaz, Iran
Interventions TCC: SMS intervention
Control: usual care
Outcomes 1. Perceived severity or air pollution; 2. Response efficacy; 3. Self-efficacy; 4. Protective behaviours
against air pollution




Methods Aim: to determine whether PRENACEL (a bi-directional, mobile-phone based, SMS) increases the
coverage of recommended antenatal care practices.
Study design: cluster-randomised controlled trial
Study dates: April to June 2015
Participants 1210 pregnant women invited through leaflets and posters in Brazil
Interventions TCC: text messages with health education and health promotion content related to pregnancy and
childbirth
Control: usual care
Outcomes Antenatal care outcomes
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Methods Aim: to explore the safety and feasibility of using text messages in Colombia as an alternative to in-
person follow-up after medication abortion for women with no clinical indication for an in-person
visit.
Study design: randomised controlled trial
Study dates: 2014
Participants Women after medication abortion recruited from a medical health centre in Bogota, Colombia
(number of participants not reported in this conference abstract)
Interventions TCC: SMS over 14 days containing clinical information and supportive messaging
Control: usual care
Outcomes 1. Abortion complications; 2. Client satisfaction




Methods Aim: to test the effects of weekly SMS for improving infant feeding practices and infant weight.
Study design: randomised controlled trial
Study dates: not reported
Participants 202 carers of healthy term infants aged 0–2 months participating in the women, infants and chil-
dren programme in Puerto Rico and Hawaii, USA
Interventions TCC: text messages on breastfeeding, preventing overfeeding, delaying introduction of solid foods,
and delaying and reducing baby juice consumption
Control: text messages related to general infant's health issues related to sleeping, bathing,
teething, travelling in a car, medications, handling baby, smoking, information related to immuni-
sation, and care of common illnesses
Outcomes 1. Infant feeding practices; 2. Infant weight status




Methods Aim: to assess effectiveness of mobile phones for personalised lactation consultation to improve
breastfeeding practices.
Study design: cluster-randomised controlled trial
Study dates: August 2010 to June 2012
Participants 1036 pregnant women residing in urban slums recruited from 4 urban, public, maternity hospitals
in Nagpur, India
Interventions TCC: weekly mobile phone counselling and daily text messages
Patel 2018 
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Control: usual care
Outcomes 1. Breastfeeding outcomes; 2. Other infant feeding practices; 3. Client satisfaction; 4. Cost effective-
ness




Methods Aim: to evaluate the role of compliance-linked incentives vs mobile phone messaging to improve
childhood immunisations.
Study design: randomised controlled trial
Study dates: July 2016 to July 2017
Participants 608 carers of children aged ≤ 24 months and pregnant women from a rural community in Mewat re-
gion, Haryana state, India
Interventions TCC: automated text and voice reminders
TCC 2: automated text and voice reminders + incentives (mobile-phone minutes)
Control: usual care
Outcomes 1. Immunisation coverage; 2. Timeliness of immunisations




Methods Aim: to evaluate the effectiveness of the vaccine reminder system among nursing mothers.
Study design: randomised controlled trial
Study dates: December 2016 and March 2017 (recruitment)
Participants 125 nursing mothers of newborn babies aged 0–3 weeks recruited from maternity wards of a ter-
tiary care teaching hospital in South Canara district, Karnataka state, India
Interventions TCC: SMS vaccination reminders
Control: usual care
Outcomes 1. Vaccination coverage; 2. Client satisfaction




Methods Aim: to examine the effectiveness of Home-but not Alone, a postnatal psychoeducational pro-
gramme delivered via a mobile-health application for parents during the early postpartum period
to improve parenting outcomes.
Shorey 2017 
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
Study design: randomised controlled trial
Study dates: December 2015 to May 2016
Participants 250 parents recruited from a local tertiary hospital in Singapore
Interventions TCC: mobile-health application
Control: usual care
Outcomes 1. Parental self-efficacy, 2. Social support; 3. Postnatal depression; 4. Parenting satisfaction




Methods Aim: to assess the effect of SMS communication on facility delivery, exclusive breastfeeding, and
contraceptive use.
Study design: randomised controlled trial
Study dates: August 2013 to April 2014 (recruitment)
Participants 300 pregnant women attending antenatal care recruited from a public sector maternal child health
clinic in Nairobi, Kenya
Interventions TCC 1: 1-way SMS
TCC 2: 2-way SMS
Control: usual care
Outcomes 1. Facility delivery; 2. Exclusive breastfeeding; 3. Contraceptive use




Methods Aim: to evaluate the effectiveness of daily text messages as a means to improve carers' adherence
to infant micronutrient powder in rural Shaanxi Province of China.
Study design: cluster-randomised controlled trial
Study dates: April to July 2013
Participants 638 carers of infants aged 6–11 months in randomly selected villages in rural Shaanxi Province, Chi-
na
Interventions TCC: daily text messages + free micronutrient powder packets
Control: usual care + free micronutrient powder packets
Outcomes 1. Adherence to infant micronutrient powder
Notes Trial ID: ISRCTN44149146
Wang 2018 
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Methods Aim: to evaluate the potential benefits of implementing the World Health Organization maternal
education programme using text messaging in a remote area in China.
Study design: cluster-randomised controlled trial
Study dates: October 2011 to August 2012 (recruitment)
Participants 13,937 pregnant women aged 16–45 years who were registered by local Maternal Child Health unit
during the study period in Hunan, China
Interventions TCC: mobile phone text messages containing maternal and newborn healthcare education
Control: usual care
Outcomes Neonatal and maternal mortality and morbidity
Notes Trial ID: NCT01775150
Xie 2018 
SMS: short message service; TCC: targeted client communication.
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name Investigating the impact of short automated text message reminder system in improving influenza
vaccine uptake in children with chronic lung conditions: a randomised controlled trial.
Methods Randomised controlled trial
Participants Parents of children aged 6 months to 18 years with chronic lung diseases attending the Sydney
Children's Hospital, Australia
Interventions TCC: SMS text reminder + education flyer
Control: usual care
Outcomes 1. Vaccination coverage; 2. Parental attitudes towards vaccination; 3. Client satisfaction
Starting date April 2018
Contact information Dr Nusrat Homaira; n.homaira@unsw.edu.au




Study name The Philani MOVIE study: a cluster-randomised controlled trial of a mobile video entertainment-ed-
ucation intervention to promote exclusive breastfeeding in South Africa.
Methods Cluster-randomised controlled trial
Participants Pregnant women within the under-resourced settlements of the Western Cape Province in South
Africa
Adam 2019 
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Interventions TCC: 13 short (2–5 minutes), educational videos shared via smartphones
Control: usual care
Outcomes 1. Exclusive breastfeeding (1 and 5 months); 2. Other breastfeeding and infant feeding outcomes
Starting date November 2018
Contact information Maya Adam; madam@stanford.edu and Charles Prober; cprober@stanford.edu




Study name Effectiveness of mHealth for improving fetal outcome: a community based intervention trial.
Methods Cluster-randomised controlled trial
Participants Pregnant women gestation > 16 weeks in urban slums of Jaipur, India
Interventions TCC: daily audio calls via interactive voice response system
Control: usual care
Outcomes 1. Birth weight; 2. Post-term/preterm; 3. Healthcare service utilisation
Starting date February 2016
Contact information Manisha Malik (drmanishamalik@gmail.com); Vaseem Naheed Baig (drvaseemnaheed@ya-
hoo.com)




Study name Affordable technology for saving maternal and infant lives
Methods Cluster-randomised controlled trial
Participants Pregnant women enrolled during the first trimester of pregnancy in villages in Pakistan
Interventions Trial has 5 arms to test the effectiveness of higher vs lower frequency of messages, messages timed
with progression of pregnancy and messages linked with small financial incentives. A concurrent
intervention provides health literacy support to LHWs.
Outcomes 1. Adoption of intrapartum care; 2. Health literacy scores; 3. Health outcomes of mother and infant
Starting date Not reported
Contact information R Cyan, Georgia State University, Atlanta
Notes Trial ID: not reported
Cyan 2016 
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Study name Effect of mobile-health on maternal health care service utilization in Eastern Ethiopia: study proto-
col for a randomised controlled trial.
Methods Cluster-randomised controlled trial
Participants Pregnant women in Haramaya and Kombolcha districts, Oromia Regional State, Eastern Ethiopia
Interventions TCC: voice messages
Control: usual care
Outcomes 1. Antenatal care visits; 2. Institutional delivery; 3. Postnatal care visits; 4. Pregnancy outcomes
Starting date Not reported
Contact information Tilayie Feto, gelanotilaye@gmail.com




Study name An mHealth trial to promote the use of postpartum contraception (PPFP).
Methods Randomised controlled trial
Participants Married, pregnant women with gestational age up to 20 weeks
Interventions TCC 1: text and voice messages regarding antenatal and postnatal care and family planning ser-
vices
TCC 2: interactive phone calls regarding antenatal and postnatal care and family planning services
Control: usual care
Outcomes 1. Postpartum contraceptive uptake; 2. Skilled birth; 3. Immunisation; 4. Intention to adopt mod-
ern contraception
Starting date September 2018
Contact information Ishaque Sheikh (ishaque.sheikh@mariestopes.org.pk); Junaid-ur-Rehman Siddiqui (ju-
naidrehman1994@hotmail.com)




Study name Effectiveness of the distance education program on the mothers' empowerment in breast-feeding.
Methods Randomised controlled trial
IRCT20180520039728N1 
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Participants 72 pregnant women referred to midwifery clinics of educational hospitals affiliated to Babol Uni-
versity of Medical Sciences, Iran
Interventions TCC: text messages
Control: standard care
Outcomes 1. Mothers' breastfeeding empowerment; 2. Exclusive breastfeeding
Starting date June 2018
Contact information Fatemeh Bakouei, f.bakouei@mubabol.ac.ir




Study name The effectiveness of theory based intervention using social media to reduce urinary incontinence
among postpartum women in Hebron city hospitals.
Methods Randomised controlled trial
Participants Women with urinary incontinence after child delivery in Hebron City, Palestinian Territory
Interventions TCC: WhatsApp messages
Control: usual care
Outcomes 1. Severity of urinary incontinence; 2. Level of practice of pelvic floor muscle exercise
Starting date August 2018
Contact information zinat.mesk@gmail.com




Study name A trial exploring the feasibility of using telephone support (SMS and call) as a means of supporting
young mothers (12–19 years) in Western Kenya soon after giving birth.
Methods Randomised controlled trial
Participants New mothers aged 12–19 and qualified midwives at the study hospitals in western Kenya
Interventions TCC: weekly text messages and telephone calls every 3 weeks for 10 weeks in total
Control: usual care
Outcomes 1. Feasibility and acceptability of the intervention; 2. Quality of data available; 3. Maternal social
support; 4. Maternal self-esteem; 5. Mother–infant bonding; 6. Postnatal depression
Starting date September 2015
ISRCTN15017499 
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Contact information Mr Elijah Kirop (elroprotich@gmail.com)




Study name Mobile phone SMS messages and automated calls in improving vaccine coverage among children
in Pakistan.
Methods Cluster-randomised controlled trial
Participants Carers of children aged < 14 days
Interventions TCC 1: 1-way SMS messages related to routine immunisation
TCC 2: 2-way SMS messages related to routine immunisation with the option to reply and receive
more information through text messages
TCC 3: 1-way automated calls related to routine immunisation
TCC 4: 2-way automated calls related to routine immunisation with the option to reply and receive
more information through phone call
Control: usual care
Outcomes 1. Number of children who got vaccinated for routine immunisation scheduled at 6, 10, and 14
weeks of life; 2. Mean improvement in on-time vaccination for routine immunisation scheduled at
6, 10 and 14 weeks of life
Starting date January 2018
Contact information Abdul M Kazi (momin.kazi@aku.edu)




Study name Impact evaluation of maternal health information messaging in India.
Methods Randomised controlled trial
Participants Women 5–7 months pregnant
Interventions TCC: mobile phone health information messages
Control: usual care
Outcomes 1. Exclusive breastfeeding; 2. Immediate breastfeeding
Starting date July 2018
Contact information Amnesty LeFevre (aelefevre@gmail.com); Aarushi Bhatnagar (aarushi.bhatnagar@btspmle.com)
Notes Trial ID: NCT03576157
Lefevre 2019 
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Study name Parent Infant Feeding Initiative (PIFI)
Methods Randomised controlled trial
Participants Mothers and their male partners attending antenatal classes at selected public and private hospi-
tals with maternity departments in Perth, Western Australia
Interventions Fathers will be randomly allocated to either the usual care control group, 1 of 2 medium intensity
(MI1 and MI2) interventions, or a high intensity (HI) intervention. MI1 will include a specialised ante-
natal breastfeeding education session for fathers with supporting print materials. MI2 will involve
the delivery of an antenatal and postnatal social support intervention delivered via a smartphone
application and HI will include both the specialised antenatal class and the social support interven-
tion.
Outcomes 1. Duration of any and exclusive breastfeeding; 2. Age of introduction of formula and complemen-
tary foods; 3. Infant feeding attitudes of both partners
Starting date August 2015
Contact information Jane A Scott (jane.scott@curtin.edu.au)




Study name Social networking on mobile phone to improve maternal and neonatal outcomes (HISONET).
Methods Randomised controlled trial
Participants Thai women who attend antenatal care clinic and have intention to deliver at the study hospital.
Interventions TCC: audio-video media via social networking on mobile phone to antenatal women from the first
antenatal care visit 4 times every month and 4 times biweekly + usual antenatal care group-health
education
Control: usual care
Outcomes 1. Rates of premature birth; 2. Rate of respiratory distress syndrome; 3. Rate of stillbirth; 4. Rate of
perinatal mortality
Starting date April 2015
Contact information Krissada Tomyabatra, Nopparatrajathanee Hospital




Study name Supporting attendance for facility delivery and infant health (SAFI).
Methods Randomised controlled trial
NCT03023033 
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Participants HIV positive and HIV negative pregnant women in Tanzania
Interventions TCC 1: SMS health promotion and reminder messages
TCC 2: SMS health promotion and reminder messages + payment scaled to reflect typical transport
costs to facility
Control: usual care
Outcomes 1. Attendance for early infant diagnosis of HIV; 2. Early identification of HIV exposed infants at re-
productive and child health clinic; 3. Antenatal care visits; 4. Facility delivery; 5. Postnatal care vis-
its; 6. Nevirapine at delivery
Starting date October 2014
Contact information Godfrey Woelk, Elizabeth Glaser Pediatric AIDS Foundation




Study name Cell-phone assisted postpartum counseling on the use of long-acting reversible contraceptives.
Methods Randomised controlled trial
Participants Women that gave birth at > 28 weeks' gestation and desire birth spacing for > 1 year
Interventions TCC: mobile phone assistance regarding postpartum family planning, including reminders and 2
follow-up phone calls
Control: usual care
Outcomes Initiation of long acting reversible contraception method
Starting date July 2017
Contact information Dr Ahmed Mohamed Abbas, Assiut University, Egypt




Study name Novel approach to improving lactation support with mobile health technology.
Methods Randomised controlled trial
Participants Women having given birth with the intention to breastfeed
Interventions TCC: EpxBreastfeeding, a phone, and text message-based system that query patients via their per-
sonal phones and subsequently collect response data, allowing clinically relevant responses to
trigger alerts to designated healthcare providers + baby book survey
Control: baby book survey
NCT03332108 
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Outcomes 1. Exclusive breastfeeding duration; 2. Time to transition feeding status; 3. Time to reported prob-
lems with: latching, concern regarding deficiency in milk production, concern for inadequate
child's weight gain; 4. Time from event to provider intervention; 5. Time to nursing status change;
6. Engagement; 7. Patient satisfaction with provider, service, and survey; 8. Breastfeeding status at
6 weeks postpartum and at 3 months postpartum; 9. Proportion of mothers exclusively breastfeed-
ing at 6 months postpartum
Starting date September 2017
Contact information Camaryn Chrisman Robbins, Washington University School of Medicine, Saint Louis, MO, USA




Study name Evaluation of conditional cash transfers (CCTs) for immunization.
Methods Randomised controlled trial
Participants Carers of children aged 0–23 months visiting the Expanded Programme on Immunization Center for
vaccination, residing within Korangi Town in Karachi, Pakistan
Interventions TCC: SMS reminder
Control: usual care
Study includes 10 more study arms of SMS reminders with various combinations of different incen-
tives and lotteries.
Outcomes 1. Proportion of fully immunised children aged 2 years; 2. Penta3, Polio3, PCV3, or Measles1 cover-
age at 12–23 months; 3. Penta3, Polio3, PCV3, or Measles1 coverage at 12 months; 4. Proportion of
fully immunised children at 12 months; 5. Proportion timely receipt of vaccine doses; 6. Immunisa-
tion system utilisation (dropout rate)
Starting date November 2017
Contact information Aamir Khan and Subhash Chandir, Interactive Research and Development




Study name Use of SMS and interactive reminders to improve timely immunisation coverage.
Methods Randomised controlled trial
Participants Carers of children presenting for pentavalent 1 vaccine residing in Korangi Town in Karachi, Pak-
istan
Interventions TCC 1: SMS reminder
TCC 2: interactive SMS reminder
Control: usual care
NCT03379467 
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Outcomes 1. Measles; 2. Completion
Starting date May 2011
Contact information Subhash Chandir, Interactive Research and Development




Study name Innovative nutrition and mHealth Evidence Building Project.
Methods Cluster-randomised controlled trial
Participants Carers of underweight (weight for age z-score < –1) children aged 6–23 months in Cambodia
Interventions TCC 1: messages on child-feeding practices
TCC 2: messages on child-feeding practices with follow-up phone calls
Control: usual care
Co-intervention: all participants receive the basic health and nutrition service package in Cambo-
dia called 5+5+5
Outcomes 1. Change in prevalence of underweight children over time; 2. Change in mean of weight (grams)
over time; 3. Change in percentage of carers correctly answering questions on child feeding, hy-
giene, health-seeking, and caring practices over time; 4. Change in percentage of carers who have
adopted proper child feeding, hygiene, health-seeking, and caring practices; 5. Change in percent-
age of carers self-reporting confidence in ability to adopt proper child feeding, hygiene, health-
seeking, and caring practices over time; 6. Percentage of siblings of enrolled children in each group
with a weight for height z-score < –2
Starting date November 2017
Contact information Oy Sreymom (sreymomoy@gmail.com); Chhea Chhorvann (cchhorvann@niph.org.kh)




Study name Mobile phone reminders (and photovoice) for routine immunisation in Nigeria – the MOPING study.
Methods Cluster-randomised controlled trial
Participants Carers of healthy infants aged 0–12 months
Interventions TCC: automated SMS and phone call reminders for routine immunisation
Other: photovoice: participants will be shown photographs of debilitating consequences of non-
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Outcomes 1. Immunisation coverage; 2. Timeliness of receipt of scheduled immunisation; 3. Incidence of any
childhood vaccine-preventable disease
Starting date May 2018
Contact information Surajudeen A Abdulrahman (abdulsuraj@gmail.com)




Study name Reducing delay in vaccination of children: logistic barriers (REDIVAC-LB).
Methods Randomised controlled trial
Participants Parents of children aged < 11 months with missing recommended vaccinations currently enrolled
at Kaiser Permanente Colorado
Interventions TCC: automated vaccination reminders (text, phone, email, or a combination)
Control: usual care
Outcomes 1. Vaccines received; 2. Vaccine dose
Starting date June 2018
Contact information Jason Glanz, Kaiser Permanente, Denver, CO




Study name Immunization schedule alert platform: determining ISAP SMS efficacy in improving childhood im-
munization timeliness and completeness in Nigeria.
Methods Randomised controlled trial
Participants Carer with child due for birth dose vaccination or at 6 weeks
Interventions TCC: text messages that provides immunisation schedule and vaccine availability at the nearest im-
munisation clinic
Control: usual care
Outcomes 1. Proportion of timely and complete vaccine uptake
Starting date November 2018
Contact information Emmanuel Ihedioha (emmanuel.ihedioha@lifespanhcr.com)
Notes Trial ID: NCT03705455
NCT03705455 
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Study name Mobile nudges to increase early vaccination coverage in rural areas: a pilot investigation in Ghana's
northern region.
Methods Randomised controlled trial
Participants Women who have given birth to a live-born, surviving infant in the last 2 weeks
Interventions TCC: voice reminder
Other: cash incentive
Control: usual care
Outcomes 1. Full on time early vaccination coverage (OPV0 and BCG); 2. On time BCG coverage; 3. On time
OPV coverage; 4. Birth documentation and reporting coverage
Starting date November 2018
Contact information Guenther Fink (guenther.fink@swisstph.ch); Gillian Levine (gillian.levine@swisstph.ch)




Study name Improving exclusive breastfeeding via mobile phone text messages: a randomized controlled trial
in southern Jordan.
Methods Randomised controlled trial
Participants Women who had an uncomplicated singleton pregnancy and express interest in breastfeeding
Interventions TCC: promotional exclusive breastfeeding text messages will be sent to women via mobile phone
Non-TCC: child healthcare-related text messages (except breastfeeding messages) will be sent to
women via mobile phone
Outcomes 1. Rate of exclusive breastfeeding; 2. Median duration of exclusive breastfeeding; 3. Rates of early
initiation of breastfeeding
Starting date January 2018
Contact information Reham M Khresheh, Mutah University, Jordan




Study name Maximizing adherence and retention for women living with HIV and their infants in Kenya (MOTI-
VATE! study).
Methods 2 × 2 factorial cluster-randomised controlled trial
Odeny 2018 
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Participants HIV-infected pregnant women and their HIV-exposed infants attending antenatal care clinic at 1 of
the study sites in Migori, Kisumu, and Homa Bay, Kenya
Interventions TCC: mobile phone text messaging intervention
TCC 2: mobile phone text messaging intervention + community mentor mother home visits
TCC 3: community mentor mother home visits
Control: usual care
Outcomes 1. Self-reported adherence on antiretroviral therapy; 2. Retention in care; 3. Maternal CD4 count
change; 4. Uptake of intervention services; 5. Mother-to-child-transmission; 6. Male partner in-
volvement
Starting date May 2014
Contact information Thomas A Odeny (taodeny@gmail.com)




Study name Effect of enhanced reminders on postnatal clinic attendance in Addis Ababa: a cluster randomized
control trial.
Methods Cluster-randomised controlled trial
Participants Women who gave birth during the study period in public health centres in Ibadan, Ethiopia
Interventions TCC: SMS or voice call appointment reminders
Control: usual care
Outcomes 1. Number of postnatal visits; 2. Acceptability
Starting date June 2017
Contact information Abraham Sahilemichael Kebede (abrishya@yahoo.com)




Study name Zinc adherence: a follow-up study of under-fives with acute watery diarrhoea using mobile phones:
a randomised controlled trial.
Methods Randomised controlled trial
Participants Parents of children aged < 5 years with acute watery diarrhoea recruited from a health centre in Dar
es Salaam, Tanzania
Interventions TCC: voice calls and text messages
PACTR201711002737120 
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Control: usual care
Outcomes 1. 10-day adherence to zinc sulphate prescribed; 2. Clinic attendance for follow-up visit; 3. Accept-
ability of mHealth; 4. Dependability of mHealth
Starting date December 2016
Contact information Fatimah Zahra Karim (fzahrakarim@gmail.com)




Study name Utilization of short message service to enhance uptake of focused ante-natal care among women in
Tharaka Nithi County, Kenya.
Methods Randomised controlled trial
Participants Pregnant women attending rural health centres in Kenya
Interventions TCC: SMS reminder to attend antenatal clinic
Non-digital TCC: date reminder in a book to attend antenatal clinic
Outcomes 1. Enhance uptake of focused antenatal care; 2. Skilled birth attendance at birth; 3. Postnatal care
at 2 weeks
Starting date January 2016
Contact information Eliphas Gitonga (gitonga.eliphas@ku.ac.ke)




Study name Efficacy of text messages, voice calls and community visits on developmental milestones of chil-
dren from teenage pregnancies: a randomized intervention trial.
Methods Cluster-randomised controlled trial
Participants Teenage mother, aged < 20 years with a child aged < 3 months
Interventions TCC 1: 1 voice call weekly, 3 text messages every week
TCC 2: 3 messages every week
TCC 3: messages to participants' phones, 1 voice call every week and visits by a community health
volunteer every month
Control: usual care
Outcomes 1. Head circumference as a marker for overall brain development (6 and 12 months); 2. Diarrhoea
incidence, wasting, stunting, motor and language milestones (6 and 12 months)
PACTR201806003369302 
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Starting date April 2019
Contact information Valerian Mwenda (valmwenda@gmail.com)




Study name mHealth to improve measles immunization in Guinea-Bissau.
Methods Randomised controlled trial
Participants Mothers of children receiving measles vaccination in the Republic of Guinea-Bissau
Interventions TCC 1: scheduled SMS reminder of the measles vaccination
TCC 2: scheduled SMS reminder + voice call reminder of the measles vaccination
Control: usual care
Outcomes 1. Measles vaccination coverage and timeliness when children reach 12 months of age; 2. Mean
number of health centre visits (with intention to obtain the measles vaccination) required before
successful administration
Starting date March 2016





Study name Saving lives with better gestational age estimation: improving the accuracy of recall and reporting
of the date of last menstrual period (LMP) in Rural Bangladesh.
Methods Cluster-randomised controlled trial
Participants 3360 adolescent girls and recently married women with no or a single child selected from the De-
mographic surveillance system database in Mirzapur subdistrict of Tangail district, Bangladesh
Interventions TCC 1: counselling and a mobile phone-based SMS alert system
TCC 2: counselling and smart-phone application
TCC 3: counselling and a paper-based calendar
Control: usual care
Outcomes Accuracy and certainty of last menstrual period – recall dates
Starting date January 2017
Contact information Shumona Sharmin Salam (shumona@icddrb.org)
Salam 2018 
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Study name Mobile-health tool to improve maternal and neonatal health care in Bangladesh.
Methods Cluster-randomised controlled trial
Participants Pregnant women in Lohagora of Narail District and Dhamrai of Dhaka District, Bangladesh
Interventions TCC: mobile short messaging and audio system
Control: usual care
Outcomes 1. Neonatal mortality; 2. Maternal mortality; 3. Stillbirth; 4. Miscarriage; 5. Preterm birth; 6. Low
birth weight; 7. Maternal morbidities; 8. Frequency of antenatal care visits; 9. Accessibility to skilled
birth attendants for delivery; 10. Referral for identified complications; 11. Utilisation of postpartum
care; 12. Status of initiating breastfeeding
Starting date February 2017
Contact information Ruoyan Gai Tobe (gai-r@ncchd.go.jp); Syed Emdadul Haque (emdad91@gmail.com)
Notes Trial ID: UMIN000025628
Tobe 2018 
BCG: Bacillus Calmette-Guérin; OPV: oral polio vaccine; SMS: short message service; TCC: targeted client communication.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Digital targeted client communication (TCC) compared to standard care (pregnant and postpartum
women)





Statistical method Effect size
1.1 Health behaviour change – exclusive breast-
feeding in short term (up to 3 months)
2   Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1.1 Low-risk setting 1 40 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.79, 1.08]
1.1.2 Moderate-risk setting 1 135 Risk Ratio (M-H, Random, 95% CI) 1.30 [1.06, 1.59]
1.2 Health behaviour change – receiving postpar-
tum help with breastfeeding (3 months postpar-
tum)
1 332 Risk Ratio (M-H, Random, 95% CI) 2.15 [1.79, 2.58]
1.3 Health behaviour change – taking iron and fo-
late tablets during pregnancy
1 908 Risk Ratio (M-H, Random, 95% CI) 1.71 [1.42, 2.07]
1.4 Health behaviour change – contraceptive use
(3 months postpartum)
2 175 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.75, 2.46]
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Statistical method Effect size
1.5 Health behaviour change – smoked in the last
30 days
1 459 Risk Ratio (M-H, Random, 95% CI) 0.43 [0.17, 1.10]
1.6 Health behaviour change – smoking cessation
(objectively verified continuous abstinence) (36
weeks' gestation)
1 407 Risk Ratio (M-H, Random, 95% CI) 2.76 [0.89, 8.54]
1.7 Health behaviour change – no alcohol con-
sumption during pregnancy
1 459 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.97, 1.03]
1.8 Service utilisation – attendance at ≥ 4 antena-
tal care appointments
1 2550 Odds Ratio (IV, Random, 95% CI) 1.54 [0.80, 2.96]
1.9 Service utilisation – attendance for antenatal
vaccination
2 714 Odds Ratio (IV, Random, 95% CI) 1.36 [0.90, 2.06]
1.9.1 Influenza vaccine 1 281 Odds Ratio (IV, Random, 95% CI) 1.22 [0.73, 2.04]
1.9.2 Tetanus vaccine 1 433 Odds Ratio (IV, Random, 95% CI) 1.67 [0.84, 3.33]
1.10 Service utilisation – attendance at antenatal
preventive treatment for malaria
1 2550 Odds Ratio (IV, Random, 95% CI) 1.69 [0.82, 3.48]
1.11 Service utilisation – skilled attendant at birth 2   Odds Ratio (IV, Random, 95% CI) Subtotals only
1.12 Service utilisation – newborn postpartum
care
2 191 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.69, 1.87]
1.12.1 Low-risk setting 1 56 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.87, 1.11]
1.12.2 High-risk setting 1 135 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.02, 1.78]
1.13 Service utilisation – attendance for postpar-
tum care appointment (mother) (10 days postpar-
tum)
1 56 Risk Ratio (M-H, Random, 95% CI) 1.50 [0.30, 7.52]
1.14 Service utilisation – attendance for newborn
vaccination
1   Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.14.1 Pentavalent and polio vaccine at up to 9
weeks
1 40 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.89, 1.32]
1.15 Health status and well-being – maternal mor-
tality and morbidity
3   Risk Ratio (IV, Random, 95% CI) Subtotals only
1.15.1 Maternal mortality up to 6 weeks postpar-
tum
1 2637 Risk Ratio (IV, Random, 95% CI) 2.86 [0.30,
27.40]
1.15.2 Maternal morbidity – severe obstetric com-
plications up to 6 weeks postpartum
1 2550 Risk Ratio (IV, Random, 95% CI) 0.86 [0.70, 1.07]
1.15.3 Maternal morbidity – any maternal health
problem up to 10 days postpartum
1 56 Risk Ratio (IV, Random, 95% CI) 0.50 [0.09, 2.76]
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Statistical method Effect size
1.15.4 Maternal morbidity – mastitis: breast pain
up to 3 months postpartum
1 332 Risk Ratio (IV, Random, 95% CI) 0.28 [0.09, 0.80]
1.15.5 Maternal morbidity – mastitis: breast en-
gorgement up to 3 months postpartum
1 332 Risk Ratio (IV, Random, 95% CI) 0.58 [0.31, 1.10]
1.16 Health status and well-being – maternal mor-
tality and morbidity




1.16.1 Acute episodes requiring clinic visit up to 3
months postpartum




1.17 Health status and well-being – neonatal mor-
tality and morbidity
3 2870 Odds Ratio (IV, Random, 95% CI) 1.00 [0.61, 1.64]
1.17.1 Neonatal mortality up to 6 weeks after de-
livery
1 2482 Odds Ratio (IV, Random, 95% CI) 0.85 [0.37, 1.95]
1.17.2 Neonatal diarrhoea up to 3 months post-
partum
1 332 Odds Ratio (IV, Random, 95% CI) 1.05 [0.53, 2.11]
1.17.3 Any newborn health problem reported up
to 10 days postpartum
1 56 Odds Ratio (IV, Random, 95% CI) 1.27 [0.36, 4.51]
1.18 Health status and well-being – neonatal mor-
tality and morbidity
1   Mean Difference (IV, Random,
95% CI)
Subtotals only
1.18.1 Acute episodes requiring clinic visit up to 3
months postpartum




1.19 Health status and well-being – neonatal
health
2   Mean Difference (IV, Random,
95% CI)
Subtotals only









1.19.3 Infant weight (kg) at 3 months 1 332 Mean Difference (IV, Random,
95% CI)
Not estimable
1.19.4 Infant length (cm) at 3 months 1 332 Mean Difference (IV, Random,
95% CI)
Not estimable
1.20 Health status and well-being – preterm birth 2 2557 Risk Ratio (IV, Random, 95% CI) 0.85 [0.31, 2.33]
1.21 Sensitivity analysis (cluster-RCTs: health sta-
tus and well-being – preterm birth
1   Risk Ratio (IV, Random, 95% CI) 0.18 [0.01, 3.64]
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Analysis 1.1.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant and













Test for overall effect: Z = 2.57 (P = 0.01)
Test for subgroup differences: Chi² = 7.04, df = 1 (P = 0.008), I² = 85.8%




























M-H, Random, 95% CI
0.92 [0.79 , 1.08]
0.92 [0.79 , 1.08]
1.30 [1.06 , 1.59]
1.30 [1.06 , 1.59]
Risk Ratio
M-H, Random, 95% CI
0.5 0.7 1 1.5 2
Favours standard care Favours TCC via mobile
Footnotes
(1) 9 weeks postpartum
(2) 3 months postpartum
 
 
Analysis 1.2.   Comparison 1: Digital targeted client communication (TCC) compared
to standard care (pregnant and postpartum women), Outcome 2: Health behaviour






Test for overall effect: Z = 8.19 (P < 0.00001)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
2.15 [1.79 , 2.58]
2.15 [1.79 , 2.58]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours standard care Favours TCC via mobile
 
 
Analysis 1.3.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant






Test for overall effect: Z = 5.66 (P < 0.00001)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.71 [1.42 , 2.07]
1.71 [1.42 , 2.07]
Risk Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=1.92, calculated with ICC=0.154 reported in Pagel 2011; original sample size=1743
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Analysis 1.4.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant






Heterogeneity: Tau² = 0.12; Chi² = 2.36, df = 1 (P = 0.12); I² = 58%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable























M-H, Random, 95% CI
1.11 [0.90 , 1.38]
2.07 [0.92 , 4.63]
1.35 [0.75 , 2.46]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) 3 months postpartum
(2) 9 weeks post-partum
 
 
Analysis 1.5.   Comparison 1: Digital targeted client communication (TCC) compared to standard care






Test for overall effect: Z = 1.76 (P = 0.08)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.43 [0.17 , 1.10]
0.43 [0.17 , 1.10]
Risk Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours TCC via mobile Favours standard care
Footnotes
(1) 4 weeks after starting intervention in pregnant and postpartum population
 
 
Analysis 1.6.   Comparison 1: Digital targeted client communication (TCC) compared to
standard care (pregnant and postpartum women), Outcome 6: Health behaviour change






Test for overall effect: Z = 1.77 (P = 0.08)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
2.76 [0.89 , 8.54]
2.76 [0.89 , 8.54]
Risk Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours standard care Favours TCC via mobile
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Analysis 1.7.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant






Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.00 [0.97 , 1.03]
1.00 [0.97 , 1.03]
Risk Ratio
M-H, Random, 95% CI
0.85 0.9 1 1.1 1.2
Favours standard care Favours TCC via mobile
Footnotes
(1) 4 weeks after starting intervention in pregnant and postpartum population
 
 
Analysis 1.8.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant





Test for overall effect: Z = 1.30 (P = 0.20)

















IV, Random, 95% CI
1.54 [0.80 , 2.96]
1.54 [0.80 , 2.96]
Odds Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT with study-adjusted estimate (adjusted for within-cluster effect)
 
 
Analysis 1.9.   Comparison 1: Digital targeted client communication (TCC) compared to standard care











Test for overall effect: Z = 1.46 (P = 0.15)
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.52, df = 1 (P = 0.47); I² = 0%
Test for overall effect: Z = 1.47 (P = 0.14)




























IV, Random, 95% CI
1.22 [0.73 , 2.04]
1.22 [0.73 , 2.04]
1.67 [0.84 , 3.33]
1.67 [0.84 , 3.33]
1.36 [0.90 , 2.06]
Odds Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) Nullipara subgroup only; cluster RCT with study-adjusted estimate (adjusted for within-cluster effect)
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Analysis 1.10.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant and





Test for overall effect: Z = 1.42 (P = 0.16)

















IV, Random, 95% CI
1.69 [0.82 , 3.48]
1.69 [0.82 , 3.48]
Odds Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT with study-adjusted estimate (adjusted for within-cluster effect)
 
 
Analysis 1.11.   Comparison 1: Digital targeted client communication (TCC) compared to standard

























IV, Random, 95% CI
1.00 [0.34 , 2.94]
0.83 [0.36 , 1.92]
4.45 [1.36 , 14.51]
Odds Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=1.24, calculated from ICC 0.041 reported in Pagel 2011
(2) rural population; cluster RCT with study-adjusted estimate (adjusted for within-cluster effect)
(3) urban population; cluster RCT with study-adjusted estimate (adjusted for within-cluster effect)
 
 
Analysis 1.12.   Comparison 1: Digital targeted client communication (TCC) compared to standard













Test for overall effect: Z = 2.13 (P = 0.03)
Total (95% CI)
Total events:
Heterogeneity: Tau² = 0.12; Chi² = 10.81, df = 1 (P = 0.001); I² = 91%
Test for overall effect: Z = 0.51 (P = 0.61)
Test for subgroup differences: Chi² = 4.38, df = 1 (P = 0.04), I² = 77.2%

































M-H, Random, 95% CI
0.98 [0.87 , 1.11]
0.98 [0.87 , 1.11]
1.35 [1.02 , 1.78]
1.35 [1.02 , 1.78]
1.14 [0.69 , 1.87]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours standard care Favours TCC via mobile
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Analysis 1.13.   Comparison 1: Digital targeted client communication (TCC) compared
to standard care (pregnant and postpartum women), Outcome 13: Service utilisation






Test for overall effect: Z = 0.49 (P = 0.62)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.50 [0.30 , 7.52]
1.50 [0.30 , 7.52]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
 
 
Analysis 1.14.   Comparison 1: Digital targeted client communication (TCC) compared to standard care
(pregnant and postpartum women), Outcome 14: Service utilisation – attendance for newborn vaccination
Study or Subgroup





Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.08 [0.89 , 1.32]
1.08 [0.89 , 1.32]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
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Analysis 1.15.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant
and postpartum women), Outcome 15: Health status and well-being – maternal mortality and morbidity
Study or Subgroup




Test for overall effect: Z = 0.91 (P = 0.36)




Test for overall effect: Z = 1.35 (P = 0.18)




Test for overall effect: Z = 0.79 (P = 0.43)




Test for overall effect: Z = 2.37 (P = 0.02)





















































IV, Random, 95% CI
2.86 [0.30 , 27.40]
2.86 [0.30 , 27.40]
0.86 [0.70 , 1.07]
0.86 [0.70 , 1.07]
0.50 [0.09 , 2.76]
0.50 [0.09 , 2.76]
0.28 [0.09 , 0.80]
0.28 [0.09 , 0.80]
0.58 [0.31 , 1.10]
0.58 [0.31 , 1.10]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours TCC via mobile Favours standard careFootnotes
(1) cluster RCT adjusted using design effect=1.33, calculated with ICC=0.003 reported in Pagel 2011
 
 
Analysis 1.16.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant
and postpartum women), Outcome 16: Health status and well-being – maternal mortality and morbidity
Study or Subgroup




Test for overall effect: Z = 0.47 (P = 0.64)
Total (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable























IV, Random, 95% CI
0.06 [-0.19 , 0.31]
0.06 [-0.19 , 0.31]
0.06 [-0.19 , 0.31]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours TCC via mobile Favours standard care
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Analysis 1.17.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant
and postpartum women), Outcome 17: Health status and well-being – neonatal mortality and morbidity
Study or Subgroup




Test for overall effect: Z = 0.38 (P = 0.70)




Test for overall effect: Z = 0.15 (P = 0.88)




Test for overall effect: Z = 0.37 (P = 0.72)
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.30, df = 2 (P = 0.86); I² = 0%
Test for overall effect: Z = 0.02 (P = 0.99)




































IV, Random, 95% CI
0.85 [0.37 , 1.95]
0.85 [0.37 , 1.95]
1.05 [0.53 , 2.11]
1.05 [0.53 , 2.11]
1.27 [0.36 , 4.51]
1.27 [0.36 , 4.51]
1.00 [0.61 , 1.64]
Odds Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours TCC via mobile Favours standard care
Footnotes
(1) cluster RCT with study-adjusted estimate (adjusted for within-cluster effect)
 
 
Analysis 1.18.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant
and postpartum women), Outcome 18: Health status and well-being – neonatal mortality and morbidity
Study or Subgroup




Test for overall effect: Z = 2.65 (P = 0.008)
Test for subgroup differences: Not applicable




















IV, Random, 95% CI
-0.53 [-0.92 , -0.14]
-0.53 [-0.92 , -0.14]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours TCC via mobile Favours standard care
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Analysis 1.19.   Comparison 1: Digital targeted client communication (TCC) compared to standard
care (pregnant and postpartum women), Outcome 19: Health status and well-being – neonatal health
Study or Subgroup




Test for overall effect: Z = 0.35 (P = 0.72)




Test for overall effect: Z = 1.23 (P = 0.22)




Test for overall effect: Not applicable




Test for overall effect: Not applicable
Test for subgroup differences: Chi² = 1.51, df = 1 (P = 0.22), I² = 33.9%














































IV, Random, 95% CI
0.10 [-0.45 , 0.65]
0.10 [-0.45 , 0.65]
-173.00 [-448.87 , 102.87]






IV, Random, 95% CI
-1000 -500 0 500 1000
Favours standard care Favours TCC via mobile
 
 
Analysis 1.20.   Comparison 1: Digital targeted client communication (TCC) compared to standard





Heterogeneity: Tau² = 0.30; Chi² = 1.25, df = 1 (P = 0.26); I² = 20%
Test for overall effect: Z = 0.32 (P = 0.75)






















IV, Random, 95% CI
0.18 [0.01 , 3.64]
1.01 [0.91 , 1.11]
0.85 [0.31 , 2.33]
Risk Ratio
IV, Random, 95% CI
0.001 0.1 1 10 1000
Favours TCC via mobile Favours standard care
Footnotes
(1) cluster RCT adjusted using design effect=1.33, calculated with ICC=0.003 reported in Pagel 2011
 
 
Analysis 1.21.   Comparison 1: Digital targeted client communication (TCC) compared to standard care (pregnant and





Test for overall effect: Z = 1.12 (P = 0.26)









IV, Random, 95% CI
0.18 [0.01 , 3.64]
0.18 [0.01 , 3.64]
Risk Ratio
IV, Random, 95% CI
0.001 0.1 1 10 1000
Favours TCC via mobile Favours standard care
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Comparison 2.   Digital targeted client communication (TCC) compared to non-digital targeted client communication
(pregnant and postpartum women)





Statistical method Effect size
2.1 Health behaviour change – exclusive breastfeeding (9
weeks postpartum)




2.2 Health behaviour change – contraceptive use (9
weeks postpartum)




2.3 Service utilisation – newborn postpartum care (10
days after delivery)




2.4 Service utilisation – attendance for newborn vaccina-
tion








2.5 Service utilisation – attendance for postpartum care
appointment (mother) (10 days postpartum)




2.6 Health status and well-being – maternal mortality
and morbidity




2.6.1 Any maternal health problem reported up to 10
days postpartum




2.7 Health status and well-being – neonatal mortality
and morbidity




2.7.1 Any newborn health problem reported up to 10
days postpartum






Analysis 2.1.   Comparison 2: Digital targeted client communication (TCC) compared
to non-digital targeted client communication (pregnant and postpartum women),






Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.92 [0.79 , 1.07]
0.92 [0.79 , 1.07]
Risk Ratio
M-H, Random, 95% CI
0.5 0.7 1 1.5 2
Favours non-digital TCC Favours TCC via mobile
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Analysis 2.2.   Comparison 2: Digital targeted client communication (TCC) compared
to non-digital targeted client communication (pregnant and postpartum women),






Test for overall effect: Z = 1.16 (P = 0.24)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.45 [0.78 , 2.69]
1.45 [0.78 , 2.69]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours non-digital TCC Favours TCC via mobile
 
 
Analysis 2.3.   Comparison 2: Digital targeted client communication (TCC) compared
to non-digital targeted client communication (pregnant and postpartum women),






Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.97 [0.87 , 1.09]
0.97 [0.87 , 1.09]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours non-digital TCC Favours TCC via mobile
 
 
Analysis 2.4.   Comparison 2: Digital targeted client communication (TCC)
compared to non-digital targeted client communication (pregnant and postpartum
women), Outcome 4: Service utilisation – attendance for newborn vaccination
Study or Subgroup





Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.01 [0.88 , 1.16]
1.01 [0.88 , 1.16]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours non-digital TCC Favours TCC via mobile
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Analysis 2.5.   Comparison 2: Digital targeted client communication (TCC) compared to non-
digital targeted client communication (pregnant and postpartum women), Outcome 5: Service






Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.56 [0.18 , 1.79]
0.56 [0.18 , 1.79]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours non-digital TCC Favours TCC via mobile
 
 
Analysis 2.6.   Comparison 2: Digital targeted client communication (TCC) compared
to non-digital targeted client communication (pregnant and postpartum women),
Outcome 6: Health status and well-being – maternal mortality and morbidity
Study or Subgroup





Test for overall effect: Z = 2.27 (P = 0.02)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.19 [0.04 , 0.79]
0.19 [0.04 , 0.79]
Risk Ratio
M-H, Random, 95% CI
0.02 0.1 1 10 50
Favours TCC via mobile Favours non-digital TCC
 
 
Analysis 2.7.   Comparison 2: Digital targeted client communication (TCC) compared
to non-digital targeted client communication (pregnant and postpartum women),
Outcome 7: Health status and well-being – neonatal mortality and morbidity
Study or Subgroup





Test for overall effect: Z = 1.79 (P = 0.07)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.52 [0.25 , 1.06]
0.52 [0.25 , 1.06]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours TCC via mobile Favours non-digital TCC
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Comparison 3.   Digital targeted client communication (TCC) compared to digital non-targeted client communication
(pregnant and postpartum women)





Statistical method Effect size
3.1 Service utilisation – attendance for antenatal in-
fluenza vaccination










Analysis 3.1.   Comparison 3: Digital targeted client communication (TCC) compared
to digital non-targeted client communication (pregnant and postpartum women),






Test for overall effect: Z = 0.26 (P = 0.80)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.05 [0.71 , 1.58]
1.05 [0.71 , 1.58]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours non-TCC via mobil Favours TCC via mobile
 
 
Analysis 3.2.   Comparison 3: Digital targeted client communication (TCC) compared to digital non-targeted client






Test for overall effect: Z = 0.00 (P = 1.00)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.00 [0.69 , 1.45]
1.00 [0.69 , 1.45]
Risk Ratio
M-H, Random, 95% CI
0.5 0.7 1 1.5 2
Favours non-TCC via mobil Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=17, calculated with ICC=0.127 reported in Pagel 2011; original sample size=274
 
 
Comparison 4.   Digital targeted client communication (TCC) compared to standard care (pregnant women with HIV)





Statistical method Effect size
4.1 Health behaviour change – mother taking any type of anti-
retroviral (ARV) (34–36 weeks' gestation)




4.2 Health behaviour change – mother taking any type of ARV
(6–8 weeks postpartum)
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Statistical method Effect size
4.3 Health behaviour change – infant ARV/prevention of moth-
er-to-child transmission treatment adherence (6 weeks post-
partum)




4.4 Health behaviour change – infant HIV tested (6–8 weeks
postpartum)




4.5 Service utilisation – postnatal care: attendance at postpar-
tum care appointment (6–8 weeks postpartum)




4.6 Service utilisation – intrapartum care: birth in health facili-
ty




4.7 Service utilisation – antenatal care: mean number of face-
to-face or mobile communications with healthcare workers




4.8 Health status and well-being – neonatal health: neonatal
death/stillbirth




4.9 Health status and well-being – neonatal health: infant HIV
test positive (6–8 weeks postpartum)






Analysis 4.1.   Comparison 4: Digital targeted client communication (TCC) compared
to standard care (pregnant women with HIV), Outcome 1: Health behaviour





Test for overall effect: Z = 0.58 (P = 0.56)

















IV, Random, 95% CI
1.04 [0.91 , 1.19]
1.04 [0.91 , 1.19]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT with study-adjusted RR (adjusted for cluster residuals and confounding variables including participant age, gestational age, whether the woman was newly diagnosed with HIV, and disclosure of HIV status to her partner and family)
 
 
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
Analysis 4.2.   Comparison 4: Digital targeted client communication (TCC) compared to standard care (pregnant





Test for overall effect: Z = 0.77 (P = 0.44)

















IV, Random, 95% CI
0.87 [0.61 , 1.24]
0.87 [0.61 , 1.24]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT with study-adjusted RR (adjusted for cluster residuals and confounding variables including participant age, gestational age, whether the woman was newly diagnosed with HIV, and disclosure of HIV status to her partner and family
 
 
Analysis 4.3.   Comparison 4: Digital targeted client communication (TCC) compared to
standard care (pregnant women with HIV), Outcome 3: Health behaviour change – infant ARV/






Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.01 [0.98 , 1.04]
1.01 [0.98 , 1.04]
Risk Ratio
M-H, Random, 95% CI
0.7 0.85 1 1.2 1.5
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=2.1085, calculated with ICC=0.055 reported in Pagel 2011; original sample size=470
 
 
Analysis 4.4.   Comparison 4: Digital targeted client communication (TCC) compared to standard care





Heterogeneity: Tau² = 0.00; Chi² = 2.13, df = 1 (P = 0.14); I² = 53%
Test for overall effect: Z = 0.85 (P = 0.39)






















IV, Random, 95% CI
0.99 [0.90 , 1.09]
1.08 [1.00 , 1.16]
1.04 [0.95 , 1.13]
Risk Ratio
IV, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=2.1085, calculated with ICC=0.055 reported in Pagel 2011
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Analysis 4.5.   Comparison 4: Digital targeted client communication (TCC) compared
to standard care (pregnant women with HIV), Outcome 5: Service utilisation –






Test for overall effect: Z = 2.06 (P = 0.04)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.66 [1.02 , 2.70]
1.66 [1.02 , 2.70]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours standard care Favours TCC via mobile
 
 
Analysis 4.6.   Comparison 4: Digital targeted client communication (TCC) compared to standard care






Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.85 [0.62 , 1.15]
0.85 [0.62 , 1.15]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=3.560, calculated with ICC=0.127 reported in Pagel 2011; original sample size=479
 
 
Analysis 4.7.   Comparison 4: Digital targeted client communication (TCC) compared to
standard care (pregnant women with HIV), Outcome 7: Service utilisation – antenatal





Test for overall effect: Z = 1.58 (P = 0.11)
Test for subgroup differences: Not applicable




















IV, Random, 95% CI
1.50 [-0.36 , 3.36]
1.50 [-0.36 , 3.36]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=1.605, calculated with ICC=0.030 reported in Pagel 2011; original sample size=476
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Analysis 4.8.   Comparison 4: Digital targeted client communication (TCC) compared to standard care (pregnant






Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.12 [0.39 , 3.28]
1.12 [0.39 , 3.28]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours TCC via mobile Favours standard care
 
 
Analysis 4.9.   Comparison 4: Digital targeted client communication (TCC) compared
to standard care (pregnant women with HIV), Outcome 9: Health status and





Heterogeneity: Tau² = 0.00; Chi² = 0.15, df = 1 (P = 0.70); I² = 0%
Test for overall effect: Z = 0.78 (P = 0.44)






















IV, Random, 95% CI
0.31 [0.01 , 7.54]
0.64 [0.11 , 3.80]
0.54 [0.11 , 2.56]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours TCC via mobile Favours standard care
Footnotes
(1) cluster RCT adjusted using design effect=2.1085, calculated with ICC=0.055 reported in Pagel 2011
 
 
Comparison 5.   Digital targeted client communication (TCC) compared to digital non-targeted client communication
(pregnant women with HIV)







5.1 Health behaviour – infant antiretroviral/prevention of moth-
er-to-child transmission adherence (6 weeks after delivery)




5.2 Service utilisation – postnatal care: attendance at postpartum
care appointment (10 weeks postpartum)
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Analysis 5.1.   Comparison 5: Digital targeted client communication (TCC) compared to digital non-
targeted client communication (pregnant women with HIV), Outcome 1: Health behaviour – infant






Test for overall effect: Z = 2.85 (P = 0.004)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.26 [1.07 , 1.48]
1.26 [1.07 , 1.48]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours non-TCC via mobile Favours TCC via mobile
 
 
Analysis 5.2.   Comparison 5: Digital targeted client communication (TCC) compared to
digital non-targeted client communication (pregnant women with HIV), Outcome 2: Service






Test for overall effect: Z = 3.68 (P = 0.0002)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.86 [1.34 , 2.58]
1.86 [1.34 , 2.58]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours non-TCC via mobile Favours TCC via mobile
 
 
Comparison 6.   Digital targeted client communication (TCC) compared to standard care (parents of children aged
under five years)





Statistical method Effect size
6.1 Attendance for necessary healthcare 10 5660 Risk Ratio (IV, Random, 95% CI) 1.21 [1.08, 1.34]
6.1.1 Vaccinations at up to 6 months 5 1586 Risk Ratio (IV, Random, 95% CI) 1.14 [1.01, 1.28]
6.1.2 Vaccinations at 12 months 4 3832 Risk Ratio (IV, Random, 95% CI) 1.24 [1.02, 1.52]
6.1.3 HIV medical appointment 2 days after
reminder
1 242 Risk Ratio (IV, Random, 95% CI) 1.63 [1.26, 2.11]
6.2 Timeliness of vaccination 4 2400 Risk Ratio (IV, Random, 95% CI) 1.18 [1.04, 1.34]
6.3 Service utilisation – no emergency de-
partment attendance (6 months)
1 129 Risk Ratio (M-H, Random, 95% CI) 1.32 [1.03, 1.70]
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Analysis 6.1.   Comparison 6: Digital targeted client communication (TCC) compared to standard
care (parents of children aged under five years), Outcome 1: Attendance for necessary healthcare
Study or Subgroup







Heterogeneity: Tau² = 0.01; Chi² = 10.69, df = 4 (P = 0.03); I² = 63%
Test for overall effect: Z = 2.19 (P = 0.03)






Heterogeneity: Tau² = 0.03; Chi² = 36.88, df = 3 (P < 0.00001); I² = 92%
Test for overall effect: Z = 2.14 (P = 0.03)




Test for overall effect: Z = 3.75 (P = 0.0002)
Total (95% CI)
Heterogeneity: Tau² = 0.02; Chi² = 58.28, df = 9 (P < 0.00001); I² = 85%
Test for overall effect: Z = 3.36 (P = 0.0008)







































































IV, Random, 95% CI
0.86 [0.66 , 1.12]
1.26 [1.14 , 1.39]
1.07 [0.96 , 1.20]
1.16 [1.01 , 1.32]
1.38 [0.98 , 1.96]
1.14 [1.01 , 1.28]
1.70 [1.11 , 2.61]
1.04 [0.97 , 1.12]
1.03 [0.95 , 1.10]
1.62 [1.40 , 1.88]
1.24 [1.02 , 1.52]
1.63 [1.26 , 2.11]
1.63 [1.26 , 2.11]
1.21 [1.08 , 1.34]
Risk Ratio
IV, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=6.9901, calculated with ICC=0.0487 reported in Gibson 2017
(2) cluster RCT adjusted using design effect=8.37805, calculated with ICC=0.0487 reported in Gibson 2017
(3) cluster RCT with study-adjusted RR accounting for correlation within clusters
(4) Combined three intervention groups (text messages, voice call, or text messages + voice call)
 
 
Analysis 6.2.   Comparison 6: Digital targeted client communication (TCC) compared to







Heterogeneity: Tau² = 0.01; Chi² = 5.79, df = 3 (P = 0.12); I² = 48%
Test for overall effect: Z = 2.57 (P = 0.01)
































IV, Random, 95% CI
0.96 [0.71 , 1.29]
1.15 [1.04 , 1.26]
1.18 [1.00 , 1.39]
1.51 [1.17 , 1.95]
1.18 [1.04 , 1.34]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours standard care Favours TCC via mobile
Footnotes
(1) cluster RCT with study-adjusted RR accounting for correlation within clusters
(2) Combined two intervention groups (educational and conventional SMS)
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Analysis 6.3.   Comparison 6: Digital targeted client communication (TCC) compared to standard care (parents of






Test for overall effect: Z = 2.21 (P = 0.03)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
1.32 [1.03 , 1.70]
1.32 [1.03 , 1.70]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours standard care Favours TCC via mobile
 
 
Comparison 7.   Digital targeted client communication (TCC) compared to non-digital targeted client communication
(parents of children aged under five years)





Statistical method Effect size
7.1 Health behaviour change – oral health in children (Visi-
ble Plaque Index, [0–100%], low = good)




7.2 Service utilisation – attendance for vaccinations at 14
weeks






Analysis 7.1.   Comparison 7: Digital targeted client communication (TCC) compared to non-
digital targeted client communication (parents of children aged under five years), Outcome 1:





Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Not applicable




















IV, Random, 95% CI
-2.10 [-7.54 , 3.34]
-2.10 [-7.54 , 3.34]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours non-digital TCC Favours TCC via mobile
Footnotes
(1) 4 weeks after intervention
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Analysis 7.2.   Comparison 7: Digital targeted client communication (TCC) compared
to non-digital targeted client communication (parents of children aged under five





Test for overall effect: Z = 1.96 (P = 0.05)

















IV, Random, 95% CI
1.13 [1.00 , 1.28]
1.13 [1.00 , 1.28]
Risk Ratio
IV, Random, 95% CI
0.01 0.1 1 10 100
Favours non-digital TCC Favours TCC via mobile
Footnotes
(1) cluster RCT adjusted using design effect=6.9901, calculated with ICC=0.0487 reported in Gibson 2017
 
 
Comparison 8.   Digital targeted client communication (TCC) compared to digital non-targeted client communication
(parents of children aged under five years)





Statistical method Effect size
8.1 Service utilisation – attendance for vaccinations at
7 months






Analysis 8.1.   Comparison 8: Digital targeted client communication (TCC) compared
to digital non-targeted client communication (parents of children aged under five






Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Not applicable


















M-H, Random, 95% CI
0.63 [0.33 , 1.20]
0.63 [0.33 , 1.20]
Risk Ratio
M-H, Random, 95% CI
0.2 0.5 1 2 5
Favours non-TCC via mobile Favours TCC via mobile
 
 
A D D I T I O N A L   T A B L E S
 
Study ID Setting Country Income groupa
Population: pregnant and post-partum women
Evans 2014 Community USA High income
Jareethum 2008 Healthcare Thailand Upper middle income
Joshi 2015 Community India Lower middle income
Table 1.   Setting and income group of included studies 
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)
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Kamau-Mbuthia 2013 Healthcare Kenya Lower middle income
Lund 2012 Healthcare Tanzania Low income
Maslowsky 2016 Healthcare and community Ecuador Upper middle income
McConnell 2016 Healthcare Kenya Lower middle income
Moniz 2013 Community USA High income
Naughton 2017 Healthcare England High income
Omole 2018 Healthcare Nigeria Lower middle income
Yudin 2017 Healthcare Canada High income
Population: pregnant and post-partum women living with HIV
Kassaye 2016 Healthcare and community Kenya Lower middle income
Kebaya 2014 Community Kenya Lower middle income
Odeny 2014 Healthcare Kenya Lower middle income
Population: parents of children under five years
Ahlers-Schmidt 2012 Healthcare USA High income
Bangure 2015 Healthcare Zimbabwe Low income
Bigna 2015 Healthcare Cameroon Lower middle income
Brown 2016 Healthcare and community Nigeria Lower middle income
Domek 2016 Healthcare and community Guatemala Lower middle income
Eze 2015 Healthcare Nigeria Lower middle income
Gibson 2017 Community Kenya Lower middle income
Haji 2016 Community Kenya Lower middle income
Hannan 2016 Community USA High income
Hofstetter 2015a Community USA High income
Niederhauser 2015 Healthcare Hawaii High income
Sharma 2011 Not reported India Lower middle income
Stockwell 2015 Healthcare and community USA High income
Table 1.   Setting and income group of included studies  (Continued)
aIncome group according to World Bank list of economies, June 2017 (iccmoot.com/wp-content/uploads/2017/07/World-Bank-List-of-
Economies.pdf).
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Personalisation Data security Assessment of fidelity
Population: pregnant and post-partum women





















Not reported Text mes-
sages
Messages tailored to date
of enrolment and baby's
gestational age. Thus, a
woman enrolling in her 10
week of pregnancy would




























Not reported Not reported Not reported















Timed and targeted as per
beneficiary's gestational
age; sent in a user spec-
ified language and time
slot.















Not reported Not reported Not reported












































































































































































































The content of the mes-
sages varied depending
on the stage of the preg-
nancy. Message content
provided as simple text
in the local language of
Swahili.


















Voice calls Each participant also indi-
cated the days of the week
and times of day that were
best to reach her.
Not reported All intervention participants
completed the 48-hour post-
discharge education session.
Only 3 participants called the



























Voice calls Process was available in
English and Kiswahili.
Not reported Not reported



















13/104 received no messages.














































































































































































































































of the intervention include
gestation, motivation to
quit, the hardest situation




were encouraged to set
and send a quit date to
MiQuit to enable them to
receive additional support
orientated around when
their quit attempt begins.
Not reported Intervention fidelity was high,
98% of MiQuit recipients re-



















tured by the age of the
pregnancy, delivered once
a week, at a time chosen
by the participant.
Not reported 1. Recording of all mes-
sages sent by the system and
archiving of messages re-
ceived from registered partic-
ipants. In addition, the time-
stamp when the SMS was re-
ceived and the response giv-
en to each SMS received were
collected.
2. Periodic contact (based
on ANC appointments) with
study participants to confirm
receipt of messages.






























































































































































































3. All responses to clients'
messages were stored in a
database.















































































recorded by sending a
text message from their
phone. This message in-
cluded date of last normal
menstrual period and pre-
ferred language (English,
Kiswahili, or Dholuo). For
participants randomised
to the intervention, the
message also included
preferred time for receiv-
Not reported Not reported






























































































































































































ing SMS, and preferred
name.







Not reported Text mes-
sages







Not reported Text mes-
sages











































Not reported Text mes-
sages
SMS messages were au-
topopulated with the
child's name and the
name of the appropriate
clinic.











Each message is tagged
with the name of the
health facility. No other
personalisation reported.
Not reported No SMS delivery log. Authors
stated that "The majority of
respondents, [93.1%] accept-
ed the option of being sent
reminder messages." Among
those who preferred not to
be sent SMS reminders, self-
confidence in not forgetting
appointments (61%) and the






























































































































































































fear of giving out phone num-
bers (28.8%) were the great-
est barriers to mHealth up-











Baby's first name, relevant
vaccine name, and rele-
vant district were person-
alised in the messages.
Not reported The vast majority of carers re-
ported receiving ≥ 1 SMS re-












Not reported Not reported 1488 messages were sent to























Not reported Not reported 681 mobile phone calls; 630
by NPs to mothers and 51
calls to NPs by mothers. The
NPs were contacted via tex-













Messages were sent in ei-
ther English or Spanish
depending on the primary






















Of 1254 parents in the text
messaging arms who were
sent ≥ 1 text
message, 7.1% experienced ≥
1 undelivered message.






















































































































































































































The SMS included word-
ing such as: "your ba-
by," "your appoint-
ment," "your health care
provider."
Not reported To validate that the partici-
pants were receiving the text
messages, 10% of the parents
were randomly selected to re-
ceive phone calls verifying the















ers by saying: "you
should," "your child teeth,
your child tongue," etc.





















SMS were sent in English
or Spanish based on the
participant's request at
enrolment.
Not reported Although no undeliver-
able SMS were registered, 1
postintervention survey re-
vealed that some families did
not remember receiving SMS.
Table 2.   Interventions in included studies  (Continued)
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Cell Phones] this term only 535
#2 MeSH descriptor: [Smartphone] this term only 73
#3 MeSH descriptor: [MP3-Player] this term only 19
#4 MeSH descriptor: [Computers, Handheld] this term only 203
#5 ((cell* or mobile*) near/1 (phone* or telephone* or technolog* or device*)):ti,ab,kw 1601
#6 (handheld or hand-held):ti,ab,kw 1174
#7 (smartphone* or smart-phone* or cellphone* or mobiles):ti,ab,kw 749
#8 ((personal near/1 digital) or (PDA near/3 (device* or assistant*)) or "MP3 player*" or "MP4 player*"):ti,ab,kw 188
#9 (samsung or nokia):ti,ab,kw 44
#10 (windows near/3 (mobile* or phone*)):ti,ab,kw 3
#11 android:ti,ab,kw 155
#12 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*):ti,ab,kw 403
#13 (tablet* near/3 (device* or computer*)):ti,ab,kw 187
#14 MeSH descriptor: [Telemedicine] this term only 1528
#15 MeSH descriptor: [Videoconferencing] this term only 134
#16 MeSH descriptor: [Webcasts as Topic] this term only 16
#17 MeSH descriptor: [Text Messaging] this term only 428
#18 MeSH descriptor: [Telenursing] this term only 25
#19 (mhealth or m-health or "mobile health" or ehealth or e-health or "electronic health"):ti,ab,kw 1305
#20 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or tele-nursing or telepsychiatry or
tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-
coach*):ti,ab,kw 3320
#21 (videoconferenc* or video-conferenc* or webcast* or web-cast*):ti,ab,kw 418
#22 (((text* or short or voice or multimedia or multi-media or electronic or instant) near/1 messag*) or "instant messenger") .ti,ab,kw 48
#23 (texting or texted or texter* or ((sms or mms) near (service* or messag*)) or "interactive voice response*" or IVR or "voice call*" or
callback* or "voice over internet" or VOIP):ti,ab,kw 1011
#24 (Facebook or Twitter or Whatsapp* or Skyp* or YouTube or "You Tube" or "Google Hangout*"):ti,ab,kw 226
#25 MeSH descriptor: [Mobile Applications] this term only 151
#26 "mobile app*":ti,ab,kw 441
#27 MeSH descriptor: [Social Media] this term only 67
#28 (social near (media or network*)):ti,ab,kw 967
#29 MeSH descriptor: [Reminder Systems] this term only 816
#30 (remind* near/3 (text* or system* or messag*)):ti,ab,kw 1228
#31 MeSH descriptor: [Electronic Mail] this term only 278
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#32 ("electronic mail*" or email* or e-mail or webmail):ti,ab,kw 1778
#33 MeSH descriptor: [Medical Informatics] this term only 76
#34 MeSH descriptor: [Medical Informatics Applications] this term only 28
#35 MeSH descriptor: [Nursing Informatics] this term only 10
#36 MeSH descriptor: [Public Health Informatics] this term only 6
#37 ((medical or clinical or health or healthcare or nurs*) near/3 informatics):ti,ab,kw 265
#38 MeSH descriptor: [Multimedia] this term only 192
#39 MeSH descriptor: [Hypermedia] this term only 8
#40 MeSH descriptor: [Blogging] this term only 14
#41 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-log*):ti,ab,kw 728
#42 MeSH descriptor: [Interactive Tutorial] this term only 0
#43 MeSH descriptor: [Computer-Assisted Instruction] this term only 1132
#44 ((interactive or computer-assisted) near/1 (tutor* or technolog* or learn* or instruct* or soIware or communication)):ti,ab,kw 1322
#45 {or #1-#44} 13953
#46 MeSH descriptor: [Family Planning Services] this term only 205
#47 MeSH descriptor: [Contraception] this term only 289
#48 MeSH descriptor: [Reproductive Behavior] this term only 11
#49 MeSH descriptor: [Contraception Behavior] this term only 187
#50 MeSH descriptor: [Contraceptive Agents] explode all trees 2318
#51 MeSH descriptor: [Contraceptive Devices] explode all trees 1411
#52 (condom* or (OC near pill) or ("depot medroxyprogest*" or NET-EN or "NET EN" or Mesigyna or Cyclofem) or ("intrauterine system"
or "intra-uterine system" or IUS or "intrauterine device*" or "intra-uterine device*" or IUD*) or (vasectomy or sterilisation or sterilization
or (tubal near ligation)) or ((vaginal near ring) or cycletel or cycle-tel or ((abstain or abstinen*) near/2 (sex* or intercourse)) or "lactational
amenorr*")):ti,ab,kw 4178
#53 (contracept* or "family planning" or (birth near (control or regulat* or spacing)) or "planned parenthood" or ((population or fertility)
near (regulat* or control))):ti,ab,kw 9149
#54 MeSH descriptor: [Pregnancy in Adolescence] this term only 185
#55 (pregnan* near/2 (adolescen* or teen* or schoolchild*)):ti,ab,kw 1541
#56 MeSH descriptor: [Pregnancy, Unplanned] this term only 73
#57 MeSH descriptor: [Pregnancy, Unwanted] this term only 48
#58 (pregnan* near/3 (prevent* or interrupt* or unplanned or unwanted or mistimed)):ti,ab,kw 2178
#59 MeSH descriptor: [Sexually Transmitted Diseases] explode all trees and with qualifier(s): [Diagnosis - DI, Drug therapy - DT,
Epidemiology - EP, Prevention & control - PC, Psychology - PX, Transmission - TM] 8731
#60 ("sexually transmi*" or STI or STIs or STD or STDs or venereal):ti,ab,kw 2535
#61 MeSH descriptor: [HIV Infections] explode all trees and with qualifier(s): [Diagnosis - DI, Drug therapy - DT, Epidemiology - EP, Prevention
& control - PC, Psychology - PX, Transmission - TM] 7638
#62 MeSH descriptor: [HIV Seropositivity] this term only and with qualifier(s): [Drug therapy - DT, Epidemiology - EP, Psychology - PX,
Transmission - TM] 380
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#63 MeSH descriptor: [Anti-HIV Agents] this term only 2641
#64 MeSH descriptor: [Antiretroviral Therapy, Highly Active] this term only 1246
#65 MeSH descriptor: [Medication Adherence] this term only 1733
#66 (#63 or #64) and #65 191
#67 (hiv or hiv-1* or hiv-2* or hiv1 or hiv2 or "human immunodeficiency virus" or "human immunedeficiency virus" or "human immuno-
deficiency virus" or "human immune-deficiency virus" or ("human immun*" and "deficiency virus") or "acquired immunodeficiency
syndrome" or "acquired immunedeficiency syndrome" or "acquired immuno-deficiency syndrome" or "acquired immune-deficiency
syndrome" or ("acquired immun*" and "deficiency syndrome")):ti,ab,kw 16777
#68 ((antiretroviral* or anti-retroviral* or ARV*) near/2 (complian* or adheren*)):ti,ab,kw 265
#69 MeSH descriptor: [Infant, Premature] this term only 3279
#70 MeSH descriptor: [Infant, Newborn] this term only 14904
#71 MeSH descriptor: [Infant, Low Birth Weight] this term only 1010
#72 MeSH descriptor: [Infant, Extremely Low Birth Weight] this term only 103
#73 MeSH descriptor: [Infant, Small for Gestational Age] this term only 254
#74 MeSH descriptor: [Infant] this term only 66
#75 MeSH descriptor: [Infant, Very Low Birth Weight] this term only 802
#76 MeSH descriptor: [Infant, Postmature] this term only 6
#77 MeSH descriptor: [Infant, Extremely Premature] this term only 100
#78 MeSH descriptor: [Child] this term only 225
#79 MeSH descriptor: [Child, Preschool] this term only 80
#80 MeSH descriptor: [Adolescent] this term only 91247
#81 {or #69-#80} and (#63 or #64) 595
#82 ((antiretroviral* or anti-retroviral* or ARV*) and (infant* or newborn* or neonat* or child* or schoolchild* or adolescen* or
teen*)):ti,ab,kw 1265
#83 MeSH descriptor: [Papillomavirus Infections] this term only and with qualifier(s): [Prevention & control - PC] 285
#84 MeSH descriptor: [Papillomavirus Vaccines] this term only and with qualifier(s): [Administration & dosage - AD, Therapeutic use - TU]
213
#85 MeSH descriptor: [Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18] this term only and with qualifier(s):
[Administration & dosage - AD, Therapeutic use - TU] 8
#86 ((hpv or "papilloma virus*" or papillomavirus*) near/2 (vaccinat* or revaccinat* or immuniz* or immunis* or immunother* or inoculat*
or innoculat* or prophyla*)):ti,ab,kw 306
#87 MeSH descriptor: [Domestic Violence] this term only 159
#88 MeSH descriptor: [Spouse Abuse] this term only 211
#89 MeSH descriptor: [Intimate Partner Violence] this term only 34
#90 MeSH descriptor: [Rape] this term only 105
#91 (((sexual or domestic or spouse* or "intimate partner") near/3 (violen* or abus*)) or rape):ti,ab,kw 1425
#92 MeSH descriptor: [Puberty] this term only 292
#93 (pubert* or pubescen*):ti,ab,kw 1161
Targeted client communication via mobile devices for improving maternal, neonatal, and child health (Review)










Cochrane Database of Systematic Reviews
#94 MeSH descriptor: [Menstruation] this term only 467
#95 (menstruat* or menstrual*):ti,ab,kw 5420
#96 MeSH descriptor: [Abortion, Legal] this term only 29
#97 MeSH descriptor: [Abortion, Induced] this term only 936
#98 (abort* or miscarr* or (pregnan* near/2 terminat*)):ti,ab,kw 4659
#99 MeSH descriptor: [Infertility] this term only 430
#100 MeSH descriptor: [Reproductive Techniques, Assisted] this term only 222
#101 MeSH descriptor: [Fertilization in Vitro] this term only 1927
#102 (infertil* or "assisted reproductive technolog*" or "in vitro fertili*" or "in-vitro fertili*" or IVF):ti,ab,kw 7649
#103 MeSH descriptor: [Sexual Behavior] this term only 1721
#104 MeSH descriptor: [Sex Work] this term only 90
#105 MeSH descriptor: [Safe Sex] this term only 224
#106 MeSH descriptor: [Unsafe Sex] this term only 256
#107 (sex* near (protected or unprotected or safe or unsafe or risk* or behavio*)):ti,ab,kw 7317
#108 MeSH descriptor: [Contact Tracing] this term only 102
#109 MeSH descriptor: [Disease Notification] this term only 24
#110 MeSH descriptor: [Sexual Partners] this term only 542
#111 (#108 or #109) and #110 31
#112 (partner* near/3 (notifi* or tracing or report*)):ti,ab,kw 338
#113 MeSH descriptor: [Prenatal Care] this term only 1322
#114 (((antenatal or ante-natal or prenatal or pre-natal or antepartum or ante-partum) near/3 (care or service* or counsel* or test*)) or
(birth near/3 prepar*)):ti,ab,kw 2581
#115 MeSH descriptor: [Maternal Health Services] this term only 232
#116 ((maternal or mother*) near/3 (health or service* or care)):ti,ab,kw 2279
#117 MeSH descriptor: [Reproductive Health] this term only 64
#118 (reproductive near/2 (health or care or service*)):ti,ab,kw 545
#119 MeSH descriptor: [Midwifery] this term only 327
#120 (midwi* or "skilled birth" or "skilled attendan*"):ti,ab,kw 1200
#121 MeSH descriptor: [Obstetric Labor Complications] this term only 472
#122 MeSH descriptor: [Pregnancy Complications] this term only 1493
#123 ((obstetric* or pregnan* or labour or labor or parturition) near/3 (emergenc* or complication*)):ti,ab,kw 5036
#124 MeSH descriptor: [Postnatal Care] this term only 391
#125 MeSH descriptor: [Perinatal Care] this term only 166
#126 MeSH descriptor: [Postpartum Period] this term only 956
#127 ((postnatal or post-natal or perinatal or peri-natal or postpartum or post-partum) near/2 (care or service*)):ti,ab,kw 1204
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#128 MeSH descriptor: [Maternal Nutritional Physiological Phenomena] this term only 205
#129 MeSH descriptor: [Prenatal Nutritional Physiological Phenomena] this term only 121
#130 MeSH descriptor: [Breast Feeding] this term only 1632
#131 ("breast feed*" or "breast fed" or breastfeed* or breastfed):ti,ab,kw 3952
#132 MeSH descriptor: [Early Diagnosis] this term only 581
#133 #132 and {or #69-#77} 27
#134 (early near/1 diagnos* near/2 (infant* or neonat* or newborn*)):ti,ab,kw 48
#135 (diagnos* and (infant* or neonat* or newborn*)):ti,ab,kw 5267
#136 MeSH descriptor: [Infectious Disease Transmission, Vertical] this term only 586
#137 (("mother-to-child transmi*" near/3 (prevent* or eliminat*)) or emtct or pmtct or (vertical near transmi*)):ti,ab,kw 835
#138 MeSH descriptor: [Immunization] explode all trees 4855
#139 MeSH descriptor: [Immunization Programs] explode all trees 465
#140 (#138 or #139) and {or #69-#80} 1539
#141 MeSH descriptor: [Pregnancy] this term only 58
#142 (#138 or #139) and #141 2
#143 ((immuniz* or immunis* or vaccinat*) and (infant* or newborn* or neonat* or child* or adolescen* or teen*)):ti,ab,kw 6911
#144 MeSH descriptor: [Child Health Services] this term only 387
#145 MeSH descriptor: [Maternal-Child Health Services] explode all trees 11
#146 MeSH descriptor: [Child Nutrition Disorders] explode all trees 149
#147 MeSH descriptor: [Infant Nutrition Disorders] explode all trees 99
#148 MeSH descriptor: [Nutrition Disorders] explode all trees 13509
#149 MeSH descriptor: [Infant] explode all trees 15237
#150 MeSH descriptor: [Child, Preschool] this term only 80
#151 #148 and (#149 or #150) 352
#152 MeSH descriptor: [Delivery of Health Care, Integrated] this term only 359
#153 ((integrat* near/3 ("health care" or healthcare or management or treat* or service*) near/3 (child* or schoolchild* or infant* or neonat*
or newborn or adolescen* or teen*)) or IMCI or IMNCI):ti,ab,kw 105
#154 MeSH descriptor: [Guideline Adherence] this term only 999
#155 MeSH descriptor: [Quality Assurance, Health Care] this term only 806
#156 (#154 or #155) and (#149 or #150) 52
#157 ((((guideline* or protocol*) near/3 (adher* or observ*)) or "prescribed care") and (infant* or newborn* or neonat* or child*)):ti,ab,kw
303
#158 MeSH descriptor: [Diarrhea] explode all trees and with qualifier(s): [Diagnosis - DI, Drug therapy - DT, Epidemiology - EP, Prevention
& control - PC, Therapy - TH] 1754
#159 #158 and {or #69-#80} 346
#160 (diarrh* and (infant* or newborn* or neonat* or child* or schoolchild* or adolescen* or teen*)):ti,ab,kw 5413
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#161 MeSH descriptor: [Hand Hygiene] this term only 41
#162 MeSH descriptor: [Hand Disinfection] this term only 339
#163 MeSH descriptor: [Water Supply] this term only 163
#164 MeSH descriptor: [Drinking Water] this term only 81
#165 MeSH descriptor: [Sanitation] this term only 62
#166 (handwash* or hand-wash* or (wash* near/1 hand*) or "hand hygiene" or hand-hygiene or soap or "water suppl*" or sanitation or
sanitary or "drinking water" or "potable water"):ti,ab,kw 1933
#167 MeSH descriptor: [Fluid Therapy] this term only 1536
#168 #167 and {or #69-#79} 107
#169 ("oral rehydration" near (solution* or salt* or therapy)):ti,ab,kw 587
#170 MeSH descriptor: [Child Development] this term only 1604
#171 MeSH descriptor: [Adolescent Development] this term only 78
#172 ((child* or schoolchild* or adolescen* or teen*) near/2 (develop* or progress*)):ti,ab,kw 4641
#173 MeSH descriptor: [Breast Neoplasms] this term only and with qualifier(s): [Diagnosis - DI, Diagnostic imaging - DG, Prevention & control
- PC] 1770
#174 MeSH descriptor: [Breast Neoplasms] this term only 10204
#175 MeSH descriptor: [Mass Screening] this term only 4818
#176 #173 or (#174 and #175) 1866
#177 MeSH descriptor: [Uterine Cervical Neoplasms] this term only and with qualifier(s): [Diagnosis - DI, Diagnostic imaging - DG, Prevention
& control - PC] 826
#178 (((breast or cervix or cervical) near (neoplasm* or cancer*)) and (screen* or diagnos*)):ti,ab,kw 6059
#179 MeSH descriptor: [Folic Acid] this term only and with qualifier(s): [Administration & dosage - AD, Therapeutic use - TU] 1046
#180 MeSH descriptor: [Folic Acid Deficiency] this term only and with qualifier(s): [Drug therapy - DT, Prevention & control - PC, Therapy
- TH] 51
#181 (folic acid near (fortif* or supplement* or treat* or therap*)):ti,ab,kw 1880
#182 MeSH descriptor: [Sex Education] this term only 242
#183 (sex* near (educat* or "health promot*")):ti,ab,kw 1551
#184 MeSH descriptor: [Pregnancy in Adolescence] this term only 185
#185 MeSH descriptor: [Kangaroo-Mother Care Method] this term only 42
#186 (kangaroo near/2 (mother* or infant* or care)):ti,ab,kw 242
#187 MeSH descriptor: [Anemia] this term only and with qualifier(s): [Drug therapy - DT, Prevention & control - PC] 1051
#188 MeSH descriptor: [Anemia, Hypochromic] this term only and with qualifier(s): [Drug therapy - DT, Prevention & control - PC] 195
#189 MeSH descriptor: [Anemia, Iron-Deficiency] this term only and with qualifier(s): [Drug therapy - DT, Prevention & control - PC] 643
#190 MeSH descriptor: [Pregnancy Complications] this term only 1493
#191 (#187 or #188 or #189) and #190 49
#192 ((maternal or mother* or pregnan*) near/2 (nutrition* or folate or folic or iron or anaemi* or anemi*)):ti,ab,kw 1369
#193 MeSH descriptor: [Malaria] this term only and with qualifier(s): [Diagnosis - DI, Drug therapy - DT, Prevention & control - PC] 863
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#194 MeSH descriptor: [Malaria, Falciparum] this term only and with qualifier(s): [Diagnosis - DI, Drug therapy - DT, Prevention & control
- PC] 1240
#195 MeSH descriptor: [Malaria, Vivax] this term only and with qualifier(s): [Diagnosis - DI, Drug therapy - DT, Prevention & control - PC] 151
#196 MeSH descriptor: [Pregnancy] this term only 58
#197 MeSH descriptor: [Pregnancy Complications, Parasitic] this term only 167
#198 (#193 or #194 or #195) and (#196 or #197) 124
#199 ((malaria* or falciparum or vivax) near/3 (pregnan* or mother* or maternal or postpartum or "post partum")):ti,ab,kw 319
#200 MeSH descriptor: [Smoking Cessation] this term only 3848
#201 #200 and (#196 or #184) 6
#202 (((smoking or smoker* or cigarette or tobacco) near/3 (ceas* or cessation or stop* or discontinu*)) and (pregnan* or maternal or
mother*)):ti,ab,kw 479
#203 MeSH descriptor: [Mental Health] this term only 1082
#204 MeSH descriptor: [Mental Disorders] this term only 2830
#205 MeSH descriptor: [Mental Health Services] this term only 727
#206 MeSH descriptor: [Community Mental Health Services] this term only 743
#207 MeSH descriptor: [Maternal Behavior] this term only 253
#208 MeSH descriptor: [Mother-Child Relations] this term only 704
#209 MeSH descriptor: [Paternal Behavior] explode all trees 28
#210 MeSH descriptor: [Depression, Postpartum] this term only 392
#211 (((mental or behavio*) near/3 (health or disorder*)) or "postpartum depression" or "post-partum depression" or "postnatal
depression" or "post-natal depression"):ti,ab,kw 25906
#212 {or #46-#62, #66-#68, #81-#107, #111-#131, #133-#137, #140, #142-#147, #151-#153, #156-#157, #159-#166, #168-#172, #176-#186,
#191-#192, #198-#199, #201-#211} 115974
#213 #45 and #212 Publication Year from 2010 to 2017, in Trials 2150 hits
Appendix 2. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid
MEDLINE(R) search strategy
1 Family Planning Services/ (24014)
2 Contraception/ (18551)
3 Reproductive behavior/ or Contraception behavior/ (8119)
4 exp Contraceptive agents/ (68445)
5 exp Contraceptive Devices/ (23921)
6 (condom* or (OC adj pill) or (depot medroxyprogest* or NET-EN or NET EN or Mesigyna or Cyclofem) or (intrauterine system or intra-
uterine system or IUS or intrauterine device* or intra-uterine device* or IUD*) or (vasectomy or sterilisation or sterilization or (tubal adj
ligation)) or ((vaginal adj ring) or cycletel or cycle-tel or ((abstain or abstinen*) adj2 (sex* or intercourse)) or lactational amenorr*)).ti,ab,kw.
(55772)
7 (contracept* or family planning or (birth adj (control or regulat* or spacing)) or planned parenthood or ((population or fertility) adj
(regulat* or control))).ti,ab,kw. (88295)
8 Pregnancy in Adolescence/ (7481)
9 (pregnan* adj2 (adolescen* or teen* or schoolchild*)).ti,ab,kw. (6460)
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10 Pregnancy, unplanned/ or Pregnancy, unwanted/ (3826)
11 (pregnan* adj3 (prevent* or interrupt* or unplanned or unwanted or mistimed)).ti,ab,kw. (12867)
12 exp Sexually Transmitted Diseases/di, dt, ep, pc, px, tm [Diagnosis, Drug Therapy, Epidemiology, Prevention & Control, Psychology,
Transmission] (203961)
13 (sexually transmi* or STI or STIs or STD or STDs or venereal).ti,ab,kw. (43434)
14 exp HIV Infections/di, dt, ep, pc, px, tm [Diagnosis, Drug Therapy, Epidemiology, Prevention & Control, Psychology, Transmission]
(172773)
15 HIV Seropositivity/dt, ep, pc, px, tm [Drug Therapy, Epidemiology, Prevention & Control, Psychology, Transmission] (8281)
16 (Anti-HIV Agents/ or Antiretroviral Therapy, Highly Active/) and Medication Adherence/ (1731)
17 (hiv or hiv-1* or hiv-2* or hiv1 or hiv2 or human immunodeficiency virus or human immunedeficiency virus or human immuno-deficiency
virus or human immune-deficiency virus or (human immun* and deficiency virus) or acquired immunodeficiency syndrome or acquired
immunedeficiency syndrome or acquired immuno-deficiency syndrome or acquired immune-deficiency syndrome or (acquired immun*
and deficiency syndrome)).ti,ab,kw. (305680)
18 ((antiretroviral* or anti-retroviral* or ARV*) adj2 (complian* or adheren*)).ti,ab,kw. (2211)
19 (Anti-HIV Agents/ or Antiretroviral Therapy, Highly Active/) and (Infant, Premature/ or Infant, Newborn/ or Infant, Low Birth Weight/ or
Infant, Extremely Low Birth Weight/ or Infant, Small for Gestational Age/ or Infant/ or Infant, Very Low Birth Weight/ or Infant, Postmature/
or Infant, Extremely Premature/ or Child/ or Child, Preschool/ or Adolescent/) (8416)
20 ((antiretroviral* or anti-retroviral* or ARV*) and (infant* or newborn* or neonat* or child* or schoolchild* or adolescen* or
teen*)).ti,ab,kw. (7849)
21 Papillomavirus Infections/pc [Prevention & Control] (4923)
22 Papillomavirus Vaccines/ad, tu [Administration & Dosage, Therapeutic Use] (3440)
23 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/ad, tu [Administration & Dosage, Therapeutic Use] (66)
24 ((hpv or papilloma virus* or papillomavirus*) adj2 (vaccinat* or revaccinat* or immuniz* or immunis* or immunother* or inoculat* or
innoculat* or prophyla*)).ti,ab,kw. (4560)
25 Domestic Violence/ or Spouse Abuse/ or Intimate Partner Violence/ or Rape/ (18904)
26 (((sexual or domestic or spouse* or intimate partner) adj3 (violen* or abus*)) or rape).ti,ab,kw. (29484)
27 Puberty/ (12854)
28 (pubert* or pubescen*).ti,ab,kw. (35751)
29 Menstruation/ (15653)
30 (menstruat* or menstrual*).ti,ab,kw. (46842)
31 Abortion, Legal/ (7401)
32 Abortion, Induced/ (26969)
33 (abort* or miscarr* or (pregnan* adj2 terminat*)).ti,ab,kw. (90766)
34 Infertility/ (13697)
35 Reproductive Techniques, Assisted/ (8232)
36 Fertilization in Vitro/ (29054)
37 (infertil* or assisted reproductive technolog* or in vitro fertili* or in-vitro fertili* or IVF).ti,ab,kw. (78409)
38 Sexual behavior/ or Sex work/ or Safe sex/ or Unsafe sex/ (59074)
39 (sex* adj (protected or unprotected or safe or unsafe or risk* or behavio*)).ti,ab,kw. (30964)
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40 (Contact tracing/ or Disease notification/) and Sexual partners/ (489)
41 (partner* adj3 (notifi* or tracing or report*)).ti,ab,kw. (4218)
42 Prenatal Care/ (24280)
43 (((antenatal or ante-natal or prenatal or pre-natal or antepartum or ante-partum) adj3 (care or service* or counsel* or test*)) or (birth
adj3 prepar*)).ti,ab,kw. (24022)
44 Maternal Health Services/ (12560)
45 ((maternal or mother*) adj3 (health or service* or care)).ti,ab,kw. (23733)
46 Reproductive Health/ (2247)
47 (reproductive adj2 (health or care or service*)).ti,ab,kw. (11738)
48 Midwifery/ (17848)
49 (midwi* or skilled birth or skilled attendan*).ti,ab,kw. (21972)
50 Obstetric Labor Complications/ (16678)
51 Pregnancy Complications/ (85905)
52 ((obstetric* or pregnan* or labour or labor or parturition) adj3 (emergenc* or complication*)).ti,ab,kw. (19704)
53 Postnatal Care/ (4878)
54 Perinatal Care/ (3796)
55 Postpartum Period/ (22535)
56 ((postnatal or post-natal or perinatal or peri-natal or postpartum or post-partum) adj2 (care or service*)).ti,ab,kw. (5636)
57 Maternal Nutritional Physiological Phenomena/ (3299)
58 Prenatal Nutritional Physiological Phenomena/ (1591)
59 Breast Feeding/ (34451)
60 (breast feed* or breast fed or breastfeed* or breastfed).ti,ab,kw. (37063)
61 (Infant, Premature/ or Infant, Newborn/ or Infant, Low Birth Weight/ or Infant, Extremely Low Birth Weight/ or Infant, Small for
Gestational Age/ or Infant/ or Infant, Very Low Birth Weight/ or Infant, Postmature/ or Infant, Extremely Premature/) and Early Diagnosis/
(2277)
62 (early adj1 diagnos* adj2 (infant* or neonat* or newborn*)).ti,ab,kw. (378)
63 diagnosis.fs. and (infant* or neonat* or newborn*).ti,ab,kw. (84137)
64 *"Infectious Disease Transmission, Vertical"/ (8524)
65 ((mother-to-child transmi* adj3 (prevent* or eliminat*)) or emtct or pmtct or (vertical adj transmi*)).ti,ab,kw. (7686)
66 (Immunization/ or Immunization, passive/ or Immunization schedule/ or Immunization, secondary/ or Immunization Programs/ or
Vaccination/ or Mass vaccination/) and (Infant, Premature/ or Infant, Newborn/ or Infant, Low Birth Weight/ or Infant, Extremely Low
Birth Weight/ or Infant, Small for Gestational Age/ or Infant/ or Infant, Very Low Birth Weight/ or Infant, Postmature/ or Infant, Extremely
Premature/ or Child/ or Child, Preschool/ or Adolescent/ or Pregnancy/) (43902)
67 ((immuniz* or immunis* or vaccinat*) and (infant* or newborn* or neonat* or child* or adolescen* or teen*)).ti,ab,kw. (45525)
68 Child health services/ or Maternal-child health services/ (19947)
69 exp child nutrition disorders/ or exp infant nutrition disorders/ or (exp nutrition disorders/ and (exp Infant/ or Child, Preschool/)) (39850)
70 "Delivery of Health Care, Integrated"/ (10651)
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71 ((integrat* adj3 (health care or healthcare or management or treat* or service*) adj3 (child* or schoolchild* or infant* or neonat* or
newborn or adolescen* or teen*)) or IMCI or IMNCI).ti,ab,kw. (935)
72 (Guideline Adherence/ or Quality Assurance, Health Care/) and (exp Infant/ or Child, Preschool/) (4112)
73 ((((guideline* or protocol*) adj3 (adher* or observ*)) or "prescribed care") and (infant* or newborn* or neonat* or child*)).ti,ab,kw. (1065)
74 (Diarrhea/di, dt, ep, pc, th, tm or Diarrhea, Infantile/di, dt, ep, pc, th, tm) and (Infant, Premature/ or Infant, Newborn/ or Infant, Low Birth
Weight/ or Infant, Extremely Low Birth Weight/ or Infant, Small for Gestational Age/ or Infant/ or Infant, Very Low Birth Weight/ or Infant,
Postmature/ or Infant, Extremely Premature/ or Child/ or Child, Preschool/ or Adolescent/) (10212)
75 (diarrh* and (infant* or newborn* or neonat* or child* or schoolchild* or adolescen* or teen*)).ti,ab,kw. (25541)
76 Hand Hygiene/ or Hand Disinfection/ (5743)
77 Water Supply/ (31018)
78 Drinking Water/ (5487)
79 Sanitation/ (6592)
80 (handwash* or hand-wash* or (wash* adj1 hand*) or hand hygiene or hand-hygiene or soap or water suppl* or sanitation or sanitary
or drinking water or potable water).ti,ab,kw. (79667)
81 Fluid Therapy/ and (Infant, Premature/ or Infant, Newborn/ or Infant, Low Birth Weight/ or Infant, Extremely Low Birth Weight/ or Infant,
Small for Gestational Age/ or Infant/ or Infant, Very Low Birth Weight/ or Infant, Postmature/ or Infant, Extremely Premature/ or Child/ or
Child, Preschool/) (4522)
82 (oral rehydration adj (solution* or salt* or therapy)).ti,ab,kw. (2174)
83 Child Development/ or Adolescent Development/ (43982)
84 ((child* or schoolchild* or adolescen* or teen*) adj2 (develop* or progress*)).ti,ab,kw. (48454)
85 Breast Neoplasms/di, dg, pc or (Breast Neoplasms/ and Mass Screening/) (60213)
86 Uterine Cervical Neoplasms/di, dg, pc [Diagnosis, Diagnostic Imaging, Prevention & Control] (22572)
87 (((breast or cervix or cervical) adj (neoplasm* or cancer*)) and (screen* or diagnos*)).ti,ab,kw. (70920)
88 Folic Acid/ad, tu, th [Administration & Dosage, Therapeutic Use, Therapy] (8376)
89 Folic Acid Deficiency/dt, pc, th [Drug Therapy, Prevention & Control, Therapy] (806)
90 (folic acid adj (fortif* or supplement* or treat* or therap*)).ti,ab,kw. (3105)
91 Sex Education/ (8484)
92 (sex* adj (educat* or "health promot*")).ti,ab,kw. (8530)
93 Pregnancy in Adolescence/ (7481)
94 Kangaroo-Mother Care Method/ (224)
95 (kangaroo adj2 (mother or infant or care)).ti,ab,kw. (546)
96 (Anemia/dt, pc or Anemia, Hypochromic/dt, pc or Anemia, Iron-Deficiency/dt, pc) and Pregnancy/ (1425)
97 ((maternal or mother* or pregnan*) adj2 (nutrition* or folate or folic or iron or anaemi* or anemi*)).ti,ab,kw. (8978)
98 (Malaria/di, dt, pc or Malaria, Falciparum/di, dt, pc or Malaria, Vivax/di, dt, pc) and (Pregnancy/ or Pregnancy Complications, Parasitic/)
(2012)
99 ((malaria* or falciparum or vivax) adj3 (pregnan* or mother* or maternal or postpartum or post partum)).ti,ab,kw. (2199)
100 Smoking Cessation/ and (Pregnancy/ or Pregnancy in Adolescence/) (1521)
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101 (((smoking or smoker* or cigarette or tobacco) adj3 (ceas* or cessation or stop* or discontinu*)) and (pregnan* or maternal or
mother*)).ti,ab,kw. (1903)
102 Mental health/ or Mental disorders/ or Mental health services/ or Community mental health services/ (207284)
103 Maternal behavior/ or Mother-child relations/ or Parenting/ or Paternal behavior/ (39063)
104 Depression, Postpartum/ (4500)
105 (((mental or behavio*) adj3 (health or disorder*)) or postpartum depression or post-partum depression).ti,ab,kw. (188278)
106 or/1-105 (1926054)
107 Cell Phones/ (7081)
108 Smartphone/ (1248)
109 MP3-Player/ (167)
110 Computers, Handheld/ (3094)
111 ((cell* or mobile*) adj1 (phone* or telephone* or technolog* or device*)).ti,ab,kw. (13097)
112 (handheld or hand-held).ti,ab,kw. (9948)
113 (smartphone* or smart-phone* or cellphone* or mobiles).ti,ab,kw. (5528)
114 ((personal adj1 digital) or (PDA adj3 (device* or assistant*)) or MP3 player* or MP4 player*).ti,ab,kw. (1294)
115 (samsung or nokia).ti,ab,kw. (816)
116 (windows adj3 (mobile* or phone*)).ti,ab,kw. (43)
117 android.ti,ab,kw. (1531)
118 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*).ti,ab,kw. (1959)
119 (tablet* adj3 (device* or computer*)).ti,ab,kw. (995)
120 Telemedicine/ (16715)
121 Videoconferencing/ or Webcasts as topic/ (1495)
122 Text Messaging/ (1659)
123 Telenursing/ (174)
124 (mhealth or m-health or "mobile health" or ehealth or e-health or "electronic health").ti,ab,kw. (15415)
125 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or tele-nursing or telepsychiatry or
tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-
coach*).ti,ab,kw. (13879)
126 (videoconferenc* or video-conferenc* or webcast* or web-cast*).ti,ab,kw. (2492)
127 (((text* or short or voice or multimedia or multi-media or electronic or instant) adj1 messag*) or instant messenger).ti,ab,kw. (3426)
128 (texting or texted or texter* or ((sms or mms) adj (service* or messag*)) or interactive voice response* or IVR or voice call* or callback*
or voice over internet or VOIP).ti,ab,kw. (2544)
129 (Facebook or Twitter or Whatsapp* or Skyp* or YouTube or "You Tube" or Google Hangout*).ti,ab,kw. (4064)
130 Mobile Applications/ (2240)
131 "mobile app*".ti,ab,kw. (1732)
132 Social Media/ (3805)
133 (social adj (media or network*)).ti,ab,kw. (16003)
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134 Reminder Systems/ (3057)
135 (remind* adj3 (text* or system* or messag*)).ti,ab,kw. (1405)
136 Electronic Mail/ (2408)
137 (electronic mail* or email* or e-mail or webmail).ti,ab,kw. (11435)
138 Medical informatics/ or Medical informatics applications/ (12875)
139 Nursing informatics/ or Public health informatics/ (2467)




144 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-log*).ti,ab,kw. (6166)
145 Interactive Tutorial/ (248)
146 Computer-Assisted Instruction/ (11266)
147 ((interactive or computer-assisted) adj1 (tutor* or technolog* or learn* or instruct* or soIware or communication)).ti,ab,kw. (2214)
148 or/107-147 (133860)
149 randomized controlled trial.pt. (470403)
150 controlled clinical trial.pt. (94471)
151 randomized.ab. (403622)
152 placebo.ab. (189095)





158 exp animals/ not humans.sh. (4445095)
159 157 not 158 (3560201)
160 106 and 148 and 159 (4615)
161 limit 160 to yr="2010 -Current" (3358)
Appendix 3. Embase Classic + Embase (Ovid) search strategy
1 family planning/ (36696)
2 contraception/ (46800)
3 reproductive behavior/ (919)
4 contraceptive behavior/ (2794)
5 exp contraceptive agent/ (150341)
6 exp contraceptive device/ (40749)
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7 (condom* or (OC adj pill) or (depot medroxyprogest* or NET-EN or NET EN or Mesigyna or Cyclofem) or (intrauterine system or intra-
uterine system or IUS or intrauterine device* or intra-uterine device* or IUD*) or (vasectomy or sterilisation or sterilization or (tubal adj
ligation)) or ((vaginal adj ring) or cycletel or cycle-tel or ((abstain or abstinen*) adj2 (sex* or intercourse)) or lactational amenorr*)).ti,ab,kw.
(66547)
8 (contracept* or family planning or (birth adj (control or regulat* or spacing)) or planned parenthood or ((population or fertility) adj
(regulat* or control))).ti,ab,kw. (95639)
9 adolescent pregnancy/ (8690)
10 (pregnan* adj2 (adolescen* or teen* or schoolchild*)).ti,ab,kw. (6730)
11 unplanned pregnancy/ (4299)
12 unwanted pregnancy/ (3137)
13 (pregnan* adj3 (prevent* or interrupt* or unplanned or unwanted or mistimed)).ti,ab,kw. (16419)
14 exp sexually transmitted disease/di, dt, ep, pc [Diagnosis, Drug Therapy, Epidemiology, Prevention] (36227)
15 (sexually transmi* or STI or STIs or STD or STDs or venereal).ti,ab,kw. (56299)
16 exp Human immunodeficiency virus infection/di, dt, ep, pc [Diagnosis, Drug Therapy, Epidemiology, Prevention] (161972)
17 (hiv or hiv-1* or hiv-2* or hiv1 or hiv2 or human immunodeficiency virus or human immunedeficiency virus or human immuno-deficiency
virus or human immune-deficiency virus or (human immun* and deficiency virus) or acquired immunodeficiency syndrome or acquired
immunedeficiency syndrome or acquired immuno-deficiency syndrome or acquired immune-deficiency syndrome or (acquired immun*
and deficiency syndrome)).ti,ab,kw. (372022)
18 ((antiretroviral* or anti-retroviral* or ARV*) adj2 (complian* or adheren*)).ti,ab,kw. (2598)
19 (antiretroviral therapy/ or highly active antiretroviral therapy/) and medication compliance/ (703)
20 (antiretroviral therapy/ or highly active antiretroviral therapy/) and (child/ or infant/ or adolescent/ or newborn/) (4203)
21 ((antiretroviral* or anti-retroviral* or ARV*) and (infant* or newborn* or neonat* or child* or schoolchild* or adolescen* or
teen*)).ti,ab,kw. (10214)
22 papillomavirus infection/pc [Prevention] (2243)
23 Wart virus vaccine/ad, dt [Drug Administration, Drug Therapy] (6083)
24 ((hpv or papilloma virus* or papillomavirus*) adj2 (vaccinat* or revaccinat* or immuniz* or immunis* or immunother* or inoculat* or
innoculat* or prophyla*)).ti,ab,kw. (5974)
25 domestic violence/ or battered woman/ or family violence/ or exp partner violence/ (19311)
26 statutory rape/ or acquaintance rape/ or rape/ or marital rape/ (7284)
27 (((sexual or domestic or spouse* or intimate partner) adj3 (violen* or abus*)) or rape).ti,ab,kw. (36302)
28 puberty/ or menarche/ (36986)
29 (pubert* or pubescen*).ti,ab,kw. (50840)
30 menstruation/ (22869)
31 (menstruat* or menstrual*).ti,ab,kw. (62512)
32 abortion/ or imminent abortion/ or recurrent abortion/ or septic abortion/ or spontaneous abortion/ (74082)
33 (abort* or miscarr* or (pregnan* adj2 terminat*)).ti,ab,kw. (120224)
34 infertility/ (38578)
35 infertility therapy/ or in vitro fertilization/ (19053)
36 (infertil* or assisted reproductive technolog* or in vitro fertili* or in-vitro fertili* or IVF).ti,ab,kw. (116136)
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37 sexual behavior/ or adolescent sexual behavior/ or casual sex/ or prostitution/ or exp safe sex/ or sexual practice/ or exp unsafe sex/
(110380)
38 (sex* adj (protected or unprotected or safe or unsafe or risk* or behavio*)).ti,ab,kw. (33582)
39 contact examination/ (3275)
40 (partner* adj3 (notifi* or tracing or report*)).ti,ab,kw. (5304)
41 prenatal care/ or prenatal screening/ (40985)
42 (((antenatal or ante-natal or prenatal or pre-natal or antepartum or ante-partum) adj3 (care or service* or counsel* or test*)) or (birth
adj3 prepar*)).ti,ab,kw. (30891)
43 maternal health service/ (467)
44 ((maternal or mother*) adj3 (health or service* or care or welfare)).ti,ab,kw. (28175)
45 reproductive health/ (13171)
46 (reproductive adj2 (health or care or service*)).ti,ab,kw. (15081)
47 midwife/ or nurse midwife/ (28959)
48 (midwi* or skilled birth or skilled attendan*).ti,ab,kw. (24665)
49 labor complication/ (9228)
50 pregnancy complication/ (71410)
51 ((obstetric* or pregnan* or labour or labor or parturition) adj3 (emergenc* or complication*)).ti,ab,kw. (32301)
52 postnatal care/ or newborn care/ (16770)
53 perinatal care/ (13024)
54 maternal care/ or maternal welfare/ (27759)
55 maternal nutrition/ (10080)
56 puerperium/ (37622)
57 ((postnatal or post-natal or perinatal or peri-natal or postpartum or post-partum) adj2 (care or service*)).ti,ab,kw. (7276)
58 breast feeding/ (44726)
59 (breast feed* or breast fed or breastfeed* or breastfed).ti,ab,kw. (45447)
60 early diagnosis/ and (exp infant/ or newborn/) (6264)
61 (early adj1 diagnos* adj2 (infant* or neonat* or newborn*)).ti,ab,kw. (556)
62 diagnosis.fs. and (infant* or neonat* or newborn*).ti,ab,kw. (103847)
63 vertical transmission/ (12794)
64 ((mother-to-child transmi* adj3 (prevent* or eliminat*)) or emtct or pmtct or (vertical adj transmi*)).ti,ab,kw. (9842)
65 (immunization/ or mass immunization/ or vaccination/) and (exp infant/ or newborn/ or exp child/ or adolescent/ or pregnancy/) (51587)
66 ((immuniz* or immunis* or vaccinat*) and (infant* or newborn* or neonat* or child* or adolescen* or teen* or pregnan*)).ti,ab,kw. (65983)
67 child health care/ or early childhood intervention/ or maternal child health care/ (37990)
68 exp nutritional disorder/ and (preschool child/ or exp infant/) (58303)
69 integrated health care system/ (9211)
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70 ((integrat* adj3 (health care or healthcare or management or treat* or service*) adj3 (child* or schoolchild* or infant* or neonat* or
newborn or adolescen* or teen*)) or IMCI or IMNCI).ti,ab,kw. (1093)
71 (protocol compliance/ or health care quality/) and (preschool child/ or exp infant/) (6812)
72 ((((guideline* or protocol*) adj3 (adher* or observ*)) or "prescribed care") and (infant* or newborn* or neonat* or child*)).ti,ab,kw. (1754)
73 infantile diarrhea/di, dm, dt, ep, pc, th [Diagnosis, Disease Management, Drug Therapy, Epidemiology, Prevention, Therapy] (1735)
74 diarrhea/di, dm, dt, ep, pc, th and (exp infant/ or newborn/ or exp child/ or adolescent/ or pregnancy/) (6447)
75 (diarrh* and (infant* or newborn* or neonat* or child* or schoolchild* or adolescen* or teen*)).ti,ab,kw. (33784)
76 hand washing/ or hand disinfection/ (11612)
77 water supply/ (34795)
78 drinking water/ (42849)
79 sanitation/ (13878)
80 (handwash* or hand-wash* or (wash* adj1 hand*) or hand hygiene or hand-hygiene or soap or water suppl* or sanitation or sanitary
or drinking water or potable water).ti,ab,kw. (106006)
81 oral rehydration therapy/ (2412)
82 (oral rehydration adj (solution* or salt* or therapy)).ti,ab,kw. (2252)
83 child development/ or adolescent development/ (45720)
84 ((child* or schoolchild* or adolescen* or teen*) adj2 (develop* or progress*)).ti,ab,kw. (57900)
85 breast cancer/di, dm, dt, pc [Diagnosis, Disease Management, Drug Therapy, Prevention] (95730)
86 breast cancer/ and cancer screening/ (15585)
87 uterine cervix cancer/di, dm, dt, pc [Diagnosis, Disease Management, Drug Therapy, Prevention] (16909)
88 (((breast or cervix or cervical) adj (neoplasm* or cancer*)) and (screen* or diagnos*)).ti,ab,kw. (110687)
89 folic acid/ad, dt [Drug Administration, Drug Therapy] (11586)
90 folic acid deficiency/dm, dt, pc, th [Disease Management, Drug Therapy, Prevention, Therapy] (1174)
91 (folic acid adj (fortif* or supplement* or treat* or therap*)).ti,ab,kw. (4146)
92 sexual education/ (10956)
93 (sex* adj (educat* or "health promot*")).ti,ab,kw. (8934)
94 kangaroo care/ (720)
95 (kangaroo adj2 (mother or infant or care)).ti,ab,kw. (725)
96 (anemia/dt, pc or iron deficiency anemia/dt, pc) and pregnancy/ (1212)
97 ((maternal or mother* or pregnan*) adj2 (nutrition* or folate or folic or iron or anaemi* or anemi*)).ti,ab,kw. (10422)
98 (malaria/di, dm, dt, pc or malaria, falciparum/di, dm, dt, pc or malaria, vivax/di, dm, dt, pc) and (pregnancy/ or pregnancy complication/)
(1493)
99 ((malaria* or falciparum or vivax) adj3 (pregnan* or mother* or maternal or postpartum or post partum)).ti,ab,kw. (2728)
100 smoking cessation/ and (pregnancy/ or adolescent pregnancy/) (1947)
101 (((smoking or smoker* or cigarette or tobacco) adj3 (ceas* or cessation or stop* or discontinu*)) and (pregnan* or maternal or
mother*)).ti,ab,kw. (2318)
102 mental health/ or community mental health/ or mental health service/ (156252)
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103 maternal behavior/ or parental behavior/ or paternal behavior/ (22837)
104 puerperal depression/ (8364)
105 (((mental or behavio*) adj3 (health or disorder*)) or postpartum depression or post-partum depression or postnatal depression or
post-natal depression).ti,ab,kw. (246537)
106 or/1-105 (2439735)
107 mobile phone/ or smartphone/ (16146)
108 mp3 player/ (162)
109 ((cell* or mobile*) adj1 (phone* or telephone* or technolog* or device*)).ti,ab,kw. (16688)
110 (handheld or hand-held).ti,ab,kw. (13317)
111 (smartphone* or smart-phone* or cellphone* or mobiles).ti,ab,kw. (7717)
112 ((personal adj1 digital) or (PDA adj3 (device* or assistant*)) or MP3 player* or MP4 player*).ti,ab,kw. (1692)
113 (samsung or nokia).ti,ab,kw. (1456)
114 (windows adj3 (mobile* or phone*)).ti,ab,kw. (67)
115 android.ti,ab,kw. (2452)
116 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*).ti,ab,kw. (3612)
117 (tablet* adj3 (device* or computer*)).ti,ab,kw. (1571)
118 telemedicine/ or telecardiology/ or teleconsultation/ or teledermatology/ or telediagnosis/ or telemonitoring/ or telepathology/ or
telepsychiatry/ or teleradiotherapy/ or telesurgery/ or teletherapy/ (27986)
119 videoconferencing/ or webcast/ (2824)
120 text messaging/ (2877)
121 telenursing/ (203)
122 (mhealth or m-health or "mobile health" or ehealth or e-health or "electronic health").ti,ab,kw. (19595)
123 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or tele-nursing or telepsychiatry or
tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-
coach*).ti,ab,kw. (17704)
124 (videoconferenc* or video-conferenc* or webcast* or web-cast*).ti,ab,kw. (3335)
125 (((text* or short or voice or multimedia or multi-media or electronic or instant) adj1 messag*) or instant messenger).ti,ab,kw. (4491)
126 (texting or texted or texter* or ((sms or mms) adj (service* or messag*)) or interactive voice response* or IVR or voice call* or callback*
or voice over internet or VOIP).ti,ab,kw. (3560)
127 (Facebook or Twitter or Whatsapp* or Skyp* or YouTube or "You Tube" or Google Hangout*).ti,ab,kw. (5883)
128 mobile application/ (4502)
129 "mobile app*".ti,ab,kw. (2078)
130 social media/ (9110)
131 (social adj (media or network*)).ti,ab,kw. (20813)
132 reminder system/ (2143)
133 (remind* adj3 (text* or system* or messag*)).ti,ab,kw. (1962)
134 e-mail/ (15606)
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135 (electronic mail* or email* or e-mail or webmail).ti,ab,kw. (23089)
136 medical informatics/ (17801)
137 nursing informatics/ (1286)




142 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-log*).ti,ab,kw. (9103)
143 teaching/ (85381)
144 ((interactive or computer-assisted) adj1 (tutor* or technolog* or learn* or instruct* or soIware or communication)).ti,ab,kw. (3142)
145 or/107-144 (260905)
146 106 and 145 (29013)
147 crossover procedure/ (53072)
148 double blind procedure/ (143697)
149 randomized controlled trial/ (465243)
150 single-blind procedure/ (28784)
151 random$.tw. (1234071)
152 factorial$.tw. (31351)
153 (crossover$ or cross over$ or cross-over$).tw. (90817)
154 placebo$.tw. (263675)
155 (doubl$ adj blind$).tw. (184763)





161 146 and 160 (4486)
162 limit 161 to yr="2010 -Current" (3567)
163 limit 162 to embase (1725)
Appendix 4. POPLINE search strategy
All Fields: ((cell OR cellular OR mobile) AND (phone OR phones OR telephone OR telephones OR technology OR technologies OR device OR
devices)) OR smartphone OR smartphones OR smart-phone OR smart-phones OR cellphone OR cellphones OR mobiles OR mhealth OR m-
health OR "mobile health" OR ehealth OR e-health OR "electronic health" OR telemedicine OR tele-medicine OR telehealth OR tele-health
OR telecare OR tele-care OR telenursing OR tele-nursing OR telepsychiatry OR tele-psychiatry OR telemonitor OR telemonitoring OR tele-
monitor OR tele-monitoring OR teleconsult OR teleconsulting OR tele-consult OR tele-consulting OR telecounsel OR telecounseling OR tele-
counsel OR tele-counseling OR telecoach OR telecoaching OR tele-coach OR tele-coaching OR videoconference OR videoconferences OR
videoconferencing OR video-conference OR video-conferences OR video-conferencing OR webcast OR webcasts OR webcasting OR web-
cast OR web-casts OR web-casting OR ((text OR texts OR texting OR short OR voice OR multimedia OR multi-media OR electronic OR instant)
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AND (message OR messages OR messaging)) OR "instant messenger" OR texting OR texted OR texter OR texters OR ((sms OR mms) AND
(service OR services OR message OR messages OR messaging)) OR "interactive voice response" OR "interactive voice responses" OR ivr
OR "voice call" OR "voice calls" OR callback OR "voice over internet" OR voip OR "mobile app" OR "mobile apps" OR "mobile application"
OR "mobile applications" OR "social media" OR ((medical OR clinical OR health OR healthcare OR nurse OR nurses OR nursing) AND
informatics) OR Keyword: × TEXT MESSAGING OR × MOBILE DEVICES OR × INFORMATION COMMUNICATION TECHNOLOGY OR × CELLULAR
PHONE
AND
All Fields: (randomised OR randomized OR "randomly allocated" OR "random allocation" OR "controlled trial" OR "control group" OR
"control groups" OR trial) OR
Keyword: × QUANTITATIVE RESEARCH OR × QUANTITATIVE EVALUATION OR
× RESEARCH METHODOLOGY OR × CLINICAL TRIALS OR × CONTROL GROUPS - 1006 hits
Appendix 5. WHO Global Health Library search strategy
(tw:(((cell* OR mobile*) AND (phone* OR telephone* OR technolog* OR device*)) OR smartphone* OR smart-phone* OR cellphone* OR
mobiles OR mhealth OR m-health OR "mobile health" OR ehealth OR e-health OR "electronic health" OR telemedicine OR tele-medicine OR
telehealth OR tele-health OR telecare OR tele-care OR telenursing OR tele-nursing OR telepsychiatry OR tele-psychiatry OR telemonitor*
OR tele-monitor* OR teleconsult* OR tele-consult* OR telecounsel* OR tele-counsel* OR telecoach* OR tele-coach* OR videoconferenc* OR
video-conferenc* OR webcast* OR web-cast* OR ((text* OR short OR voice OR multimedia OR multi-media OR electronic OR instant) AND
messag*) OR "instant messenger" OR texting OR texted OR texter* OR ((sms OR mms) AND (service* OR messag*)) OR "interactive voice
response*" OR ivr OR "voice call*" OR callback* OR "voice over internet" OR voip OR "mobile app*" OR (social AND (media OR network*))
OR ((medical OR clinical OR health OR healthcare OR nurs*) AND informatics) )) OR (mh:("Telemedicine" OR "Cell Phones" OR "Internet"
OR "Mobile Applications" OR "Medical Informatics" OR "Information Technology" OR "Smartphone")) AND (mh:("Controlled Clinical Trials,
Randomized" OR "Controlled Clinical Trials as Topic" OR "Controlled Clinical Trial" OR "Clinical Trial")) OR (tw:(randomised OR randomized
OR "randomly allocated" OR "random allocation" OR "controlled trial" OR "control group" OR "control groups" OR trial)) – 1121 hits
Appendix 6. WHO ICTRP search strategy
Search 1:
Title: reproductive health OR maternal health OR child health OR adolescent health OR immunization OR immunisation OR pregnancy
AND
Intervention: mobile device OR mobiles OR smartphone OR phone OR cellphone
Result: 80 hits
Search 2:
Title: mobile device OR mobiles OR smartphone OR phone OR cellphone
AND
Intervention: reproductive health OR maternal health OR child health OR adolescent health
Result: 22 hits
Search 3:
Intervention: sexually transmitted OR HIV OR nutrition OR mental health OR family planning OR contraception OR abortion OR prenatal
OR postnatal
AND
Title: mobile device OR mobiles OR smartphone OR phone OR cellphone
Result: 240 hits
Search 4:
Title: mobile device OR mobiles OR smartphone OR phone OR cellphone
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AND




Title: sexual behavior OR sexual behaviour OR sexual health OR safe sex OR unsafe sex OR sex education OR breastfeeding OR integrated
delivery
AND
Intervention: mobile device OR mobiles OR smartphone OR phone OR cellphone
Result: 41 hits
Search 6:
Title: mobile device OR mobiles OR smartphone OR phone OR cellphone
AND
Intervention: sexual behavior OR sexual behaviour OR sexual health OR safe sex OR unsafe sex OR sex education OR breastfeeding OR
integrated delivery
Result: 90 hits
Amalgamated Results (duplicates removed): 492 hits
Appendix 7. ClinicalTrials.gov search strategy
Search 1: ("reproductive health" OR "maternal health" OR "child health" OR "adolescent health" OR immunization OR immunisation OR
pregnancy) AND ("mobile phone" OR "mobile phones" OR "mobile devices" OR mobiles OR smartphone OR smartphones) | Child, Adult |
Studies received on or aIer 01/01/2000 | Studies updated on or before 08/31/2017 – 275 hits
Search 2: ("sexually transmitted" OR HIV OR nutrition OR "mental health" OR "family planning" OR contraception OR abortion OR prenatal
OR postnatal) AND ("mobile phone" OR "mobile phones" OR "mobile devices" OR mobiles OR smartphone OR smartphones ) | Child, Adult
| Studies received on or aIer 01/01/2000 | Studies updated on or before 08/31/2017– 481 hits
Search 3: ("sexual behavior" OR "sexual behaviour" OR "sexual health" OR "safe sex" OR "unsafe sex" OR "sex education" OR breastfeeding
OR "integrated delivery") AND ("mobile phone" OR "mobile phones" OR "mobile devices" OR mobiles OR smartphone OR smartphones) |
Child, Adult | Studies received on or aIer 01/01/2000 | Studies updated on or before 08/31/2017 – 180 hits
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
In the protocol, we specified that the 'Summary of findings' tables for pregnant and postpartum populations would include the
following outcomes: maternal morbidity and mortality combined; neonatal morbidity and mortality combined; initiation of breastfeeding;
attendance for antenatal care; birth in a health facility; and unintended consequences (Palmer 2018a). In conducting the review, we decided
to include any measure of breastfeeding, instead of only including initiation of breastfeeding, and any measure of access to intrapartum
care, thereby including births in a health facility and births occurring with a skilled attendant present.
We had planned that when a study reported the same outcome measure for multiple time points of follow-up, we would extract data from
all time points. However, in the review, we extracted data for the outcome at the longest follow-up point.
For the purpose of pooling data, we planned to categorise lengths of follow-up as follows: short-term follow-up: three months or less;
moderate-term follow-up: three to 12 months; long-term follow-up: greater than 12 months. However, given the limited number of studies
with the same aim, comparison, and outcome measure that could we pooled, we decided to pool across diQerent lengths of follow-up.
We planned to carry out the following subgroup analyses for the objective outcomes of health status: income region (by World Bank income
group) (World Bank 2017); and delivery mechanisms (i.e. mobile phone messaging only, mobile applications only, combined mobile phone
messaging and applications, combined application, and other). However, there were an insuQicient number of studies reporting the same
objective health status outcomes to conduct these subgroup analyses.
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We planned to carry out the following sensitivity analyses: only including studies with low risk of bias on the sequence generation,
allocation concealment, and incomplete outcome data domains; and only including studies with objectively measured outcomes. However,
there were insuQicient studies to conduct the second specified sensitivity analyses.
As part of the risk of bias assessments of included studies, we also reported an assessment of 'Other bias'. Under this domain, we
considered other potential sources of bias such as the presence of baseline imbalances related to the outcome under study, and evidence
of contamination.
In the protocol, we stated we would not pool studies with substantial heterogeneity in meta-analyses. However, some of the pooled
analyses do exhibit substantial statistical heterogeneity. We intended to explore possible reasons for variability by conducting our
prespecified subgroup analysis; however, there was an insuQicient number of studies in the pooled analyses to conduct meaningful
subgroup analyses. Where we noted other potential explanations for high heterogeneity (e.g. diQering baseline level of risk), and there
were a suQicient number of studies, subgroup analyses were conducted to examine these.
N O T E S
The protocol for this review is based on standard text and guidance provided by Cochrane Consumers and Communication (Ryan 2016).
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